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Zusammenfassung
Wiederholtes messen desselben Patienten impliziert, dass die erhobenen Beobachtungen nicht
unabha¨ngig sind, da diese von denselben patientenspezifischen Eigenschaften beeinflusst wer-
den. Ein generalisiertes lineares gemischtes Modell (GLMM) beru¨cksichtigt diese Abha¨ngig-
keiten, indem patientenspezifische Modellparameter eingefu¨hrt werden, die als zufa¨llige Ef-
fekte bezeichnet werden. Die Struktur der Abha¨ngigkeiten in den Daten kann Formen anneh-
men, die verschieden sind von der, welche durch wiederholtes beobachten derselben Patien-
ten auftritt. Es kann eine zeitliche, ra¨umliche oder zeit-ra¨umliche Abha¨ngigkeit, im zugrunde
liegenden Prozess, vorhanden sein. Auch ein Netzwerk aus verschiedenen Einheiten, die ver-
bunden sind und wiederholt beobachtet werden, kann den Einschluss von zufa¨lligen Effekten
in einem GLMM motivieren.
Ein GLMM scha¨tzt, bei gegebener Struktur der zufa¨lligen Effekte, den bedingten Erwartungs-
wert der interessierenden Parameter, die als fixe Effekte bezeichnet werden. Die Likelihood In-
ferenz bestimmt die bedingten Scha¨tzwerte durch numerische Integration u¨ber die zufa¨lligen
Effekte, da dieses Problem generell nicht analytisch lo¨sbar ist. Die numerische Integration
kann rechnerisch schwer lo¨sbar sein, je nach Komplexita¨t der Struktur der zufa¨lligen Effekte
und der verfu¨gbaren Daten.
Ein Bayesianischer Inferenz Ansatz bildet die Struktur der zufa¨lligen Effekt, unter Einschluss
von Priori-Verteilungen fu¨r diese Parameter, ab. Der Einschluss von Priori-Verteilungen ist
flexibel und kann die unterschiedliche, verfu¨gbare Information auf verschiedenen Ebenen des
Modells abbilden. Bayesianische Inferenz wird u¨blicherweise mit einer Markov chain Monte
Carlo (MCMC) Simulation durchgefu¨hrt, die eine grosse Rechenleistung verlangt. Falls der
Struktur der zufa¨lligen Effekte ausschliesslich Gaussche Priori-Verteilungen zugewiesen wer-
den, nur eine zusa¨tzliche Ebene von Hyperparametern und eine beschra¨nkte Ordnung der
Abha¨ngigkeiten zwischen den Einheiten angenommen wird – so dass ein Gaussches Markov
Zufallsfeld resultiert – kann die Methode der integrated nested Laplace approximations (INLA)
als Alternative zu MCMC verwendet werden. INLA verlangt weniger Rechenleistung, was
insbesondere fu¨r komplexe Modelle ein Vorteil ist.
Diese Dissertation untersucht beide Inferenz Methoden fu¨r GLMMs, diskutiert damit ver-
bundene rechen-technische Aspekte und erla¨utert diese anhand mehrerer epidemiologischen
Anwendungen. Als Erstes wird die Likelihood Inferenz fu¨r ein linear gemischtes Modell, ba-
sierend auf longitudinale Daten aus der Schweizerischen HIV Kohortenstudie durchgefu¨hrt.
Das Modell untersucht, ob vorherig beobachtete Lymphozyt-Subtypen relevante Pra¨diktoren
fu¨r den Krankheitsverlauf von unbehandelten und behandelten HIV infizierte Patienten sind.
Im darauf folgenden Teil wird diskutiert wie die spezielle Situation, bei welcher patienten-
spezifische longitudinale Profile keine Variation in der Ausgangsgro¨sse haben, die Likelihood
und Bayesianische Inferenz mit INLA beeinflussen. Wir zeigen, dass mit einem zunehmenden
Anteil an Patienten, welche keine Variation in der Ausgangsgro¨sse haben, die Maximum like-
lihood (ML) Scha¨tzung der Parameter, in einem Modell mit einer bina¨ren Ausgangsgro¨sse,
numerische Probleme verursacht. Weiterhin zeigen wir, dass in einem solchen Fall INLA
Scha¨tzungen generiert, die weder mit ML noch mit MCMC Scha¨tzungen u¨bereinstimmen. Im
dritten Teil diskutieren wir wie die besondere Abha¨ngigkeitsstruktur einer Netzwerk Meta-
Analyse, unter Beru¨cksichtigung der versuchsspezifischen Heterogenita¨t und mo¨glicher In-
konsistenzen im Netzwerk, mit INLA implementiert wird. Der letzte Teil der Dissertation
untersucht die Verwendung von informativen Priori-Verteilungen, welche adaptive Gewich-
te verwenden, die anhand der beobachteten Daten bestimmt werden. U¨blicherweise werden
nicht informative und unkorrelierte Priori-Verteilung fu¨r die fixen Effekte in einem GLMM
angenommen. In manchen Situationen kann diese Annahme zu unrealistischen Parameter
Scha¨tzungen fu¨hren. Adaptives gewichten der Priori-Verteilungen, basierend auf den beob-
achteten Daten und unter Einschluss von Korrelationen, kann dazu dienen dieses Problem zu
beheben.

Abstract
Repeatedly observing the same patient implies that these samples will not be independent,
as they are affected by the same common patient-specific characteristics. A generalized linear
mixed model (GLMM) takes this dependency structure into account by introducing patient-
specific model parameters which are called random effects. The dependency structure in the
collected data could have various forms, though other than the one which arises from repeat-
edly observing patients in a study population. A temporal, spatial or even spatio-temporal
pattern may be present in the underlying sampling process. Or a network of different clusters
which are connected and repeatedly observed may motivate the inclusion of random effects
in a GLMM.
Given the random effect structure, a GLMM investigates the conditional expectation for the
parameters of interest, which are called fixed effects. In likelihood inference, the conditional
estimates are determined by numerically integrating over the random effects, as in general
this problem is not analytically solvable. The numerical integration may be computationally
difficult to solve, depending on the complexity of the random effect structure and the data at
hand.
A Bayesian inference approach maps the random effect structure by including prior distri-
butions for these parameters. The inclusion of prior distributions is flexible and may reflect
different stages of information at different levels of the model. Bayesian inference is commonly
carried out using computationally intensive Markov chain Monte Carlo (MCMC) sampling. If
exclusively Gaussian priors are assigned to the random effect structure, with only one addi-
tional level of hyperparameters and a limited order of dependencies between clusters – such
that a Gaussian Markov random field results – one can apply integrated nested Laplace ap-
proximations (INLA). INLA is an alternative to MCMC and requires less computational effort,
which especially for complex models is an huge advantage.
This thesis investigates both inference approaches for GLMMs, discusses related computa-
tional issues and illustrates these with several epidemiological applications. First, likelihood
inference is carried out for a model based on longitudinal data from the Swiss HIV cohort
study. This model investigates if past lymphocyte subtypes are relevant predictors for the dis-
ease progression among untreated and treated HIV infected patients. In the second part we
discuss how the special situation, in which patient-specific longitudinal profiles show no vari-
ation in the response, influences the likelihood and Bayesian inference with INLA. We show
that, with an increasing proportion of patients who have no variation in the response, nu-
merical issues arise in the Maximum likelihood (ML) estimation of a binary response GLMM.
Furthermore, we show that in this case INLA produces estimates that are inconsistent with
ML or MCMC inference. In the third part we discuss how the particular dependency structure
of a network meta-analysis is implemented with INLA, taking into account trial specific het-
erogeneity and possible network inconsistencies. The last part of the thesis examines the use
of informative priors which use adaptive weights that are based on the observed data. Usually
the prior distributions for the fixed effects in a GLMM are assumed to be uninformative and
uncorrelated. In some situations this assumption may lead to unrealistic parameter estimates.
An adaptively weighted informative prior distribution may help to resolve this problem.
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Introduction
Statistical models describe deterministic and stochastic components of a data generating pro-
cess by using as few parameters as necessary. In most applications model parameters map an
underlying structure related to the problem. Some information about this structure may be
known and thus may serve to adequately incorporate dependencies between model parame-
ters. Repeatedly observing the same entities (e. g. patients), or collecting several observations
under different environments (e. g. hospitals), will inherently induce possible dependencies
within these entities or circumstances, which differ from the ones between entities. Taking
into account and parameterizing such entity-specific dependencies is necessary, such that the
observations can be considered to be conditionally independent, given the entity-specific pa-
rameters. This conditional independence implies the exchangeability of the observed entities
which is crucial if one considers to carry out inference for the model parameters.
The recognition and formalisation of the statistical analysis for such repeated and dependent
observations dates back to more than one hundred years. Models developed during these days
and for a long time thereafter were limited in their applications. Progress in the development
of statistical methods but also the increasing availability of computers and more and more
computing power lead to the dissemination of such models for repeated measurements. A
long history of developing methods suited for particular applications, such as non-normal
distributed outcomes and trials with unequally observed or unbalanced data, finally lead to
the comprehensive generalized linear mixed model (GLMM) framework: a regression model
class for outcomes with a distribution from the exponential family and with different types of
entity-specific effects.
The generic concept of GLMMs allows to address a broad set of different applications: the
dependency structure may come from independent entities, from a spatial, temporal, or com-
bined spatio-temporal pattern, or may describe dependencies in any other connected graph.
Longitudinal data for epidemiological studies are one of the most prominent examples, but
also a meta-analysis which describes repeated observations of the same treatment comparison
may make use of GLMMs. The success of GLMMs during the last years was supported by
an increasing number of sophisticated, ready to use software. However, implemented algo-
rithms sometimes put limitations on the distribution or the dependencies between and within
different entities. Such limitations are mainly driven by the complexity of the problem, e. g.
numerical integration. Computing issues arise in Bayesian as well as in likelihood based infer-
ence for GLMMs. The strength of one inference approach may be the others weakness. Either
way it is important to recognize similarities and limitations in both practices.
This chapter introduces GLMMs, including likelihood and Bayesian inference and is struc-
tured in the following way: Section 1 starts with a short historical outline of the origins
and the milestones in the development of the GLMM framework. Subsequently the model as-
sumptions and data structure for GLMMs will be introduced and extensions as well as related
model classes will be discussed shortly. In Section 2 the focus is on likelihood inference, fol-
lowed by a introduction of the Bayesian inference approach to GLMMs in Section 3. Sections
2 and 3 will be complemented with a short discussion of limitations and by a description of
available software for each inference approach.
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1 Generalized linear mixed models
1.1 The origins
According to Scheffe´ (1956) the idea of including different error terms for observations col-
lected under different circumstances was probably first formally noted by Airy (1861, Part IV),
a British astronomer. He was interested in collecting several observations of the same phe-
nomena with a telescope at several nights. It was this setup which lead him to introduce in
his model a special variance component for each night, reflecting the specific but varying cir-
cumstances, e. g. in the atmosphere or the personal condition, encountered during each night.
With this work he described the foundations of a linear mixed model, preceding the work by
Fisher (1918, 1925) who laid out the same problem in a more formal way in the context of the
analysis of variance (ANOVA).
The univariate repeated measures ANOVA is a precursor of the linear mixed model (LMM)
which is applicable to outcomes with a normal distribution. In an ANOVA, covariates must
be discrete factors, observations must be balanced, the covariance structure among repeated
measures is restricted and variances assumed to be constant. The regression approach of
LMMs relaxes these assumptions and allows for unbalanced and unequally spaced data, such
that the number of observations per entity need not be the same and time periods between
subsequent observations can vary. The inclusion of continuous covariates and more general
correlation structures for the variance within an entity is also possible with a LMM. Con-
tributions which were relevant in establishing LMMs also came from the interest to analyse
growth curves, for which individual-specific random effects were introduced and regression
coefficients were allowed to vary across individuals (Wishart, 1938; Rao, 1958). The basic prin-
ciples for LMMs were established early and fundamental work has been successively added
e. g. by Harville (1976, 1977). It took some time until the application of LMMs to longitudinal
data was discussed by Laird and Ware (1982).
Naturally, also models with random effects for discrete outcomes were of interest and there are
several contributions, e. g. for binary data (Ashford and Sowden, 1970; Cox, 1972). In parallel
Nelder and Wedderburn (1972) and McCullagh and Nelder (1989) established the generalized
linear model (GLM), a framework for regression models with outcomes from any distribution
that is part of the exponential family. The combination of the LMM and of GLMs lead to the
extension of the model framework for repeated measures. The two methodological strains
were formally embraced by the GLMM definition, described and illustrated with a broad
variety of applications by Breslow and Clayton (1993). A GLMM is a regression model for
an outcome from the exponential distribution family which takes dependencies for repeated
observations from the same entities into account by introducing random effects. The term
GLMM appears to be introduced already by Gilmour et al. (1985). Ideas for applying Bayesian
inference to GLMMs evolved in parallel and were discussed by Karim and Zeger (1992).
The mixed effects model approach must be distinguished from a second model framework,
which is also concerned about dependencies arising from repeated measures. This other
model class, known under the term marginal model, describes the population mean. This is
in contrast to mixed models, also called random effects models, which investigate the entity-
specific mean, conditional on the entity-specific parameters. In contrast to mixed models,
marginal models do not specify the full distribution but only make assumptions for the first
two moments. The estimation of marginal models with generalized estimating equations
(GEE) was proposed by Liang and Zeger (1986) and is a generalization of the quasi-likelihood
approach by Wedderburn (1974). An overview of the development of GLMMs with a focus
on longitudinal data can be found in Fitzmaurice, M., Verbeke and Molenberghs (2008).
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1.2 Model and data structure
A good introduction to GLMMs can be found in Fahrmeir et al. (2013, Chapter 7). The outcome
of interest yij is repeatedly observed for entities i = 1, . . . , m at occasions j = 1, . . . , ni. The
number of observation per entity ni does not have to be equal, thus a GLMM can handle
unbalanced designs and the total number of observations is N = ∑mi=1 ni. The distribution of
yij comes from the exponential family such that the GLM framework (McCullagh and Nelder,
1989) can be applied. In a GLMM the conditional expectation E(yij | xij, zij,bi) is linked to a
linear predictor ηij with a monotone link function h(·)−1
h−1{E(yij | xij, zij,bi)} = ηij = x>ij β+ z>ij bi (1)
where xij is a vector of covariates of length p, including an intercept and β a vector of the same
length with the parameters of interest, also called fixed effects. Usually zij is a sub-vector of
xij of length q < p and bi is a vector with entity-specific parameters, or random effects, of
length q. In a random intercept model q is equal to one and zij = 1. The linear predictor in
Equation (1) includes one level of random effects bi. Of course one could imagine that there
exist several different or nested levels of entities for which random effects could be required
to correctly reflect dependencies. For the sake of keeping the notation simple we here restrict
the model to one level of random effects only. Possible extensions are discussed in Section 1.3.
Aggregating the data at each entity-specific level illustrates how the design matrices must be
organised. All observations of one cluster i are contained in the vector yi = (yi1, . . . , yij, . . . , yini)
>
of length ni. Then the linear predictor for cluster i is
ηi = Xiβ+ Zibi (2)
where now
Xi =

x>i1
...
x>ij
...
x>ini
, Zi =

z>i1
...
z>ij
...
z>ini

and Xi is a fixed effects design matrix of dimension ni × p and Zi a random effects design
matrix of dimension ni × q. Aggregating the data to the next level, across all entities, results
in a vector with all observations y = (y1, . . . , yi, . . . , ym)> of length N, such that the linear
predictor is
η = Xβ+ Zb.
The fixed effects design matrix X of dimension N× p and the random effects design matrix Z
of dimension N × qm are defined as
X =

X>1
...
X>i
...
X>m
, Z =

Z1 0
. . .
Zi
. . .
0 Zm

and each cluster i has q random effects, such that the vector b has length qm.
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The GLMM is complemented by the assumption that the entity-specific random effects b1, . . . ,bm
are independent and follow the same multivariate normal distribution
bi ∼ N(0,D),
where D is a q × q covariance matrix. The zero expectation of bi implies that random ef-
fects are symmetric deviations from the respective population mean, which is an element of
Xβ. As random effects between entities are uncorrelated, it follows that b ∼ N(0,G) and
G = diag(D1, . . . ,Dm), which is a positive definite and block-diagonal covariance matrix of
dimension qm× qm.
The following two examples give an impression on how diverse the observed data structure
for repeatedly observed entities can be.
Longitudinal data
A specific disease in a study population is often observed repeatedly at several occasions for
the same patients. Such longitudinal data has two sources of possible dependencies: one is
from repeatedly observing the same patient, the other from possible temporal dependencies
for pairs of observations from the same patient i. e. serial correlation.
Based on the notation introduced above, i would be a subscript identifying one among m
different patients that was observed at occasion j. The observations are ordered by the times tij
at which they took place, which defines a sequence (ti1, . . . , tij, . . . , tini). Usually the temporal
ordering is considered to imply a causal relationship as described by Diggle (2002, Chapter
12). If besides a random intercept one also assumes a serial correlation between observations,
then the linear predictor in Equation (2) is supplemented by an additional term such that
ηi = Xiβ+ Zibi +Wi(tij), (3)
where Wi(tij) are independent realizations from a stationary Gaussian process with mean
zero, variance ν2 and correlation function ρ( | tij − tik | ) (see Chapter 5 in Diggle, 2002). The
correlation function captures the serial correlation of the stochastic process. This functional
relationship can be defined as e. g. an exponentially decaying correlation function or an au-
toregressive process for discrete, equally spaced observations.
The observed outcomes for the longitudinal observations may follow a normal distribution,
which requests a LMM, such as for the square root transformed CD4 lymphocyte counts in
HIV-1 infected patients presented in Paper I. The outcome may also be from any other dis-
tribution of the exponential family, which implies a GLMM, such as the Bernoulli distributed
data for the probability of having a toenail infection presented in Paper II. The analysis of lon-
gitudinal data with GLMMs is well described in Diggle (2002), by Verbeke and Molenberghs
(2000) for LMMs or in Molenberghs and Verbeke (2005) for discrete outcomes.
Network meta-analysis
Evidence for a relative effect of two treatments is usually collected in a series of independent
trials. Such a comparison may be extended to a set of different treatments or interventions,
which forms a network of treatment comparisons, as discussed in Paper III. A GLMM for
such a network meta-analysis usually introduces random effects for comparisons between
two treatments, if they were repeatedly observed in different trials. This is motivated by the
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assumption of possible heterogeneity in the circumstances, e. g. the different study populations
which were used in the trials. The trials i = 1, . . . , m investigate the same relative treatment
effect j among the set of different treatments 1, . . . , T. The outcome of the GLMM may be
the log odds ratio for the relative treatment comparison, which follows a normal distribution
(Lumley, 2002). Alternatively, the outcome may also be the number of observed events among
all study participants for each trial, which implies a binomial distributed outcome and the
relative treatment effect is included as a model parameter (Lu and Ades, 2006).
1.3 Related model classes and extensions
Sometimes it is difficult to find a suitable functional relationship between an observed metric
covariate uij and the outcome yij. An extension of the linear predictor with a flexible function
f (uij) may be adequate. Possible smooth, non-linear functions for L different metric covariates
uij1, . . . , uijL can be used as additive terms to extend the linear predictor in Equation (2) to
ηi = Xiβ+ Zibi + f1(ui1) + . . . + fl(uil) . . . + fL(uiL). (4)
In Equation (3) a similar extension was anticipated by introducing the term Wi(tij) to cap-
ture serial correlation between observations. However, the function may also describe a
smooth, non-parametric relationship which leads to a generalized additive mixed model
(GAMM) (Ruppert et al., 2003, 2009). Generalized additive models (GAM) without entity-
specific random effects but with a linear predictor which combines the component Xβ with
non-parametric functional relationships are discussed by Hastie and Tibshirani (1990). The
functional term fl(uil) could also describe a spatial effect for location variables uil , which
leads to a geo-additive model. Fahrmeir et al. (2004) coin the term structural-additive regres-
sion (STAR) for describing a model class which extends the GAMM framework. They relax
the additive form of the functional relationships and allow also for non-linear interactions
between two metric covariates f (uil , uik) and for functions which have varying effects depend-
ing on components of X. In this generic STAR setup the functional relationships can describe
entity-specific random effects, a spatial, temporal or combined spatio-temporal structure but
also any other form of non-linear dependency which is added to the linear predictor.
The functions f (uil) usually depend on a continuous or discrete criterion, such as the distance
between two locations or two points in time. For discrete observations in time e. g. a random
walk can serve as smooth function. In general one can define Markov random fields to in-
troduce conditional dependencies of some order for neighbouring entities, e. g. for different
regions in space (Rue and Held, 2005). Rue et al. (2009) use the term latent Gaussian model to
define a subgroup of STAR models which uses a Gaussian prior for the components β,bi and
on each function f (uil). The Gaussian distribution assumption for the model components is
particularly attractive to use in combination with Gaussian Markov random fields (GMRF), as
the sparsity of the implied structure has attractive computational properties as described by
Rue and Held (2005, Chapter 2).
Here it is appropriate to draw a line to hierarchical models. Hierarchical, or multilevel mod-
els are motivated from a Bayesian perspective as discussed by e. g. Gelman et al. (2014). The
hierarchical approach distinguishes different levels of observational units for which informa-
tion is available. The units or entities on each level in a hierarchical model are exchangeable
and each level is described by different model parameters. Hierarchical models can be seen
as a broader approach which includes GLMMs as special case, sometimes under the term
hierarchical linear models (Gelman et al., 2014, Chapter 5) or hierarchical regression models
(Blangiardo and Cameletti, 2015, Chapter 5). Also latent Gaussian fields (Rue et al., 2009),
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sometimes called hierarchical GMRFs (Rue and Held, 2005, Chapter 4) fit into the context of
hierarchical modelling. Hierarchical GMRFs use the following constitutive elements: on the
first level a distribution assumption from the exponential family for observations yij is deter-
mined. The second level assumes a multivariate Gaussian prior distribution for the model
components β,bi and for all functions f (uil) in the form of a GMRF. The parameters, which
define the covariance structure of the GMRF, build the third level in the model hierarchy. A
prior distribution is assigned again to each of these hyperparameters.
2 Likelihood inference
A compact description of likelihood inference for GLMMs can be found in Fahrmeir and Tutz
(2001, Chapter 7) or Fahrmeir et al. (2013, Chapter 7). In a GLMM we assume that the outcome
yi is conditionally independent, such that we can write the conditional density for an entity i
as
f (yi |β,bi) =
ni
∏
j=1
f (yij |β,bi)
where here f (·) is a density or probability mass function from the exponential family. The
marginal density f (yi) can be determined by integrating over the random effects in the con-
ditional density
f (yi) =
∫
f (yi |β,b) f (bi |D(δ))dbi
such that the marginal likelihood for all m entities is defined as
L(β,b, δ) =
m
∏
i=1
∫ ni
∏
j=1
f (yij |β,bi) f (bi |D(δ))dbi (5)
where δ are unknown hyperparameters which determine the distribution of the random ef-
fects covariance matrix D(δ).
2.1 Linear mixed models
For a LMM there exists an analytical solution of the integral contained in Equation (5), which
results in the marginal distribution y ∼ N(Xβ,V(δ)), where V(δ) = σ2IN + ZG(δ)Z>. The
residual variance is σ2 and IN is the identity matrix of dimension N. The corresponding
distribution for the conditional distribution of the LMM outcome is y | b ∼ N(Xβ+Zb, σ2IN).
For LMMs with unknown random effects covariance structure the inference problem is still
challenging: one needs to find estimates for β,bi and δ. Maximising the LMM likelihood for
β with a fixed δ gives the estimate
β˜(δ) = (X>V(δ)−1X)−1X>V(δ)−1y
which can be derived as best linear unbiased estimator (BLUE) (Harville, 1977). If δ is known,
then the estimates for the random effects
b˜ = G(δ)Z>V(δ)−1(y− Xβ˜)
are estimated best linear unbiased predictors (EBLUP) (Harville, 1976). However, if δ is un-
known one can now use a profile likelihood by plugging in β˜(δ) to determine an estimate for
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δ, or one could use the marginal likelihood, integrating over β∫
L(β,b, δ)dβ (6)
to determine the estimates for the hyperparameters δ with a Fisher-scoring algorithm. The
marginal likelihood in Equation (6) can be embedded into the restricted maximum likelihood
(REML) approach for linear models. The REML estimation corrects the bias of the Maximum
likelihood (ML) covariance parameter estimates (Diggle, 2002, Chapter 4.5). For LMMs the ML
estimator based on the profile likelihood ignores the loss of degrees of freedom for estimating
the fixed effects, thus is biased and so in general the REML approach should be preferred.
2.2 Generalized linear mixed models
In contrast to LMMs there is no analytical solution for the integral in Equation (5) for GLMMs.
A GLMM requires a numerical integration over the q-dimensional vector bi in the marginal
likelihood. There exist different approaches to solve this task. One could apply a Laplace ap-
proximation (see Held and Sabane´s Bove´, 2014, Appendix C). Laplace’s method approximates
the integral
∫
f (x)dx =
∫
exp(log f (x))dx by applying a Taylor series expansion around x?,
which is the mode x? = argmaxx log f (x). This implies that the first derivative at x = x
? is
zero and
log f (x) ≈ log f (x?) + (x− x
?)2
2
∂2 log f (x)
∂x2
∣∣∣∣
x=x?
which results in an approximation of the integral with a Gaussian kernel∫
f (x)dx ≈ f (x?)
∫
exp
{
− (x− x
?)2
2σ?2
}
dx
where σ?
2
is equal to the inverse, negative second derivative for x evaluated at x?.
Alternatively one can also approximate the marginal likelihood in Equation (5) with a Gauss-
Hermite approximation (see Fitzmaurice et al., 2008, Chapter 4). Instead of using b it is
useful to use a Cholesky decomposition of the random effects covariance D(δ), such that
bi = D(δ)1/2b?i , and an independent standard normal distribution for b
?
i ∼ N(0, I) results.
For each random effect b?ik, among q random effects for entity i, the one dimensional integral
can be approximated by
∫ ni
∏
j=1
f (yij | b?i ) f (b?ik)db?ik ≈
R
∑
r=1
wr
ni
∏
j=1
f (yij | ar,b?i,−k)
where b?i,−k is a vector with all standardized random effects for entity i, except the kth one and
wr, ar are the weights and locations of the Gauss-Hermite quadrature rule of degree (2R− 1)
(Stroud and Secrest, 1966). The quadrature points and weights can also be defined adaptively
(Pinheiro and Bates, 1995), such that they depend on the cluster-specific mean and variance,
which results in an improved approximation (Lesaffre and Spiessens, 2001; Rabe-Hesketh et
al., 2002). Increasing the number of quadrature points increases the accuracy of the approx-
imation. With a single quadrature point the Gauss-Hermite approximation is equal to the
Laplace approximation. There exists no general applicable rule in how one should determine
the number of quadrature points, but robust estimates with respect to a changing number of
quadrature points is certainly desirable.
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Stiratelli et al. (1984) proposed to use a penalized quasi-likelihood approach (PQL) for GLMMs.
Breslow and Clayton (1993) motivate the PQL estimation for GLMMs with a Laplace approx-
imation to the marginal likelihood. They state that the likelihood
L(β,b; δ) = f (y | b,β) f (b |D(δ))
can be rewritten as penalized log-likelihood of the form
l(β,b, δ) = l(β,b)− 1
2
b>G(δ)−1b (7)
where l(β,b) = ∑mi=1 ∑
ni
j=1 f (yij |β,b) is the log-likelihood of the implied GLM, and the pe-
nalization term −b>G(δ)−1b follows from the normal distribution assumption for f (b). The
PQL approach uses some starting values for β, b and δ and computes working responses
which are used to solve the score functions of the penalized likelihood for β,b. In a second
step the estimates for δ are found by numerically solving the restricted likelihood with Fisher
scoring by using the estimates β and b from the first step. The two steps are iteratively re-
peated until the required convergence criteria are met. The score functions are the same as
for the LMM but with different weights. Thus this iteratively reweighted least squares (IRLS)
algorithm can also be applied to LMMs to improve estimates of δ. Estimation with PQL
can yield a substantial bias, especially for binary responses with few observations per patient.
Therefore there were efforts in adapting the penalization criterion to establish a bias correction
by Breslow and Lin (1995) and Lin and Breslow (1996) which was even taken further by using
Laplace approximations based on a Taylor series expansion of higher order by Raudenbush et
al. (2000).
The second common estimation algorithm for GLMMs also involves two steps: first the es-
timates for b are determined by a penalized iteratively reweigthed least squares (P-IRLS)
algorithm (Bates and DebRoy, 2004) with β, b and δ fixed at some starting values. The pe-
nalized least squares criterion is optimized by iteratively updating estimates for b and then
reweighting the working responses until convergence. In the second step the marginal like-
lihood is approximated with a Laplace or Gauss-Hermite approximation, given the estimates
b from the first step, which is then maximized for β and δ. Both steps are repeated until
convergence of the deviance −2l(β,b, δ) is reached.
In general, ML inference for GLMMs will neglect any uncertainty coming from the estimation
of the random effects b. Furthermore, the penalization term in Equation (7) is proportional
to G(δ)−1 which reflects the inverse of the random effect variance. If G(δ) → ∞ then the
penalization term goes to zero, such that b will not be treated differently than the fixed effects
β. The penalization also increases for increasing deviations from E(b) = 0. The penalization
term has an influence on the estimates for bi, which are shrunk more towards the overall
mean Xβ with increasing entity-specific random effect variance D(δ). Also fewer numbers
per entity ni result in stronger shrinkage for the corresponding bi. For LMMs the EBLUP can
be shown to be a weighted average between the population averaged mean response profile
and the entity-specific response profile and the weight depends on the relation between the
entity-specific within variance σ2Ini and the overall variance V(δ) (Fitzmaurice et al., 2004,
Chapter 8.6).
In contrast to that, the extreme case of D(δ) = 0, which means that e. g. for a GLMM with
binary outcome the observations for a specific entity have always the same value, the penal-
ization term goes to infinity such that the ML estimate for bi will not be defined any more.
The problem of non existent ML estimators in a GLM for such a setting is commonly de-
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scribed as complete separation, because one covariate perfectly predicts the outcome, or as
quasi-complete separation if the covariate predicts a subset of the outcome (Albert and An-
derson, 1984). Firth (1993) suggested a penalized likelihood approach to solve this problem
for GLMs. However, for GLMMs the complete separation problem may also be present for
the entity-specific effects bi. Depending on the proportion of clusters which have no varia-
tion, this cluster-specific quasi-complete separation may cause numerical instabilities in the
marginal likelihood approximation.
2.3 Software
Nowadays there exist several software packages for likelihood inference in GLMMs. The
following overview is restricted to software packages in R (R Core Team, 2015), although other
statistical software has similar routines implemented, like PROC NLMIXED in SAS or xtmelogit
for logistic GLMMs in Stata. For R the most commonly used packages are nlme (Pinheiro
et al., 2015) which is for LMMs only, its extension to GLMMs with the function glmmPQL
in the package MASS (Venables and Ripley, 2002) and the package lme4 (Bates et al., 2014).
There are several differences between the packages: the estimation algorithm, the covariance
structure for the random effects and whether they can include serial correlation. The software
packages differ also with respect to the combination of multiple random effects they allow for,
especially whether crossed random effects (i. e. each second level is observed within each first
level random effect) and whether nested random effects (i. e. each second level random effect
varies within each first level random effect) are possible.
Package: nlme MASS lme4
Model: LMM GLMM GLMM
Function name: lme glmmPQL glmer
Algorithm: IRLS PQL-IRLS P-IRLS
Marginal likelihood: Laplace Laplace Gauss-Hermite or Laplace
Random effects: nested only nested only nested and crossed
Covariance D(δ): generic generic diagonal or unstructured
Table 1.: Comparison of common R software packages for likelihood inference in GLMMs.
An overview for the comparison of these criteria is given in Table 1. Serial correlation models
are only available for nlme and glmmPQL. The within-correlation can be generically defined
by the user or a predefined correlation structure, such as an exponential correlation, can
be used. In lme4 the random effects covariance is assumed to be unstructured or diagonal
i. e. uncorrelated, and has no possibility for serial correlation. Each package involves an IRLS
algorithm with Fisher scoring based on similar numerical optimization routines. Nevertheless,
the algorithms differ between packages: nlme updates the estimates for δ to increase the
accuracy, glmmPQL applies the PQL algorithm and lme4 uses the P-IRLS algorithm. For the
Gauss-Hermite approximation the number of quadrature points in lme4 is hard-coded to
a maximum of 25 since version 1.0-0. Only a Laplace approximation is available in lme4
since version 1.0-0 for non-scalar random effects (q > 1), e. g. for a random intercept plus
random slope model, or for two different random effect levels. Results with different software
packages may differ substantially, although they implement the same estimation algorithm as
discussed by Zhang et al. (2011).
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3 Bayesian inference
Model parameters are treated as unknown random quantities in a Bayesian inference ap-
proach. This is in contrast to likelihood inference where model parameters are assumed to be
true, fixed quantities. The basis for Bayesian inference is Bayes’ theorem or Bayes’ rule, which
states how the conditional probability of an event can be reformulated as probability of the
condition, given the event. The theorem is named after Reverend Thomas Bayes, whose work
on probabilities of a binomial distribution was posthumously published in 1763. Bayes’ rule
for probabilities can be applied to f (·), a density function or probability mass function. It
states that the so called posterior probability distribution of the unknown parameters θ given
the observed data y is
f (θ | y) = f (y | θ) f (θ)
f (y)
, (8)
where f (y) =
∫
f (y | θ) f (θ)dθ is the marginal distribution function and in the case of discrete
values for θ is obtained by f (y) = ∑θ f (y | θ) f (θ). The marginal likelihood in the denomi-
nator in Equation (8) serves as normalizing constant which is independent of θ such that one
can write
f (θ | y) ∝ f (y | θ) f (θ). (9)
The distribution of the parameters f (θ) is called prior distribution and f (y | θ) is the sampling
distribution, which in likelihood inference, under the assumption of θ being fixed quantities,
is just the likelihood L(θ) = f (y | θ). Equation (9) states that the posterior distribution is
proportional to the likelihood times the prior distribution. It also shows that if the prior
distribution f (θ) is flat, i. e. uninformative, then the likelihood is just multiplied by a constant
such that the posterior mode will coincide with the ML estimate. It also gets clear from
Equation (9) that the influence of the prior relative to the likelihood decreases with increasing
sample size. Adding observations will increase the product, or on the log-scale the sum,
involved in the likelihood term f (y | θ) and thus increase its relative weight, compared to
the prior. The posterior distribution f (θ | y) is the fundament for inference about θ. If one
is interested in a particular model parameter θk then one examines the marginal posterior
distribution
f (θk | y) =
∫
f (y | θ) f (θ)dθ−k (10)
where θ−k are all but the kth model parameter in θ. The marginal posterior can be used
to obtain interval estimates, or point estimates for θk. This can e. g. be the posterior mean
E(θk | y) =
∫
θk f (θk | y)dθk, the posterior mode Mode(θk | y) = arg maxθk f (θk | y) or a credible
interval [tl , tu] with credible level CIψ =
∫ tu
tl
f (θk | y)dθk. The lower and upper bound are equal
to the quantiles tl = (1− ψ)/2 and tu = (1 + ψ)/2 such that θk is within this interval with
probability ψ. An introduction to Bayesian inference is given by Held and Sabane´s Bove´ (2014,
Chapter 6).
3.1 Posterior distributions for generalized linear mixed models
As mentioned in Section 1.2, the GLMM can be expressed as Bayesian hierarchical model.
A Gaussian prior is assigned to the model parameters θ = (β,b)>, with b ∼ N(0,D(δ)).
The distribution of the random effects is the same as in likelihood inference in Section 2. A
Gaussian prior for the fixed effects β ∼ N(0,Σβ) is usually chosen such that the covariance
matrix Σβ is diagonal with very large and equal entries for each corresponding component of
β such that essentially an uninformative prior results. The third layer in the hierarchical model
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assigns a prior distribution to the hyperparameters of the latent Gaussian field θ, which are
the parameters δ that define the random effects covariance matrix and which will be included
as additional factor in the computation of the posterior distribution. The model parameters
θ define a latent Gaussian field, for which the elements are conditionally independent, given
the entity-specific stochastic dependence structure, such that a GMRF with a sparse precision
matrix Q(δ) results (Rue and Held, 2005, Chapter 4). The posterior distribution for the GLMM
model parameters and hyperparameters, given the data y is
f (θ, δ | y) ∝ f (δ) f (θ | δ)
I
∏
i=1
f (yi | θ, δ)
∝ f (δ) |Q(δ) | 12 exp
{
−1
2
θ>Q(δ)θ+
I
∑
i=1
log f (yi | θ, δ)
}
as discussed by Fong et al. (2010) who review the GLMM applications presented by Breslow
and Clayton (1993) in the context of Bayesian inference for hierarchical latent Gaussian models.
The marginal posterior distribution for a GLMM of the kth model parameter θk is then
f (θk | y) =
∫
δ
∫
θ−k
f (θ, δ | y)dθ−k dδ
=
∫
δ
f (θk | δ, y) f (δ | y)dδ
(11)
and for the kth component of the hyperparameters the marginal posterior distribution is
f (δk | y) =
∫
δ−k
f (δ | y)dδ−k (12)
where θ−k and δ−k are vectors with all components in the corresponding parameter vector
except the kth one.
The possibilities to apply Bayesian inference used to be limited, as the integrals in Equation
(10), or respectively in (11) and (12) and the summary statistics based on these marginal pos-
terior distributions were only analytically solvable for selected problems. This was e. g. the
case if likelihood and posterior were conjugate, i. e. posterior and prior belong to the same
distribution family. From a Bayesian point of view Equation (5) in Section 2 for LMMs is
in accordance with the desirable setting of having a conjugate prior distribution, namely a
normal distribution for the likelihood and for the random effects, which results in an analyt-
ically solvable problem with a normal posterior distribution. The development of computers
opened up the possibility of numerical integration. Coming along with the increase and avail-
ability of computing power, Bayesian inference experienced a boom during the nineties of the
last century (Robert and Casella, 2011), using Markov chain Monte Carlo (MCMC) sampling.
In the meantime also other strategies for evaluating integrals as in Equation (10) were estab-
lished, such as the integrated nested Laplace approximations (INLA) (Rue et al., 2009). Both
methods, MCMC and INLA, are shortly introduced in the following two sections.
3.2 Markov chain Monte Carlo sampling
An introduction to numerical methods for Bayesian inference is provided by Held and Sa-
bane´s Bove´ (2014, Chapter 8). Robert and Casella (2011) give a short account about the roots
and developments of modern MCMC techniques used in statistics. Numerical Monte Carlo
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(MC) integration with computers was explored at the Los Alamos research center during the
Second World War. An MC integration approximates e. g. the mean of the posterior f (θ | y),
where θ is a scalar parameter. MC integration generates L independent random samples
θ(1), . . . , θ(l), . . . θ(L) from the posterior distribution and computes the mean as
E(θ | y) =
∫
θ f (θ | y)dθ ≈ 1
L
L
∑
l=1
θ(l)
which converges to the true value E(θ | y) for L → ∞. Similarly, one can construct estimates
by using MC integration for other summary statistics based on the posterior distribution.
Obtaining independent samples from the posterior distribution is difficult if there are many
unknown model parameters θ. Sampling from the distribution of a high-dimensional vector
θ may result in large and persistent correlations between samples. A solution to this prob-
lem is to simulate a Markov chain θ(1), . . . ,θ(l) . . . ,θ(L), which generates samples θ(l) that
depend only on the previous sample θ(l−1) and which converges to the posterior distribution
f (θ | y). Given that the Markov chain converged to the posterior distribution one can again
apply MC integration to obtain the summary statistics of interest. The combination of the
two eponymous procedures defines MCMC sampling. The Metropolis Hastings algorithm
(Metropolis et al., 1953; Hastings, 1970) describes how a Markov chain can be generated such
that it converges to the posterior distribution. Starting with some values for model parameter
θk a proposal θ?k is defined by drawing randomly from the proposal density f
?
(
θ?k | θk,θ−k
)
which depends only on the current value θ(l) of the simulated Markov chain. The parameter
is updated to θ(l+1)k = θ
?
k with acceptance probability α equal to
α = min
1, f
(
θ?k | θ−k, y
)
f
(
θ
(l)
k | θ−k, y
) f ?
(
θ
(l)
k | θ?k ,θ−k
)
f ?
(
θ?k | θ(l)k ,θ−k
)

and otherwise θ(l+1)k = θ
(l)
k . Each model parameter θk in θ can be updated, conditional on all
other current model parameters θ−k with some proposal density f ?(·) and the MH algorithm
will converge to the posterior distribution if L is large enough.
The Gibbs sampler, introduced by Geman and Geman (1984) and later discussed by Gelfand
and Smith (1990), modifies the MH algorithm by setting f ?
(
θ?k | θ(l)k ,θ(l)−k
)
= f
(
θ?k | θ−k, y
)
i. e. the proposal density is equal to the target posterior density. The Gibbs algorithm thus
samples component-wise from the full conditionals of every model parameter θk and has an
acceptance probability equal to one. Instead of component-wise updating every θk one can
use block-updating schemes (Rue and Held, 2005, section 4.1.2), which is preferable if model
parameters are highly correlated, which is discussed by Gamerman (1997) in the context of
GLMMs. The hypothesis that the generated Markov chain converged to a stationary posterior
distribution must be examined for every model parameter by e. g. visual inspection of the
trace plots, examination of the autocorrelation function of the samples or checking different
convergence diagnostics (Cowles and Carlin, 1996).
3.3 Integrated nested Laplace approximations
An alternative to MCMC sampling was proposed by Rue et al. (2009) and is called integrated
nested Laplace approximations (INLA) which is an approximate Bayesian approach. An in-
troduction to INLA is provided by Blangiardo and Cameletti (2015, in Chapter 4). INLA
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approximates the marginal posterior distribution f (θk | y, δ) for a Bayesian hierarchical model
with a latent Gaussian field that follows a GMRF and which has relatively few, say less than
six, hyperparameters according to Rue et al. (2009).
The first task is to approximate the joint distribution of all hyperparameters f (δ | y), which
appear in Equation (11) and from which the marginals in Equation (12) can be derived. The
distribution of the hyperparameters is approximated by
f (δ | y) = f (θ, δ | y)
f (θ | δ, y) ∝
f (y | θ, δ) f (θ | δ) f (δ)
f (θ | δ, y) ≈
f (y | θ, δ) f (θ | δ) f (δ)
f˜G(θ | δ, y)
∣∣∣∣
θ=θ?(δ)
= f˜ (δ | y)
(13)
where f˜G(θ | δ, y) is a Gaussian approximation to the full conditional of θ evaluated at the
mode θ?(δ) for a given δ. The approximation f˜ (δ | y) corresponds to the Laplace approxima-
tion to marginal posteriors discussed by Tierney and Kadane (1986). The proportionality in
(13) is with respect to the normalizing constant f (y) in the posterior distribution f (θ, δ | y).
The approximation to the second term in Equation (11) can be done with three different
methods, with different levels of accuracy. The first, simplest and least accurate approach is
to use f˜G(θ | δ, y) and derive a normal distribution to approximate each marginal distribution
f˜G(θk | δ, y) using the mean of the Gaussian approximation and the marginal variance. As
there may be errors due to shifts in location or due to skewness (Rue and Martino, 2007),
a second Laplace approximation to the marginal f (θk | δ, y) by the approach of Tierney and
Kadane (1986) results in a higher accuracy.
This full Laplace approximation is obtained by
f (θk | δ, y) = f (θk,θ−k | δ, y)f (θ−k | θk, δ, y) =
f (θ, δ | y)
f (δ | y)
1
f (θ−k | θk, δ, y)
∝
f (θ, δ, y)
f (θ−k | θk, δ, y) ≈
f (θ, δ, y)
f˜G(θ−k | θk, δ, y)
∣∣∣∣
θ−k=θ?−k(θk ,δ)
= f˜ (θk | δ, y)
(14)
where f˜G(θ−k | θk, δ, y) is a Gaussian approximation to the full conditional f (θ−k | θk, δ, y) eval-
uated at the mode θ?−k of the full conditional for a given θ−k and given δ. The approximation
f˜G(θ−k | θk, δ, y) requires a high computational effort as it needs to be evaluated for each en-
tity in the GMRF and for each δ. Thus Rue et al. (2009) suggest two simplifications. First,
they propose to use conditional densities derived from the already computed approximation
f˜G(θ | δ, y) from Equation (13) to approximate the mode θ?−k(θk, δ). Secondly, they restrict
the influence of θ−k on the approximation for θk, as the dependence between two entities in
the GMRF is assumed to decay with increasing distance. With these two simplifications the
Laplace approximation f˜ (θk | δ, y) corresponds to the Gaussian approximation multiplied by
a term which is equivalent to a cubic spline for each entity-specific parameter θk.
The accuracy and computational costs of the third approximation, called simplified Laplace
approximation, is between the simple Gaussian and the more precise full Laplace approxima-
tion. The simplified Laplace approximation applies a Taylor series expansion up to the third
order to the nominator f (θ, δ, y) and to the denominator f˜G(θ−k | θk, δ, y) in Equation (14)
around the mean for entity k which is derived from f˜G(θ | δ, y). This adds a correction term to
the Gaussian approximation for location and skewness and reduces the computational costs
to approximate f˜ (θk | δ, y), compared to the full Laplace approximation which involves the
cubic spline term for every entity-specific model parameter θk.
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For INLA both terms, f˜ (δ | y) and f˜ (θk | δ, y), are used to numerically integrate over different
integration points δu and different weights ∆u
f˜ (θk | y) ≈∑
u
f˜ (θk | δu, y) f˜ (δu | y)∆u (15)
to get the approximated marginal posterior distribution f˜ (θk | y). The choice of the points δu
and the weights ∆u is discussed in more detail in Section 3.5.
INLA was demonstrated to deliver accurate approximations of the marginal posterior distri-
butions coming with reduced computational costs compared to MCMC. See Rue et al. (2009)
for examples or Schro¨dle et al. (2011) for applications to spatio-temporal models. Lindgren et
al. (2011) illustrate the numerical advantages of sparse matrices implied by GMRFs for large
geostatistical models which are solved fast and accurately by INLA. For the applicability of
INLA to GLMMs see Rue et al. (Section 5.2 2009) and Fong et al. (2010).
3.4 Choice of prior distribution
Selecting a prior distribution for f (θ) and disclose its influence on the posterior distribution
is one of the most disputed elements in Bayesian inference. Gaining new knowledge about
θ based on the inclusion of prior beliefs may come with the flavour of being subjective, i. e.
biased and was criticised beyond the field of statistics (Popper, 1959). On the other hand,
Bayes’ theorem offers a rationale on how historical data, which was observed and perhaps
should not be ignored, could be taken into account and how to evaluate it in the context of
new evidence. Historical data from similar previous studies may be available, which is rather
common for clinical trials and could serve as prior information, also by introducing a prior
weight on the historical data directly, like suggested by Ibrahim and Chen (2000).
Depending on the choice of the prior distribution, one may establish links between Bayesian
inference and a ML approach. For instance, a Bayesian interpretation of the REML in LMMs
is discussed by Harville (1974). One could choose a non-informative, flat prior which is
proportional to a constant on the fixed effects f (β) ∝ c and as well for the hyperpameters
f (δ) ∝ c. The mode of the joint posterior distribution with respect to δ is in this case equivalent
to the ML estimate of the hyperparameters. In contrast, the mode of the the marginal posterior
distribution with respect to δ is equivalent to the REML estimate of δ, which is also mentioned
in Section 2.1.
Instead of assigning a prior distribution on the hyperparameters one could assume unknown
and fixed values for δ. An estimate for δ could be obtained by maximizing the marginal
likelihood, which results in the REML estimate for δ. Using this REML estimate of the hy-
perpameters to analyse the posterior mean of β and b results in the same EBLUP estimates
for β and b as in Section 2.1. This approach, without assigning a prior distribution to δ, is
called empirical Bayes. Also for GLMMs the posterior modes, based on Bayesian inference
with empirical Bayes, correspond to the ML estimates.
A fully Bayesian approach, in contrast to empirical Bayes, assigns a prior distribution to all
parameters θ and additionally to the hyperparameters δ. The choice of a non-informative,
improper prior for δ, which does not integrate to unity, does not guarantee in general that
the posterior distribution will be proper. This holds also especially for Jeffreys’ prior, which
is invariant to a reparametrisation. Usually one resorts to choose a weakly informative prior
instead. In the case of one single random effect, say a random intercept, only a single hyper-
parameter δ = σ2RI results, which is the random intercept variance. An inverse gamma prior
σ2RI ∼ IG(α1, α2) is conjugate (Held and Sabane´s Bove´, 2014, Chapter 6.3.3) to the normal dis-
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tribution of b, meaning that f (σ2RI | b) again belongs to an inverse gamma distribution. One
could of course choose the parameters α1 and α2, such that the prior is only weakly informa-
tive. The extension of this conjugate prior to the case where q > 1, e. g. a random intercept
plus slope model, with a q× q random effects covariance matrix, leads to an inverse Wishart
distribution (Held and Sabane´s Bove´, 2014) for D(δ). Fong et al. (2010) motivate the choice of
an informative prior in GLMMs for such an inverse gamma or inverse Wishart distribution.
However, the inverse gamma prior on random effect variances like σ2RI was found by Roos
and Held (2011) to result in a large sensitivity for the parameter estimates. As an alternative,
they propose to use a half-normal prior distribution on the standard deviation, which is also
suggested by Gelman (2006). Gelman et al. (2008) discusses how to assess a weakly informative
default prior in the context of hierarchical models.
On the other hand, there may occur situations, such as sparse data, for which an explicit
informative prior on β may be favourable (Greenland, 2006). The choice of an informative
prior for δ affects the amount of shrinkage for the estimates of bi. In Section 2 the estimates
were asserted to be shrunk towards the population averaged mean response profile. As the
posterior is obtained by multiplying likelihood and prior distribution, the location and the
amount of shrinkage for bi can directly be influenced by choosing the moments for the prior
distribution which is assigned to δ. The problem of (quasi) complete separation, mentioned
in Section 2, may be put into the context of a sparse data problem (Firth, 1993). In the case
of a binary covariate in a binomial GLM, where the ML estimates are not defined, complete
separation arises if the off diagonal entries of the corresponding 2× 2 contingency table are
zero. According to Firth (1993) this can be addressed by a penalized likelihood, for which
the penalization term depends on the inverse Fisher information and is related to Jeffreys’
invariant prior. For a logistic regression with a completely separating binary covariate this
approach corresponds to adding 1/2 to each cell of the 2× 2 table. A penalization term is in
this situation related to a Bayesian approach which assigns an informative prior distribution,
based on which the implied shrinkage may help to solve the problem of a non-existent ML
estimate in a consistent way.
Similarly, according to Greenland (2006, 2007a,b, 2009) the use of proper, informative priors
may help e. g. in epidemiological studies with few data, to avoid possibly unrealistic assump-
tions of a likelihood inference approach. For the fixed effects in a Bayesian hierarchical re-
gression, the normal prior β ∼ N(0,Σβ), is usually chosen such that Σβ is diagonal with
large values for the corresponding variances. An informative prior would motivate smaller
variances for some components of β and possibly also deviate form the mean zero location
parameter. In Paper IV such informative priors are proposed for GLMs as well as for GLMMs,
which is in line with the motivation by Greenland (2006). Furthermore, in Paper IV also the
diagonal structure for Σβ is relaxed and a prior weight, based on the observed correlations
in the data, is used for β. These adaptive prior weights are perfectly treatable with the INLA
approach and were implemented by using the r-inla software. Motivating an informative
prior or using default or reference priors will not circumvent the indispensable questions
about the impact of the prior and the sensitivity of the estimates with respect to alternative
prior specifications. Investigating prior sensitivity becomes attractive with computationally
less intensive methods such as INLA (Roos and Held, 2011; Roos et al., 2015), compared to the
prohibitive computational costs inflicted by MCMC. Any disagreement between the observed
data and the chosen prior, which implies a relatively strong influence of the prior on the pos-
terior estimates, can be disclosed by e. g. Box’s-p value (Box, 1980), which is also discussed in
Paper IV.
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3.5 Software
There also exist several software packages for Bayesian inference in GLMMs. In the follow-
ing, a short overview is given for generic MCMC samplers and the r-inla package, which
implements the INLA approach discussed in Section 3.3.
MCMC
After the potential of MCMC sampling for Bayesian inference was recognized it did not last
long until efforts for a common computer language which implements generic Gibbs samplers
and which allows for a broad set of different applications, were initiated (Gilks et al., 1994).
This resulted in the BUGS (Bayesian Inference Using Gibbs Sampling) project (Lunn et al.,
2009), which defined a program language for generic MCMC samplers like Win-BUGS and
Open-BUGS (Lunn et al., 2000), JAGS (Plummer, 2003). They all have a common syntax to set
up Bayesian hierarchical models. These generic MCMC samplers can be used for hierarchical
models with several layers of parameter levels and are not restricted to latent Gaussian fields.
There are several interfaces, like the R package R2jags or coda among others, which provide
access to the flexible R environment and a collection of specific functions to analyse MCMC
sampling results. Another common software package in R is MCMCglmm (Hadfield, 2010) which
is a MCMC sampler for multivariate GLMMs, uses a similar syntax as the package nlme and
allows for correlated random effects. Yet another software package, called STAN Gelman et
al. (2014); Stan Development Team (2014), uses a distinct modelling language and different
methods for MCMC sampling. Most of these MCMC samplers implement a Gibbs sampler,
or a general Metropolis Hastings algorithm. Nevertheless, there may be crucial differences in
the implemented algorithms, for example if it comes to block updating, where e. g. JAGS uses
the algorithm proposed by Holmes and Held (2006).
INLA
The R package r-inla (Rue et al., 2014), which is available on http://www.r-inla.org, is
essentially an interface to the standalone package INLA which in turn calls the GMRFLib library
(Rue and Held, 2005) which is written in C and Fortran. The r-inla package defines models
with a similar syntax like the established glm regression model framework in R and offers the
possibility to process results by the flexible facilities of the R environment.
Gaussian approximations to the marginal posterior (Tierney and Kadane, 1986) are obtained
in r-inla by a Fisher scoring algorithm based on numerical optimization routines. The ap-
proximation to the joint posterior of the hyperparameters f (δ | θ, y) involves three steps: first
the mode is searched by a quasi-Newton method involving differences between gradients.
The second step evaluates the curvature at the mode to get the Fisher information matrix
and for which an Eigen decomposition is computed. Based on the standardized, orthogonal
components the approximated posterior f˜ (δ | y) is explored. The points δu in Equation (15)
at which f˜ (δ | y) is explored can be determined by two different strategies: the first places a
grid of ’interesting’ points around the mode in each direction of the standardized variables
with a certain step-length, as long as the difference in the log-densities does not exceed a stop-
ping criterion. The second integration strategy, the central composite design (CCD) (Rue et
al., 2009, Section 6.5), explores the posterior density with less points, thus is less accurate and
requires less computational effort. This second integration strategy exploits the curvature in
the Fisher information matrix to determine a sphere around the mode, at which the evaluation
points are chosen. The corresponding weights ∆u in Equation (15) are determined depending
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on the selected integration strategy. The grid integration uses equal weights and determines
the new points depending on δu, which are the points that were already explored. The CCD
integration adapts ∆u depending on the radius of the computed sphere.
In the r-inla package there are control parameters to set the step-length for the gradient
calculations in finding the mode, the step-length for finding the points on the standardized
scale at which f˜ (δ | y) is explored and the difference in the log-densities if the grid integration
strategy is chosen. Each marginal posterior f˜ (δk | y) is obtained by interpolating between the
points at which the joint posterior f˜ (δ | y) was already explored.
The r-inla package provides a set of implemented likelihood functions for f (y | θ, δ) which fit
into the GLM framework. A collection of GMRFs, such as a random walk, an autoregressive
or an independent model but also models for spatial dependencies or a generic GMRF for
which a user-specified covariance matrix can be provided, are implemented in r-inla. A
combination of these implemented latent fields, as denoted by the additive functional terms
in Equation (4), is possible. Each functional term, or GMRF, can have weights and the point
in the different latent fields may be correlated. A simple example for such a model is a
random intercept and random slope model for longitudinal data: both random effects define
a functional component for each entity and both random effects are correlated within each
entity where the random slope use the time covariate as weight. For the hyperparameters
f (δ) there is also a collection of ready to use priors implemented, but a user-specified prior of
suitable form for each hyperparameter can be passed as argument in the form of a tabulated
vector. It is possible to evaluate also linear combinations of the marginal posteriors, although
they must be defined in advance. Furthermore it is possible to use a model with multivariate
response in r-inla, as for example discussed by Paul et al. (2010), which just requires that the
response matrix and the covariates are organized in an adequate form. The software allows
for the use of different likelihoods in the case of a multivariate response model, as discussed
by Martino et al. (2011) who use two likelihoods for a joint model for longitudinal and survival
data, or illustrated by Muff et al. (2015) in the context of a measurement error model. Another
feature of r-inla is that one can relax the assumption that every entity-specific response yi is
related to one single entity in the latent field. A correlation in the latent field across different
entities is possible, as discussed Riebler et al. (2012) who correlate the multivariate response of
different countries in an age-period-cohort model. An overview about these special features
in r-inla is given by Martins et al. (2013).
INLA is an approximate Bayesian inference approach and comes with a certain analytically
not assessable error (see the discussion in Rue et al., 2009). MCMC sampling requires the user
to assess if the stationary distribution was reached for the obtained samples. Additionally,
MCMC sampling also comes with a sampling error, as the convergence property only holds
asymptotically. The key advantage of INLA compared to MCMC sampling, which for a long
enough Markov chain converges to the true distribution, is its comparably low computational
cost, which especially plays out in complex models. The broad model class of latent Gaussian
fields together with the r-inla software package makes it possible to set up various kinds of
different models by using distributions from the exponential family for the outcome, setting
up own priors for the hyperparameters and offering a range of features, such as the correlation
across entities in the latent Gaussian field, or by allowing for multiple likelihoods, which
makes r-inla attractive for a diverse set of applications.
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Thesis Summary
This thesis consists of four papers. The four projects evolved at different paces during the
last three years. They all have in common that they deal with GLMMs and in all papers
the discussed statistical methods are illustrated with epidemiological applications. Paper I
uses likelihood inference for a longitudinal data analysis with an LMM. The second, Paper II,
discusses the inaccuracy encountered with INLA in the special case of cluster-specific quasi-
complete separation in a binary response GLMM. Paper III discusses the application of INLA
to a special form of GLMM, namely in the context of a network meta-analysis. Paper IV intro-
duces adaptive prior weights for the fixed effects in a GLMM, which are possibly correlated.
The content of each paper is briefly summarised below.
Paper I
CD8 counts and CD4/CD8 ratio independently predict CD4 response in drug naive and
in patients on cART Rafael Sauter, Ruizhu Huang, Bruno Ledergerber, Manuel Battegay,
Enos Bernasconi, Matthias Cavassini, Hansjakob Furrer, Matthias Hoffmann, Mathieu Rouge-
mont, Huldrych F. Gu¨nthard, Leonhard Held & the Swiss HIV cohort study.
This paper analyses if the CD8 lymphocyte subtype is a predictor for the HIV disease progres-
sion which is measured by CD4 lymphocyte cell counts. The paper analyses this hypothesis
based on longitudinal data from the Swiss HIV cohort study with a LMM and uses likelihood
inference methods. Other studies investigated extensively the relationship between CD4 lym-
phocyte cell counts and the viral load, measured as number of RNA copies per blood volume.
However, there seems to be a lack of knowledge about the relationship between CD4 and CD8
lymphocyte subtypes among HIV-1 infected patients.
The research question was proposed by Prof. Huldrych Gu¨nthardt from the University Hos-
pital, Zurich and was financially supported by the SHCS research council. A large part of
the data preparation and initial inference was part of the master thesis by Rhuizu Huang
and was supervised by Leonhard Held and myself. The final analyses and the writing of the
manuscript were done by myself. Leonhard Held, Bruno Ledergerber, Huldrych Gu¨nthardt
and Ruizhu Huang reviewed the manuscript at several stages and contributed to improve it.
The remaining co-authors read and contributed comments to the final version of the paper.
The main contribution of this paper is the new insight about the dependencies between CD4
and CD8 lymphocyte subtypes among HIV-1 infected patients based on the SHCS data.
Paper II
Quasi-complete Separation in Random Effects of Binary Response Mixed Models: Integrated
Nested Laplace Approximations vs. MCMC by Rafael Sauter, Leonhard Held.
This paper compares the results for GLMMs with a binary response outcome obtained by
INLA to the results based on MCMC sampling and ML estimation. Initially the intention was
to examine the possibility to use a correlated random effect structure, as proposed by Riebler
et al. (2012), for longitudinal data. Based on the toenail data example, which repeatedly
served as example for methodological discussions (Lesaffre and Spiessens, 2001; Verbeke and
Molenberghs, 2013), I found that INLA can not reproduce the results obtained by MCMC nor
by ML estimation.
The relatively large inaccuracy of INLA in the case of binary responses was already mentioned
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by Rue et al. (2009). Fong et al. (2010) documented in a simulation study for binary response
GLMMs the degree of the error for INLA, which was found to be acceptable by Grilli et al.
(2014) if an informative prior is chosen. The particular problem in the toenail dataset goes
back to a patient-specific quasi complete separation for the random effect parameters, as there
is a large proportion of patients who always stay in the same response state. This paper
illustrates, based on the toenail example and a simulation study, that INLA may be rather
inaccurate depending on the degree of quasi-complete separation in the data, exceeding the
degree of the error reported earlier (Fong et al., 2010; Grilli et al., 2014). I did the computations
and wrote the manuscript, which was read and amended by Leonhard Held at several stages.
Paper III
Network meta-analysis with integrated nested Laplace approximations by Rafael Sauter,
Leonhard Held.
This paper illustrates that it is possible to carry out network-meta analyses (NMA) as dis-
cussed by Lumley (2002) and by Lu and Ades (2006) with INLA, taking into account possible
heterogeneity between trials and inconsistencies in the network through random effects. Also
the node splitting approach suggested by Dias et al. (2010) is carried out with INLA. The
idea to carry out a NMA with INLA goes back to Prof. Martin Schumacher of the University
of Freiburg. I implemented several examples for different NMAs and the node-splitting ap-
proach in INLA and discussed the special features one needs to address, such that the NMAs
fit the requirements by INLA. The manuscript was written by myself and Leonhard Held,
who also contributed to the work by regularly discussing intermediate results and providing
various suggestions for improvements. The main contribution of this paper is that it illus-
trates that NMA and especially node-splitting is possible with INLA, which allows to apply
this method to large networks which were found to be computationally too involved to be
addressed by MCMC sampling (Veroniki et al., 2013).
Paper IV
Adaptive prior weighting in generalized linear models by Leonhard Held, Rafael Sauter.
This paper investigates possible prior-data conflicts in a regression model based on Box p-
value and suggests to use adaptive prior weights, by including the information of the observed
data. The prior weights can be introduced for the joint prior distribution of the regression
coefficients, for independent coefficients or for specified blocks. The method is implemented
in INLA and it is illustrated how to use adaptive prior weights for GLM’s and how to extend
this to GLMMs.
This paper addresses the use of informative priors in a situation of sparse data. Informative
priors avoid unrealistic estimates as discussed by Greenland (2006, 2007a,b, 2009). The infor-
mative priors are constructed by using adaptive weights based on the collected observations
and possible prior-data conflicts are discussed.
Leonhard Held had the idea to examine adaptive prior weighting in this context and he
wrote the manuscript to which I contributed comments. I implemented the applications in
INLA with the inspiration of code for a related analysis Held et al. (2012), written and kindly
provided by Daniel Sabane´s Bove´. I wrote the supplementary material to the paper, which
was reviewed by Leonhard Held.
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Background: Plasma HIV viral load is related to declining CD4 lymphocytes. The extent to
which CD8 cells, in addition to RNA viral load, predict the depletion of CD4 cells is not well
characterized so far. We examine if CD8 cell counts is a prognostic factor for CD4 cell counts
during an HIV infection.
Methods: A longitudinal analysis is conducted using data from the Swiss HIV cohort study col-
lected between January 2000 and October 2014. Linear mixed regression models were applied to
observations from HIV-1 infected treatment naive patients (NAIVE) and cART treated patients
to predict the short-term evolution of CD4 cell counts. For each subgroup it was quantified to
which extent CD8 cell counts or CD4/CD8 ratios are prognostic factors for disease progression.
Results: In both subgroups, 2’500 NAIVE and 8’902 cART patients, past CD4 cells are pos-
itively (p<0.0001) and past viral load is negatively (p<0.0001) associated with the outcome.
Including additionally past CD8 cell counts improves the fit significantly (p<0.0001) and in-
creases the marginal explained variation 31.7% to 40.7% for the NAIVE and from 44.1% to
50.7% for the cART group. The past CD4/CD8 ratio (instead of the past CD8 level) is pos-
∗Corresponding author: rafael.sauter@uzh.ch
1Members of the Swiss HIV Cohort Study Group are provided in the Acknowledgments.
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itively associated with the outcome, increasing the explained variation further to 41.8% for
NAIVE and 51.9% for cART.
Conclusions: CD8 lymphocytes contain essential information on HIV-1 disease progression.
Incorporating CD4/CD8 ratio in combination with CD4 counts is more informative among
NAIVE as well as for cART patients, compared to the use of the level of both lymphocyte sub-
types.
1. Introduction
An untreated HIV-1 infection is characterized by declining CD4 target cells which
is associated with the viral load level. Over time, viral load levels in general tend to in-
crease and CD4 levels continue to decline with subsequent cellular immunodeficiency
leading to AIDS and ultimately death [1, 2]. Successful antiretroviral treatment (ART)
results in sustained suppression of HIV-1 plasma RNA levels below the detection limit
of currently available assays. Today’s combined antiretroviral therapy (cART) is a com-
bination of at least three different substances consisting of a non-nucleoside reverse
transcriptase, a boosted protease or an integrase inhibitor with a combined two drug
nucleoside/nucleotide backbone [3].
Past research based on randomized trials and cohort studies mainly focused on
the HIV-1 plasma RNA load and CD4 cell count interactions over time [4, 5, 6] and
the restoration of the CD4 cell counts [7, 8, 9]. However, already in the early times
of HIV research it was suggested to include additional immune-activation measures
such as CD8 lymphocyte cell counts, CD4/CD8 ratios or CD4 and CD8 percentages
[10, 11, 12, 13]. A negative correlation between changes in CD4 and CD8 cell counts
during an intensification of the antiretroviral therapy was reported [14]. In the Swiss
HIV cohort study (SHCS) larger changes in CD4 cell counts were found to be negat-
ively associated with CD8 cell counts measured at baseline for HIV-1 patients receiving
antiretroviral therapy [15]. For HIV-1 infected treatment naive patients, CD8 counts in-
crease while CD4 counts decline [16] but only viral load and CD4 counts and not CD8
cell counts, were considered to be the most relevant predictors for disease progression
[17]. Time to normalisation of the CD4/CD8 ratio, defined as two subsequent measure-
ments with a ratio above between one and 1.2 was found to be negatively associated
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with its baseline value [18, 19] but only a minority of HIV-1 infected individuals un-
der antiretroviral therapy normalize their CD4/CD8 ratio [18, 19, 20], in particular if
treatment was started at low CD4 counts [15, 21, 3]. Low CD4/CD8 ratios were also
found to be associated with increased morbidity and mortality of non-AIDS related
death causes [19, 22, 23].
These studies all hint towards a possibly important role of CD8 cell counts during
an HIV infection. However, up to now an analysis of the time-dependent relationship
between changing CD8 and CD4 lymphocytes based on a cohort study is lacking. Fur-
thermore, there is a large inter-patient variation in disease progression, in CD4 recovery
under therapy and in CD4/CD8 normalization, depending on a multitude of factors
such as viral and host factors [24, 25, 26]. Here, by taking patient-specific variation into
account, we examined whether past CD8 cell counts contain additional information to
determine future CD4 cell counts and investigated this effect separately, for treatment
naive individuals and for patients receiving cART.
2. Methods
2.1. Study population
The SHCS [27], established in 1988, includes HIV-1 infected persons older than
18 years, living in Switzerland. The SHCS schedules regular follow-up visits every
six months, while the common clinical follow-up interval is three months, at which
CD4 and CD8 lymphocyte cell counts and plasma HIV-1 viral load are measured. The
lymphocyte cell counts per µL blood were measured by flow cytometry. Since the year
2000 all assays used for HIV-1 RNA detection had a detection limit of 50 copies per
mL or lower. For this study, the RNA detection limit was set at 50 RNA copies/mL of
plasma, independent of the applied assays and all values below this limit, or without
detection, were set to 25 copies/mL. Data were extracted from the October 2014 update
of the SHCS database. Observations prior to the year 2000 were excluded in order to
guarantee comparable assay technology used to measure plasma RNA load and that an
established cART was available to all patients. We extracted from the database 280’554
lymphocyte cell counts and 325’984 RNA measurements obtained from 11’899 patients.
The study population was divided into two subgroups, one covers all observations
obtained from patients with an untreated HIV-1 infection (NAIVE), observed as long
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as they did not start cART. The second group includes observations from patients re-
ceiving available standard cART. Accordingly the same patient may be included in both
groups, which is the case for 1’797 patients or 71.9% of the NAIVE study population.
Lymphocytes and RNA are not always measured at the same time, so we matched res-
ults of the two laboratory analyses if the time difference was less than eight days and
the date of the RNA analysis was kept Observed lymphocyte cell counts for which no
RNA measurement was available were omitted. If a patient quit or interrupted cART
therapy, all follow-up observations were omitted, independent of a likely therapy re-
sumption. As it was shown that Hepatitis C co-infection influences CD4 cell counts,
all patients with indetermined HCV status were excluded [28]. Moreover, all obser-
vations with a follow-up time between two subsequent measurements of more than
twelve months were excluded, as the information of past lymphocyte cell counts and
past RNA measurements for future CD4 counts was assumed to diminish over time. If
a patient met all of the above inclusion criteria he additionally had to have at least three
measurements of CD4 and CD8 cell counts as well as RNA blood viral load, observed
at three different occasions. The selection of the study population according to these
eligibility criteria is described in Figure 1.
2.2. Statistical methods and analysis
The hypothesis that past CD4/CD8 ratios predict current CD4 cell counts was ex-
amined by linear mixed regression models for longitudinal data [29] for each patient
subgroup. The outcome in each model is the square root transformed CD4 cell count
[4, 30] observed at the current follow-up visit. We estimated for both patient groups
three models for which we included different combinations of suitably transformed
CD4 and CD8 cell counts, observed at the preceding follow-up visit, as predictors. In
this way the influence of CD4 and CD8 lymphocytes, which are lagged by one follow-
up visit, on the outcome is examined. The lag between two subsequent follow-up visits
corresponds on average to a time period of three months. From here on predictors are
called lagged if, relative to the observed CD4 cell count outcome, they were observed
at the preceding follow-up visits. In the first model formulation (M1) we included the
lagged square root transformed CD4 cell counts and the lagged log10 transformed RNA
measurement as predictors, both observed at the preceding of two subsequent follow-
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SHCS data (1/2000 to 10/2014)
pat: 11’899
CD4, CD8 obs: 280’554
RNA obs.: 325’984
pat: 5’757
obs. (CD4 or RNA): 29’090
pat: 10’582
obs. (CD4 or RNA): 248’758
NAIVE cART
incomplete measurements (RNA missing)
pat: 5’643 (98 %)
RNA missing: 27’529 (94.6 %)
pat: 10’579 (99.97 %)
RNA missing: 244’100 (98.1 %)
pat: 114 (2 %)
obs: 1’561 (5.4 %)
pat: 3 (0.03 %)
obs: 4’658 (1.9 %)
therapy interruption
pat: 9’915 (93.67 %)
obs: 195’616 (78.6 %)
pat: 664 (6.3 %)
obs: 48’484 (19.5 %)
indeterminate HCV status
pat: 5,498 (95.5 %)
obs: 27’031 (92.9 %)
pat: 9,599 (90.67 %)
obs: 191’996 (77.1 %)
pat: 145 (2.5 %)
obs: 498 (1.7 %)
pat: 316 (3 %)
obs: 3’620 (1.5 %)
time difference > 12 months
obs: 26’221 (90.1 %) obs: 189’912 (76.3 %)
obs: 810 (2.8 %) obs: 2’084 (0.8 %)
less than 3 observations
included NAIVE
pat: 2’500 (43.4 %)
obs: 22’405 (77 %)
included cART
pat: 8’902 (84.07 %)
obs: 188’898 (75.9 %)
pat: 2’998 (52.1 %)
obs: 3’816 (13.1 %)
pat: 697 (6.6 %)
obs: 1’014 (0.4 %)
Figure 1: SHCS data and study population with number of observations (obs.) and number of patients (pat.).
Percentages (%) are based on the initial NAIVE or cART data given on the second level in the diagram.
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up visit. In the second model (M2) we added the lagged square root transformed CD8
cell counts as additional predictor. In the third approach (M3) we replaced the lagged
CD8 cell counts by the natural log transformed, lagged CD4/CD8 ratio.
In order to assess which of the three model is most suitable for each patient group
we compared the marginal R2 [31, 32], which is the proportion of explained variation
by the predictors as proportion of the overall variation. Additionally the models were
compared by a version of the Bayesian information criterion (BIC), modified for linear
mixed models [33]. The modified BIC penalizes the inclusion of model parameters and
lower values indicate that the corresponding model captures more information and
thus should be preferred.
Time was set to zero at cohort entry for the NAIVE and at therapy initiation for
the cART subgroup. The time scale was standardised to three month intervals, as this
corresponds to the common clinical follow-up period in the SHCS. For the cART group
time since therapy start was square root transformed [34], as this allowed to capture the
sharp increase in CD4 cell counts after therapy initiation [35]. We also included AIDS
(yes, no) and age, which are time-dependent, the transmission group (transmission) and
the status of a hepatitis C co-infection (HCV), both observed at baseline, as predictors
in all models. The probable HIV transmission [36] is a categorical predictor with six
groups: homosexual men (MSM), male and female intravenous drug users (IDU-male,
IDU-female), heterosexual males and females (HET-male, HET-female) and a group
for which the transmission path is not further specified (other). The HCV status has
three categories: HCV negative, patients with inactive and patients with replicating
(active) HCV. For the cART patient group we additionally included the time period
prior to cART during which an individual was receiving mono or dual regimens with
nucleoside reverse-transcriptase inhibitors (NRTI).
In order to address patient-specific heterogeneity at baseline we included a random
intercept in each model and heterogeneity between patients in the CD4 cell time course
is taken into account by a random slope, which allows for patient-specific deviations
from the average time course [4]. The random effect structure is the same for both
subgroups and all three model specifications. An analysis of the model residuals did
not provide evidence for any longitudinal structure or other dependency. All statistical
6
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Baseline characteristics NAIVE (n=2’500) cART (n=8’902)
CD4 at baseline 491 (376 , 670) 367 (231 , 539)
CD8 at baseline 904 (654 , 1265) 846 (601 , 1185)
CD4/CD8 at baseline 0.55 (0.38 , 0.8) 0.41 (0.25 , 0.67)
log(RNA) at baseline 4.23 (3.58 , 4.8) 1.95 (1.40 , 3.11)
AIDS at baseline 46 ( 1.8%) 1843 (20.7%)
age at baseline 36 (30 , 42) 39 (33 , 46)
transmission
MSM 1181 (47.2%) 3723 (41.8%)
IDU-male 208 ( 8.3%) 841 ( 9.4%)
IDU-female 94 ( 3.8%) 423 ( 4.8%)
HET-male 415 (16.6%) 1602 (18.0%)
HET-female 506 (20.2%) 1892 (21.3%)
other 96 ( 3.8%) 421 ( 4.7%)
HCV
HCV negative 2001 (80.0%) 7056 (79.3%)
HCV inactive 109 ( 4.4%) 367 ( 4.1%)
HCV active 390 (15.6%) 1479 (16.6%)
Longitudinal characteristics NAIVE (n=22’405) cART (n=188’898)
CD4 457 (346 , 609) 497 (338 , 688)
CD8 952 (694 , 1300) 796 (573 , 1096)
CD4/CD8 0.48 (0.34 , 0.69) 0.62 (0.40 , 0.92)
log(RNA) 4.13 (3.50 , 4.66) 1.40 (1.40 , 1.40)
follow-up visits per patient 7 (4 , 12) 17 (9 , 31)
follow-up time (months) 3.5 (3.0 , 5.6) 3.3 (2.8 , 5.3)
Table 1: Patient characteristics for baseline (upper part) and longitudinal (lower part) characteristics of the
study population for both subgroups. Data are patient numbers (with %) for discrete and median (with the
first and third quartile) for continuous predictors. Lymphocyte cell counts and ratio are untransformed, the
RNA is log10-transformed.
analyses and data preparation were done in R version 3.2.3 (2015-12-10). All linear
mixed models were fitted with the software package nlme [37] version 3.1-119.
3. Results
3.1. Patient characteristics
According to the above inclusion criteria 2’500 patients were eligible in the NAIVE
subgroup with 22’405 observations, while 8’902 patients were included in the cART
subgroup with 188’898 observations (see Figure 1). The patient characteristics for both
subgroups are shown in Table 1. The upper part in Table 1 shows the patient char-
acteristics for predictors observed at baseline and the lower part for time-dependent,
longitudinal predictors based on all included observations.
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Patients in the NAIVE, compared to the cART subgroup, had lower CD4 cell counts
(NAIVE 457, cART 497), higher CD8 cell counts (NAIVE 952, cART 796), a lower
CD4/CD8 ratio (NAIVE 0.48, cART 0.62), and higher log-transformed RNA levels (NA-
IVE 4.13, cART 1.40). The cART group had more follow-up visits per patient (NAIVE
46, cART 1843), as usually most of the patients start cART rather quickly and continu-
ously stay under therapy for the remaining observation time, thus patients are also
older at baseline in the treated group (NAIVE 36, cART 39). The proportion of patients
having AIDS was higher in the cART group (NAIVE 4.9%, cART 24.1%). All other
characteristics (follow-up time, transmission, HCV) were similar for both subgroups.
3.2. Model comparison and predictive value of CD8 lymphocytes
The first two columns in Table 2 give the marginal R2 for the three models and for
each patient group. For the NAIVE subgroup the marginal R2 increases from 31.7% for
M1, to 40.7% for M2 after inclusion of the lagged CD8 cell counts. For cART the increase
is from 44.1% to 50.7%. Including the lagged CD4/CD8 ratio instead of the lagged CD8
cell counts, increases the R2 measure even more to 41.8% for the NAIVE and to 51.9%
for the cART group. The modified BIC for the three models and each patient group
is shown in the last two columns of Table 2. The modified BIC is decreasing from
model M1 to M3 for both patient groups. Thus, consistent with the marginal R2, also
the information criterion prefers the model which includes the CD4/CD8 ratio over the
other two models.
marginal R2 modified BIC
NAIVE cART NAIVE cART
M1: CD4 + RNA 31.7% 44.1% 95’594 865’332
M2: CD4 + CD8 + RNA 40.7% 50.7% 95’060 862’400
M3: CD4 + CD4/CD8 + RNA 41.8% 51.9% 94’962 861’192
Table 2: Marginal R2 and modified BIC for both patient subgroups and three models including different
lagged longitudinal predictors. All models additionally include an intercept and were adjusted for AIDS,
age, transmission, HCV and for time since cohort entry for NAIVE and time since therapy start plus NRTI at
baseline for cART (see also Table 3).
8
- 36 - Paper I
Figure 2 illustrates the relationship between the lagged lymphocyte predictors, ob-
served at the first follow-up visit and the outcome, observed at the second of two
subsequent follow-up visits. Figure 2 depicts the relationship for the population mean
in the NAIVE (left) and cART (right) group. Square root transformed lymphocyte cell
counts were back transformed to absolute cell count values and the log-transformation
of the CD4/CD8 ratio was also reversed. The lower and upper limits for the predictors
in Figure 2 were set to the 2.5% and 97.5% quantiles of all observation (0.13 to 1.8 for the
lagged CD4/CD8 ratio and 114 to 1184 for the lagged CD4). The contour lines of the
plots in the first two rows indicate the predicted CD4 cell count at the next follow-up
visit, for a given combination of lagged CD4/CD8 ratio and lagged CD4 cell count. All
other predictors in model M2 and M3 were set to a constant value: time since cohort
entry for NAIVE or since therapy start for cART was set to three months, the age to 40
years, we assumed a median viral load equal to 4.1 (corresponding to 13’380 copies per
ml blood) for NAIVE and a suppressed RNA level for cART (equal to a viral load of 1.4
or 25 copies per ml blood), which occurs for 76.4% of the observations in this group.
The categorical predictors, transmission and HCV, were set to the reference category
and NRTI duration was set to zero.
Figure 2 demonstrates that for model M2 and M3 the relationship between the
lymphocyte predictors and the outcome is similar for untreated and cART patients.
However, the two models give considerably different predictions. The plots for cART
and NAIVE based on model M2 (first row) show converging contour lines in the upper
left corner. This leads to almost vertical contour lines for Model M2, if the CD4/CD8
ratio is below 0.25, implying a CD8 count which is four times larger than the CD4 cell
count. The vertical contour lines mean that in this range the CD4 lymphocyte level
has, according to Model M2, no more impact on the prediction of CD4 at the next
follow-up visit. Model M3 in contrast, which instead of the CD8 cell counts includes
the CD4/CD8 ratio as predictor, does not have this feature of quickly converging con-
tour lines (second row). In model M3 the level of CD4 lymphocytes is still an important
predictor, even if the CD4/CD8 ratio is below 0.25.
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M2: CD4 cell count response surface for cART
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M3: CD4 cell count response surface for NAIVE
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M3: CD4 cell count response surface for cART
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Figure 2: Relation between lagged CD4/CD8 ratio predictor (abscissa), lagged CD4 cell counts predictor
(ordinate) and the predicted CD4 cell count outcome (contour lines) for the population mean in NAIVE (left)
and cART (right) subgroups in model M2 (top) and M3 (middle) and the empirical distribution of the data
(bottom) for which the contour lines indicate the location of 70%, 50%, 30% and 10% of the data.
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The bottom row in Figure 2 shows the empirical bivariate distribution of CD4 cell
counts and the CD4/CD8 ratio for NAIVE and cART patients. The contour lines indic-
ate where 70%, 50% and 10% of the observations are located. For the NAIVE subgroup
8.3% and for cART 9.7% of the observed data are below a CD4/CD8 ratio equal to 0.25.
The empirical distribution in Figure 2 underpins the fact, that the differences between
model M2 and M3 are relevant, as there is a substantial proportion of observations
situated in the bottom left corner, where the models differ most.
3.3. Estimates of regression coefficients
The upper part in Table 3 shows the regression coefficients together with a 95% con-
fidence interval (CI) for the intercept and the longitudinal predictors, based on model
M3 only which according to the criteria in Table 2 and Figure 2 is the preferred model.
The intercept represents the population mean of the square root transformed CD4 cell
counts at baseline (18.02 NAIVE, 15.56 cART). The regression coefficient for time re-
flects the population mean course of the outcome since cohort entry for the NAIVE
(-0.10) and since therapy start for cART ( 0.34). These estimates are in agreement with
the established finding that for untreated HIV infected patients the CD4 count declines,
while an antiretroviral therapy causes an increase. The lagged square root CD4 cell
count, observed at the preceding follow-up visit, is positively associated with the out-
come and has a similar coefficient for both subgroups ( 0.36 NAIVE and 0.39 cART). The
negative coefficient for the plasma viral load (-0.46 NAIVE and -0.27 cART) is in line
with the acknowledged decline of CD4 cell counts for higher viral loads. The lagged
log-transformed CD4/CD8 ratio is positively associated with the outcome for both sub-
groups ( 1.79 NAIVE and 1.65 cART). As the CD4/CD8 ratio is log-transformed, this
implies a positive effect if CD4 exceeds the CD8 cell count, but a negative effect if the
ratio is below one. A patient with an imbalanced immune system, for whom the CD4 is
below the CD8 cell count, has a lower prediction for the CD4 cells at the next follow-up
visit, compared to a patient with equal CD4 count but with a higher CD4/CD8 ratio.
The regression coefficients for the remaining predictors are shown in the lower part
of Table 3. In contrast to the predictors in the upper part, these predictors are not time-
dependent and have an effect on the predicted CD4 cell count level only. However, they
do not imply differences in the decline or relapse of the outcome, as they do not include
11
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NAIVE cART
coef. 95% CI p-value coef. 95% CI p-value
intercept 18.02 17.43 to 18.61 < 0.0001 15.56 15.32 to 15.80 < 0.0001
time -0.10 -0.11 to -0.10 < 0.0001 < 0.0001
square root time < 0.0001 0.34 0.32 to 0.36 < 0.0001
square root CD4 0.36 0.35 to 0.38 < 0.0001 0.39 0.39 to 0.40 < 0.0001
log RNA -0.46 -0.53 to -0.40 < 0.0001 -0.27 -0.29 to -0.25 < 0.0001
log CD4/CD8 1.79 1.66 to 1.93 < 0.0001 1.65 1.60 to 1.70 < 0.0001
AIDS at follow-up visit -0.88 -1.28 to -0.48 < 0.0001 -1.01 -1.12 to -0.90 < 0.0001
age at follow-up visit -0.01 -0.02 to 0.00 0.0018 -0.03 -0.03 to -0.02 < 0.0001
NRTI at baseline -0.02 -0.02 to -0.01 0.00013
transmission 0.01 < 0.0001
MSM (reference) 0.00 0.00
IDU-male -0.14 -0.61 to 0.32 -1.13 -1.39 to -0.88
IDU-female -0.12 -0.71 to 0.46 -0.75 -1.05 to -0.44
HET-male -0.32 -0.60 to -0.05 -0.64 -0.79 to -0.49
HET-female -0.40 -0.66 to -0.15 -0.47 -0.61 to -0.32
other -0.04 -0.55 to 0.46 -0.34 -0.60 to -0.08
HCV 0.47 < 0.0001
negative (reference) 0.00 0.00
inactive -0.08 -0.59 to 0.44 0.04 -0.26 to 0.34
active -0.13 -0.49 to 0.23 -0.44 -0.64 to -0.23
Table 3: Coefficient estimates (coef.) with 95% confidence intervals (CI) and p-values for model M3 and for
both patient subgroups (NAIVE and cART). Upper part shows longitudinal predictors and the lower part
time constant predictors for AIDS and age at follow-up visit, NRTI at baseline, transmission and HCV.
any interactions with time dependent longitudinal predictors reported in the upper part
of Table 3. If a patient had AIDS at the time of observation, the CD4 cell count will be
lower. Also the patients age and the duration of NRTI prior to cART has a negative level
effect on the outcome. The estimates for the transmission group provides evidence that
the heterosexual transmission categories (HET-male, HET-female) are different from the
homosexual men reference category (MSM) in the NAIVE group as the upper bound
of the 95% CI is negative. For the cART group the 95% CI’s imply that, compared
to the reference category (MSM), all other transmission categories have a lower CD4
cell count level. For the HCV predictor in the NAIVE group there is no evidence for a
difference between the three categories. However, in the cART group the corresponding
p-value is small, implying that at least one HCV category has a different CD4 level
compared to the HCV negative reference category, which probably concerns the active
HCV category.The Supplementary Material provides results for model M1 and M2, as
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well as additional information.
4. Discussion
Based on a large dataset from the Swiss HIV cohort study we have shown that CD8
cell counts contain crucial predictive information for the HIV disease progression in
drug naive patients and as well for the CD4 cell count recovery in patients receiving
cART. Both lymphocyte cell subtypes, CD4 and CD8, as well as the RNA viral load,
have been identified as important prognostic factors for the CD4 cell count over the next
months. We could show that the model which includes the lagged levels of CD4 and
CD8 as two separate predictors was inferior compared to an approach which included
the lagged CD4/CD8 ratio instead of the CD8 level. These findings persisted, also if we
applied alternative transformations to the lagged lymphocyte predictors, such as the
log instead of the square root transformation. The CD4/CD8 ratio can be interpreted
as a measure for the imbalance of the patient’s immune system which captures essential
information, additional to the cell count levels of both lymphocyte subtypes. The CD8
cell count is a marker for immune activation, which has been found to be an important
factor for disease progression [38, 39].
The relationship between the lagged CD4 cell count predictor, the lagged CD4/CD8
ratio predictor and the CD4 cell count at the next follow-up visit were found to be
surprisingly similar for untreated patients and patients under a cART. This was illus-
trated by the response surface for the CD4 cell counts in Figure 2 and the comparable
estimates between NAIVE and cART for the lymphocyte predictors shown in Table 3.
Furthermore we could quantify the relative importance of the two lymphocyte sub-
types and the viral load as prognostic factors. It was previously found that the viral
load only explains a low proportion (below 10%) of the variation for changes in CD4
cell counts over one year [6]. Such a statement crucially depends on the outcome and
time period for which the prediction is made. We found that even for NAIVE patients
lagged CD8 cell counts are more important than lagged viral loads in explaining the
variation in future CD4 cell counts. If the lagged RNA predictor is omitted then the
marginal R2 reduces from 31.7% to 27.2% in the approach which includes lagged CD4
as predictor. For the cART group the marginal R2 is even increasing for the same model
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formulation, if the viral load predictor is omitted. This reflects the fact that the associ-
ation between CD4 cell counts and viral load is fundamentally different for treatment
naive and patients under therapy. The improved marginal R2 and also the difference
in the regression coefficients of the lagged RNA for the NAIVE and cART group, sup-
ports the argument that although the viral load is a relevant predictor for future CD4
cell counts, it explains perhaps only a small proportion of the observed variation. As
the plasma RNA load is often suppressed below the assay detection limit under cART
we also examined the possible influence of recurrent detectable plasma RNA viral loads
("blips"), but no evidence for an additional effect was found.
By choosing a linear mixed model for the longitudinal SHCS data we could incor-
porate patient specific-variation for the CD4 cell count at baseline and for its patient-
specific time course. The applied model simplified the observation pattern, ignoring
interval censored data and assumed regular follow-up times, although in the SHCS
data there is notable variation for the time between two follow-up visits (see Supple-
mentary Material).
Of course, causal pathways between the quantities of interest, CD4, CD8 and RNA,
are inherently difficult to assess and not possible to estimate without a minimal set of
assumptions. Nevertheless, we have derived a statistical model, which allowed to ad-
dress the clinically important question of how the patients immune system will evolve
given the current state. It would be of interest to examine the sensitivity of the res-
ults with respect to the underlying assumptions. For example an alternative analysis
would incorporate the underlying rather than the observed lymphocyte and viral load
measurements as predictors [40].
With this statistical analysis of a large HIV cohort we could confirm the findings
by other studies, which attributed an important role to CD8 cells for describing the
HIV-1 disease progression. We were able to show that the CD4/CD8 ratio is an im-
portant time-dependent prognostic factor, both for treatment naive and cART-treated
patients. The SHCS data could be used for further investigations concerning the role of
CD8 during an HIV-1 infection, which could reveal more details about the connections
between HIV-1 disease progression and variation for the time needed to normalize the
CD4/CD8 ratio. Elaborating such associations in more detail, also for interactions of
14
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other risk factors [41, 42], would support the understanding of the mechanisms leading
to the high variation in different individual immune responses.
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1 Linear mixed model for longitudinal SHCS data
The SHCS data is collected for patients i = 1, . . . ,m who are observed repeatedly at
follow-up visits j = 1, . . . , ni at times ti1, ti2, tij, where j = 1, . . . , ni. The square root
transformed CD4 cell counts is the outcome
√
CD4ij = yij which is assumed to follow
a normal distribution. The observations for a single patient i are modeled by a linear
predictor
yi = xiβ+ zibi + ei.
The observations for this patient are collected by the vector yi of length ni. The p
different fixed effect covariates are in the design matrix xi of dimension (ni × p). The
coefficients for the fixed effect predictors are in the vector β and is of length p. The
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patient-specific random effects vector bi is usually a subvector of β with length q < p
and is multiplied by the random effects design matrix zi of dimension (ni × q).
The linear mixed model assumes that the residuals follow a normal distribution ei ∼
N (0, σ2e) and the errors are independent and identical distributed. The patient-specific
random effects bi are also assumed to follow a normal distribution bi ∼ Nq(0,D).
In the case of random intercept and random slope q = 2 and the random effects
covariance matrix D is of dimension 2× 2. Further the error term ei and the random
effects bi are assumed to be independent. The patient-specific marginal likelihood
integrates over the random effects bi and follows a multivariate normal distribution
with mean xiβ and covariance matrix ziDz>i + Ini , where here Ini is the identity matrix
of dimension ni.
Model M1, described in the main text, included the following covariates for which
a fixed effect coefficient was estimated:
xij = (1, tij,
√
CD4i,(j−1), log(RNAi,(j−1)), AIDSij, ageij, transmissioni, HCVi) and in the
cART group additionally the effect for NRTIi. Model M2 estimated the same fixed
effects as M1 but additionally included
√
CD8i,(j−1). Model M3 estimated the same
fixed effects as M1 but additionally included log(CD4i,(j−1)/CD8i,(j−1)). The random
effects structure is the same in all models and included a patient-specific random
intercept and random slope such that q = 2 and the design matrix zij = (1, tij).
1.1 Model choice criteria
Different models with different predictors can be compared by model choice criteria
such as the AIC or BIC. Common model selection criteria, like AIC or BIC, are not ap-
plicable to linear mixed models. The main reason for this is the difficulty to assess the
degree of freedom for the random effects included in a linear mixed model. Different
proposals for extensions of the common model choice criteria to linear mixed models
exist. One suggestion for a model choice criteria to mixed models with different fixed
effects but the same random effects structure is the modified BIC [1], who defines the
version of the BIC, modified for linear mixed models as
BIC = −2 log L+
p
∑
k=1
log(nk)
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where L is the likelihood and nk is equal to the number of individuals I if the predictor
is included as fixed and as random effect, or the number of observations n = ∑Ii=1 ni
if the predictor is included as fixed effect only. See also [2] for a description of model
choice criteria and about predictive comparisons for generalized linear mixed models.
1.2 Explained variation
A goodness of fit criteria for linear regression models is the R2, which is a measure for
the variation expressed by the model in relation to the overall variation in the data. In
the case of a multiple regression model the R2 needs to be adjusted for the number
of included parameters, in order to gain comparability across different models with
different parameters. For linear mixed models one needs to adapt the R2 additionally
for the variation explained by the random effects, which can be done in different ways.
Properties for a sensible R2 measure are discussed by [3], who suggest a R2 meas-
ure for linear mixed models with random intercepts. They distinguish between the
marginal R2, which expresses the variance explained by fixed effects as proportion of
all variance components and the conditional R2, which is a measure for the variance
explained by fixed and random effects. This idea was extended to linear mixed models
with random intercepts and random slopes by [4].
According to equation 29 in [3] the marginal R2 for a random intercept model is
defined as
R2marignal =
σ2f
σ2f +∑
q
l=1 σ
2
l + σ
2
e
where σ2f is the variance attributable to the fixed effects, σ
2
l is the variance of the lth of
the q random effects. For the extension to random intercepts and random slopes [4]
proposes to replace ∑
q
l=1 σ
2
l by the mean random effect variance
σ¯2 = tr(zDz>)/n
where n is the number of observations (n = ∑Ii=1 ni) and z the random effects design
matrix for all patients of dimension n× 2.
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1.3 Time course for NAIVE and cART
In this section we illustrate in more detail how the applied linear mixed model for
longitudinal data takes the time trend since cohort entry (NAIVE) or since therapy
start (cART) into account. The time trend for both subgroups is illustrated in the
upper two plots in Figure 1 which is based on the model M3 presented in the main
text but would look rather similar for model M2. For Figure 1 all covariates are set to
its average values and held constant and categorical variables are set to the reference
category, while only the time since cohort entry for NAIVE or since therapy start for
cART is increasing.
The fixed effect time trend, representing the population mean of the square root
transformed CD4 course and given the reference categories for the transmission and
the HCV factors, is plotted as black line. The dark grey area around the global fixed
time effect shows a 95% confidence interval (CI) for the average population time trend.
The light grey area shows a 95% CI for the time-dependent prediction error based on
the standard deviation of the model residuals (σe) and the standard deviation of the
fixed time effect (σf ). This prediction error band is based on the artificial data used
for the plot, for which time since cohort entry (NAIVE) or since therapy start (cART)
is the only varying covariate.
The linear decreasing time trend for NAIVE is opposed by a sharply increasing time
trend in cART, as the time scale was square root transformed for the cART subgroup.
This reflects that CD4 cells for untreated HIV infected patients are steadily declining
where on average the CD4 level is recovering after cART initiation.
The dashed lines in the upper two plots of Figure 1 show patient-specific deviations
from the population mean based on random intercepts and random slopes of 20 differ-
ent, randomly sampled patients. These individual intercepts and time courses reflect
how the linear mixed model takes the between patient variation at baseline and during
disease progression into account. The model yields a rather high flexibility to cover
individual time courses, especially just after cART initiation: a positive random slope
on the square root transformed time scale leads to a sharp but flattening increase in
CD4, especially if the CD4 level was already impaired which is reflected by a relatively
small random intercept. A negative random slope instead is often present among the
cART group if the CD4 level at therapy start was still high. A negative random slope
implies a flattening decline in CD4 cell counts after cART initiation.
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Figure 1: Profiles with time trend in the NAIVE and cART based on model M3 for the
population average and 20 randomly selected patients (pat.) in the upper
two plots. Observed values and model predictions for two selected patients
in each group in the lower two plots.
The lower two plots in Figure 1 show observed square root transformed CD4 cell
counts obtained from two NAIVE and two cART patients, as well as each correspond-
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ing model prediction for disease progression. The four patients in the lower plots are
chosen such that their response values do not overlap and that they have a substantial
record of observed lymphocytes. The lower two plots serve for illustration purposes
only and should clarify how the model applies to the patient-specific longitudinal
data.
1.4 Random effect structure and residual analysis
The parameter estimates of the random effect covariance matrix (Dˆ) are shown in
Table 1 based on model M2 and model M3, presented in the main text, together with
the residual standard deviations (σˆe). The estimated random effect structure and the
standard deviation for the residuals are very similar for both models. From Table 1 we
see that the patient-specific variation of the intercept has about the same magnitude as
the residual standard deviation. The size of the residual standard deviation for model
M3 is also visualized in Figure 1 in the 95% prediction error band as light grey area.
NAIVE cART
M2 M3 M2 M3
RI Stdev. 2.272 2.267 3.330 3.130
RS Stdev. 0.093 0.090 0.517 0.502
correlation -0.260 -0.309 -0.685 -0.646
Resid. Stdev. 2.281 2.280 2.430 2.425
Table 1: Estimated random effect structure and residual standard error of linear mixed
models M2 and M3 for each patient subgroup (NAIVE and cART).
Figure 2 shows a QQ-plot of the residuals for models M2 and M3 and the NAIVE
and cART patient groups. The residuals in Figure 2 and 3 are raw residuals divided by
the corresponding standard errors and further normalized by the inverse square-root
factor of the estimated error correlation matrix (see residuals.lme in the R-package
nlme for more information).
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Figure 2: QQ-plots with standardized reisduals in model M2, M3 for NAIVE, cART.
Figure 3: Variogram with standardized reisduals in model M2, M3 for NAIVE, cART.
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2 Effect size of predictors
To overcome the difficulties in giving an interpretation of the model coefficients, which
are transformed to different non-linear scales, we illustrate the effect sizes of the pre-
dictors and the transformation from
√
CD4 to original CD4 cell counts with a plots in
Figure 4 and 5 for model M2 and in Figure 6 and 7 for model M3. The horizontal bars
indicate the lower 2.5% and the upper 97.5% quantile as well as the median (black dot)
of each covariate multiplied by its coefficient estimate, labelled with the corresponding
quantiles of the covariates. As the level effect sizes for the categorical predictors HCV
and transmission are very small, they are omitted in Figure 4 to 7.
The contribution of each predictor to the square root transformed response (here√
CD4) is additive and can be read off for every predictor from the line at the bottom
(predicted
√
CD4). Summing up each contribution to the response for all predictors
gives the prediction of the square root transformed CD4 cell counts at the next follow-
up visit. The vertical scale on the right allows to translate from the predicted square
root scale (small figures) to the CD4 cell counts (large figures). On the right vertical
scale also the fixed effect intercept, which must be added to the predicted value, is
indicated by a black dot. The error bar for the fixed effect intercept is representing a
95% CI based on the estimated random intercept standard deviation. One can read off
from the scale for the absolute CD4 cell counts on the right, that the same difference
in the linear predictor causes a larger difference in the absolute CD4 cell count, if the
predicted square root CD4 cell count is higher.
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Figure 4: Effect size of predictors for NAIVE patients and model M2.
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Figure 5: Effect size of predictors for cART patients and model M2.
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Figure 6: Effect size of predictors for NAIVE patients and model M3.
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Figure 7: Effect size of predictors for cART patients and model M3.
10
- 58 - Paper I
3 Coefficient estimates for Model M2
Table 2 shows the coefficient estimates for the longitudinal predictors for model M2,
corresponding to Table 3 in the main text, which reported the estimates for model
M3. Equivalently Table 3 shows the coefficient estimates for the additional coefficients
based on Model M2, corresponding to Table 4 in the main text.
NAIVE cART
coef. 95% - CI coef. 95% - CI
intercept 16.78 16.21 to 17.36 14.54 14.30 to 14.78
time -0.11 -0.12 to -0.10
square root time 0.38 0.36 to 0.40
CD4 0.51 0.50 to 0.52 0.53 0.53 to 0.54
RNA -0.47 -0.53 to -0.40 -0.34 -0.36 to -0.32
CD8 -0.10 -0.11 to -0.09 -0.10 -0.10 to -0.09
Table 2: Coefficient estimates (coef.) with 95% confidence intervals (CI) for longitud-
inal predictors and both patient subgroups (NAIVE and cART) for model M2.
All p-values are <0.0001. Estimates for additional predictors are in Table 3.
NAIVE cART
coef. 95% CI p-value coef. 95% CI p-value
AIDS at follow-up visit -1.00 -1.41 to -0.60 < 0.0001 -1.10 -1.21 to -0.99 < 0.0001
age at follow-up visit -0.01 -0.02 to 0.00 0.0023 -0.03 -0.03 to -0.02 < 0.0001
NRTI at baseline -0.02 -0.02 to -0.01 < 0.0001
transmission 0.01 < 0.0001
MSM (reference) 0.00 0.00
IDU-male -0.13 -0.60 to 0.34 -1.19 -1.45 to -0.93
IDU-female -0.11 -0.70 to 0.49 -0.73 -1.04 to -0.42
HET-male -0.35 -0.63 to -0.07 -0.64 -0.79 to -0.48
HET-female -0.40 -0.65 to -0.14 -0.44 -0.58 to -0.29
other -0.07 -0.58 to 0.43 -0.34 -0.61 to -0.08
HCV 0.39 < 0.0001
negative (reference) 0.00 0.00
inactive -0.09 -0.61 to 0.42 0.02 -0.28 to 0.33
active -0.16 -0.52 to 0.21 -0.45 -0.66 to -0.24
Table 3: Estimates for additional predictors for model M2.
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4 Time spans between follow-up visits
Figure 8 shows a histogram for the time between two subsequent follow-up visits for
the NAIVE and the cART subgroups. The vertical dashed line indicates a follow-up
time of 12 months. All observations with a follow-up time of more than one year were
censored.
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Figure 8: Histograms for time differences between two subsequent follow-up visits in
months. Time is equal to zero at cohort entry for NAIVE and at therapy
initiation for cART.
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Clustered observations such as longitudinal data are often analysed with generalized linear mixed
models (GLMM). Approximate Bayesian inference for GLMMs with normally distributed random
effects can be done using integrated nested Laplace approximations (INLA), which is in general
known to yield accurate results. However, INLA is known to be less accurate for GLMMs with
binary response. For longitudinal binary response data it is common that patients do not change
their health state during the study period. In this case the grouping covariate perfectly predicts a
subset of the response, which implies a monotone likelihood with diverging maximum likelihood (ML)
estimates for cluster-specific parameters. This is known as quasi-complete separation. In this paper
we demonstrate, based on longitudinal data from a randomized clinical trial and two simulations, that
the accuracy of INLA decreases with increasing degree of cluster-specific quasi-complete separation.
Comparing parameter estimates by INLA, Markov chain Monte Carlo sampling and ML shows that
INLA increasingly deviates from the other methods in such a scenario.
Keywords: integrated nested Laplace approximations; Bayesian generalized mixed models;
cluster-specific quasi-complete separation
1. Introduction
There has been recent interest in the accuracy of integrated nested Laplace approxima-
tions (INLA) [1] for Bayesian inference in binary response mixed models. INLA has been
successfully applied to generalized linear mixed models (GLMMs) [2], and a generally
high accuracy has been reported. However, for the special case of binary responses, a
thorough comparison with Markov chain Monte Carlo (MCMC) sampling has identified
larger discrepancies [2]. Here, the relative approximation error, measured as the differ-
ence between the marginal posterior mean with MCMC and INLA, and scaled with the
(MCMC) posterior standard deviation, was around 30%. These results are in contrast to
a more recently published simulation study [3], which reported a high accuracy of INLA.
There is also interest in the accuracy of classical maximum likelihood (ML) estimates
in GLMMs with binary responses. ML inference requires numerical integration over the
random effects, for which penalized quasi likelihood (PQL) or adaptive Gauss Hermite
quadrature (GHQ) are the two most common approaches. In response to the increasing
usage of GLMMs in ecology and evolution, an overview of commonly used software
packages for GLMMs has been published [4]. A detailed comparison of the estimates
obtained by different statistical software packages has identified substantial differences
[5], e. g . between PROC NLMIXED in SAS and the function glmer() in R, although both use
adaptive GHQ integration. Also, the accuracy of Bayesian and ML estimation methods
has been compared [6], who also consider results with INLA produced in the simulation
study by [2].
∗Corresponding author. Email: rafael.sauter@uzh.ch
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Unfortunately, there is no analytical expression for the approximation error of INLA
[1]. A straightforward way to assess INLA’s accuracy is a direct comparison with MCMC.
Alternatively, the accuracy of INLA in binary response models has been contrasted with
the computationally more intensive expectation propagation (EP) algorithm [1] originat-
ing from the machine learning literature [7, 8].
There seems to be room for further comparisons of INLA and MCMC in other scenarios
than investigated so far. We challenge INLA with a special but still realistic situation, in
which not only INLA but also other estimation methods may run into problems. Specif-
ically, we consider a situation, where a covariate is (almost) perfectly classifying the
response, known as (quasi) complete separation [9]. For longitudinal data with binary
response, cluster-specific (quasi) complete separation may occur if a patient shows no
variation in the response, i. e. has longitudinal profile (0, . . . , 0) or (1, . . . , 1). Based on
longitudinal data from a clinical trial on the presence of toenail infections and an addi-
tional simulation study, we show that in this case the INLA parameter estimates do not
agree with those obtained by MCMC or ML. Further we assess the root mean squared
error and bias of the parameter estimates by INLA in a second simulation study. Cluster-
specific quasi-complete separation causes a bias for INLA which implies a substantially
lower accuracy than reported elsewhere [2, 3, 6].
This paper is organized as follows. We start by reviewing likelihood and Bayesian infer-
ence in GLMMs in Section 2. In Section 3, we empirically compare parameter estimates
obtained from applying INLA, MCMC and ML to the toenail clinical trial data. Section
4 describes results from two simulation studies with varying degree of cluster-specific
quasi-complete separation. We close with some discussion in Section 5.
2. Inference for binary response mixed model
Consider a GLMM for (possibly unbalanced) longitudinal data with binary response
yij ∈ {0, 1} from individuals i = 1, . . . , I at occasions j = 1, . . . , ni, linked to times tij at
which the measurements are taken. The total number of observations is n =
∑I
i ni. The
logistic mixed model
logit(piij) = x
>
ijβ + z
>
ijbi
assumes that the binary observations yij are conditionally independent, given the random
effects bi, with success probability piij = Pr(yij = 1 |β,bi,D). Here xij is a vector of
length p with explanatory variables and associated fixed effects vector β. The cluster-
specific random effects bi are linked to the covariate vector zij of length q. The random
effects are assumed to follow a multivariate normal distribution, i. e. bi ∼ N (0,D).
In the random intercept (RI) model, q = 1, zij = 1 and D is defined by only one
hyperparameter δ = σ2b , the variance of the random intercept. For a random intercept and
slope model (RI+RS), q = 2, zij = (1, tij)
> and the covariance matrix D consists of three
hyperparameters δ, two random effect variances on the diagonal and the corresponding
correlation.
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2.1. Likelihood inference
Likelihood inference is based on the marginal likelihood of the GLMM. The marginal
likelihood contribution of individual i is
f(yi |β,D) =
∫ ni∏
j=1
f(yij |β,bi)f(bi |D)dbi (1)
where f(·) denotes either a probability mass or a density function and yi =
(yi1, . . . , yini)
> is the response vector of the i-th individual.
Corresponding to yi the matrices xi and zi collect the fixed and random effect vectors
for all ni observations and are of dimension ni × p and ni × q. In a linear mixed model,
the individual marginal likelihood follows a multivariate normal distribution with mean
equal to xiβ and covariance matrix ziDz
>
i + σ
2Ini , here Ini is the identity matrix of
dimension ni. This is not the case for a GLMM with non-normal response, where numer-
ical integration over the q-dimensional vector bi is required to compute (1). This task
is usually solved by numerical integration e. g . via the Laplace approximation [10]. An
alternative approach is based on PQL [11], where bias-corrections are available [12, 13],
or the GHQ-approximation, which can be improved by selecting the points, at which
the function is evaluated, adaptively [14]. Increasing the number of quadrature points
also increases the accuracy of this approximation. With a single quadrature point the
GHQ-approximation reduces to the Laplace approximation. In practice, numerical opti-
mization of the marginal likelihood with respect to β and D is performed with random
effects fixed at the empirical Bayes estimates b˜i. Finding b˜i for fixed β and D is the
first step and numerical optimization of the approximated likelihood is the second step,
which both are iteratively updated until convergence is reached.
2.2. Bayesian inference
A Bayesian GLMM is a hierarchical model with three stages. The first stage is a model
f(y |θ) for the observed data y, given the unknown parameters θ = (β>,b>1 , . . . ,b>I )>.
The second stage f(θ | δ) is the distribution of θ, given unknown hyperparameters δ. For
a GLMM the distribution f(θ | δ) is assumed to be Gaussian, such that the GLMM can
be described as a Gaussian Markov random field (GMRF) with precision matrix Q(δ) =
D(δ)−1 [15]. The GMRF is controlled by a relatively small number of hyperparameters
δ. The corresponding prior distribution f(δ) is the third stage of the formulation. In
GLMMs, the hyperparameters δ describe the covariance structure of the random effects.
The posterior distribution of θ and δ is
f(θ, δ |y) ∝ f(δ)f(θ | δ)
I∏
i=1
f(yi |θ, δ)
∝ f(δ) |Q(δ) | 12 exp
{
−1
2
θ>Q(δ)θ +
n∑
i=1
log f(yi |θ, δ)
}
and one of the major goals is to calculate the marginal posterior distribution of the k th
component of θ:
f(θk |y) =
∫
δ
∫
θ−k
f(θ, δ |y)dθ−kdδ =
∫
δ
f(θk | δ,y)f(δ |y)dδ, (2)
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here θ−k denotes all components of θ except the k th one. Usually MCMC sampling
is used to generate samples from f(θk |y). A binary response GLMM may require ad-
vanced sampling algorithms such as block updating [16, 17]. The computationally less
intensive INLA approach [1] approximates the marginal posterior distributions by first
applying a Laplace approximation [10] to the posterior distribution of δ and a second
Laplace approximation to the posterior of the components of θ for selected values of δ.
INLA uses numerical integration over the hyperparameters to finally obtain the marginal
posterior distributions f(θk |y) of all components of θ. Three different approximation
strategies to the first component f(θk | δ,y) in equation (2) are discussed in [1]: the first
is the least accurate and uses a Gaussian approximation, the second is more precise and
computationally more intensive and applies a Laplace approximation while the third is
intermediate in accuracy and computing time and uses a simplified Laplace approxima-
tion. For all computations involving INLA, we used the intermediate simplified Laplace
approximation strategy.
Bayesian inference requires specification of a prior distribution for f(β) and f(δ). A
common approach, also employed in this paper, are independent normal distributions
with large variance, e. g . 1/σ2β = 0.0001, for each component of β. In the RI model, we
follow the approach by [2] and use an inverse gamma IG(a1, a2) prior [18] for the variance
σ2b . Integration over the hyperparameter for a normal distributed f(bi |σ2b ) results in a
marginal t(0, a2/a1, 2a1) distribution [18]. For this marginal t distribution a range is
defined, which covers the odds ratio exp(bi) with a probability of 95%. The values a1 =
0.5 and a2 = 0.00802 for the inverse Gamma prior f(σ
2
b ) are derived from the relationship
between the marginal t distribution f(bi) and the assumed range for exp(bi), which is
[0.2, 5] in this case. The same derivation with a range of [0.1, 10] for exp(bi) was used by
[2, 3]. As discussed by [2] the same approach to determine an informative prior can be
extended to the RI+RS model. In the RI+RS model, the covariance matrix D is assumed
to follow an inverse Wishart IWi(r,R) distribution [18], where r = 5 and R is a diagonal
matrix with entries equal to 1.34.
2.3. Quasi-complete separation
Fitting a logistic regression model is problematic if a covariate perfectly predicts the
response. Such a covariate implies that the ML estimate will be infinite as the likelihood
is increasing monotonically. Although a perfect predictor is desirable, one would rarely
accept such an extreme estimate based on a finite sample. The problem of divergent ML
estimates for such a data configuration is defined as complete separation [9]. A weaker
form is quasi-complete separation which occurs if the covariate predicts a subset of the
response vector perfectly. Quasi-complete separation leads to infinite ML estimates for
the covariate almost perfectly predicting the response but not for additional covariates,
if present, which explain the remaining variation in the response.
In the particular case of a binary covariate, which completely separates the response,
the corresponding 2×2 table has no off-diagonal entries. For a quasi-complete separation
only one of the off-diagonal entries would be zero. A continuous covariate implies complete
separation if e. g . for all negative values the response is one and for all positive values the
response is zero. Quasi-complete separation is present if additionally for covariate values
equal to zero the response is either one or zero.
Divergent ML estimates caused by complete separation in generalized linear models
(GLMs) may be addressed by a penalized likelihood approach [19]. The suggested pe-
nalization depends on the inverse Fisher information matrix and is related to Jeffreys’
invariant prior [19]. For a logistic regression with a completely separating binary co-
variate this approach corresponds to adding 1/2 to each cell of the 2 × 2 table. While
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removing the small sample bias the penalized likelihood approach yields consistent es-
timates [19] and there exist different approaches to improve the coverage probability of
the corresponding confidence intervals [20, 21].
Addressing quasi-complete separation in a logistic regression model with random in-
tercept is discussed by [22]. However, complete separation may now be not only fixed
covariate-specific but also be cluster-specific, affecting the random effects bi. More specif-
ically, if the grouping covariate, which defines the random effect clusters, is separating
the response, we encounter a cluster-specific complete separation for the random inter-
cepts. For a logistic mixed model this occurs if all components of yi are either equal to
one or equal to zero. We have a cluster-specific quasi-complete separation if this occurs
only for some i but not all I clusters.
The assumption bi ∼ N(0,D) penalizes deviations of bi away from zero which in
the case of cluster-specific quasi-complete separation stabilizes the marginal likelihood
such that the estimates for bi are defined. But the penalization decreases if the covari-
ance matrix of the random effects D increases such that the parameter estimates bi
are not treated different from the fixed effects if D−1 → 0. Thus in the extreme case
of cluster-specific complete separation, the ML estimates for bi will not be defined, as
the penalization term vanishes with the random effects variance going to infinity. For
a random intercept plus random slope model the penalization term may be increased
through the random effects correlation, if only one of the two random effect covariates is
causing quasi-complete separation.
Depending on the degree of cluster-specific quasi-complete separation, i. e. the propor-
tion of clusters with constant response, convergence problems will arise in the numerical
optimization algorithms described in Section 2.1. Also depending on how many clusters
are perfectly predicted by the grouping covariate, the normal assumption for the ran-
dom effects may be inappropriate. Indeed, random effect estimates tend to have extreme
values in the presence of cluster-specific quasi-complete separation.
Bayesian inference for GLMMs addresses the complete separation problem in random
effects by an additional, possibly informative prior f(δ) [23]. The prior distribution f(δ)
needs to be proper [24], so the posterior f(θ, δ |y) will also be proper. Nevertheless,
even for Bayesian inference, numerical problems may arise with increasing degree of
quasi-complete separation.
3. INLA vs. MCMC for toenail infection data
The data considered in this section are the result from a randomized, double-
blinded clinical trial comparing two oral treatments for toenail infections [25–27]. The
data are available on http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%
291467-9876/homepage/50_3.htm. The primary response was the degree of onycholy-
sis, i. e. the degree of separation of the nail plate from the nail-bed. The response was
classified into absent, mild, moderate or severe onycholysis and was further aggregated
to a binary response with either absent or mild (0, not severe) or moderate to severe (1,
severe) degree [26, 27].
Follow-up visits were planned to take place 1, 2, 3, 6, 9 and 12 months after baseline.
However, the actual times tij of follow-up visits varied around the foreseen schedule and
some patients have less than 6 follow-up measurements due to drop out. For the following
analysis 5 patients with no follow-up measurements have been removed such that the
dataset consists of 1903 observations from 289 individuals. There are 160 patients who
stay always in the not severe state throughout the observation period and 14 patients
who remain always in the severe state, while all remaining 115 patients change their
5
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disease state at least once. Time since baseline was centred at the overall mean in order
to improve the mixing of the MCMC algorithm [23]. The fixed effects for all models
consist of an intercept, the treatment effect, the centred time since baseline in months
and the interaction for centred time and treatment, i. e. xij = (1, trti, tij , tij × trti)>.
The toenail infection data is analysed with a binary response RI (zij = 1) and with a
RI+RS (zij = (1, tij)
>) model. The RI model has only one hyperparameter which is
the random intercept variance σ2b . For the RI+RS model the random effect covariance
matrix D is defined by three hyperparameters: the variance for the random intercept σ2b1 ,
the variance for the random slope σ2b2 and the correlation parameter between the two
variances ρ.
INLA is implemented in a software package and an R-interface is available on http:
//www.r-inla.org/. We used the r-inla version built on 14. July 2014. All MCMC
sampling was done with JAGS [28] through the R-interface R2jags and the R-package
coda [29]. For binary or binomial response data, JAGS uses the algorithms proposed
by [17] and [30]. Still we used a relatively large number of 500’000 MCMC iterations
with 20’000 additional burnin iterations and thinning of 200 in both models, the RI and
RI+RS model, to reach convergence and to ensure a negligible Monte Carlo error of the
parameter estimates. ML estimation of the models was undertaken with the R package
lme4 [31], version 0.999999-2. We did not use the latest lme4 version because it restricts
the maximal number of quadrature points in the GHQ-approximation to 25 for the RI
model and to 1 for the RI+RS model. In the RI model we use 20 quadrature points for
the one-dimensional integration and the results are the same as with the current lme4
version, whereas we use 50 quadrature points for the two-dimensional integration over
the joint random effects distribution in the RI+RS model. All computations were done
with R version 2.15.3 (2013-03-01). See Appendix A for more details about the influence
of the number of quadrature points for the toenail data models.
We compare the ML estimates with the marginal posterior means for all components
of β, while fixing the hyperparameters δ for the Bayesian methods at the ML estimates.
Under an uninformative prior for the components of β and without any uncertainty in
the hyperparameters, the posterior means should be very close to the ML estimates.
The only difference between the ML estimate and the mean of the marginal posterior
distribution of a fixed effect is the integration over both, random and the remaining fixed
effects, while the marginal likelihood only integrates over random effects. Alternatively,
the (joint) posterior mode could be used, but this is not the standard output for r-inla,
which is approximating the marginal posteriors. Anyhow, posterior means and modes will
coincide to a reasonable accuracy, since the posterior of β is known to be asymptotically
Gaussian.
3.1. Differences in the parameter estimates
The estimated marginal posterior densities of β for both the RI and the RI+RS model are
shown in Figure 1. Both are obtained using a fully Bayesian approach with hyperpriors for
δ as described in Section 2.2. Each histogram is based on the MCMC samples provided by
JAGS and the lines show the corresponding marginal posterior density estimate produced
by r-inla. For the RI model in the upper row of Figure 1 we see that MCMC and INLA
agree rather well for all fixed effects, except for the time covariate, where there is a slight
shift towards zero for the posterior by INLA compared to the MCMC histogram. In the
lower row of Figure 1 we see more substantial differences between INLA and MCMC for
the treatment effect and the interaction between time and treatment.
Figure 2 shows the posterior distributions of the same fixed effects and the same mod-
els as in Figure 1 but now with hyperparameters fixed at values which were determined
6
- 70 - Paper II
0.
0
0.
4
0.
8
β
 
  intercept
po
st
er
io
r d
en
sit
y 
of
 β
−6 −4 −2
0.
0
0.
4
0.
8
RI model
β treatment
po
st
er
io
r d
en
sit
y 
of
 β
−3 −1 1
0
2
4
6
8
β time
po
st
er
io
r d
en
sit
y 
of
 β
−0.6 −0.4 −0.2
0
2
4
6
β time × treatment
po
st
er
io
r d
en
sit
y 
of
 β
−0.5 −0.2 0.1
0.
0
0.
2
0.
4
0.
6
β intercept
po
st
er
io
r d
en
sit
y 
of
 β
−11 −7 −3
INLA MCMC
0.
0
0.
2
0.
4
RI+RS model
β
 
  treatment
po
st
er
io
r d
en
sit
y 
of
 β
−6 −2 2
0.
0
1.
0
2.
0
3.
0
β time
po
st
er
io
r d
en
sit
y 
of
 β
−1.4 −0.7 0.0
0.
0
1.
0
2.
0
β time × treatment
po
st
er
io
r d
en
sit
y 
of
 β
−1 0 1
Figure 1. Marginal posterior distributions of fixed effects β with MCMC (histogram) and INLA (line).
by ML with lme4. The additional red lines now give approximate normal “posterior”
distributions based on the ML estimates and the corresponding standard errors. In all
plots of Figure 2 we see that the approximate posterior distributions based on the ML es-
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Figure 2. Marginal posterior distributions of β by MCMC (histogram), INLA (black line) and based on ML
estimates (red line). Hyperparameters values are fixed at corresponding ML estimates.
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timates agree well with the MCMC histograms. However, the posterior density estimates
provided by INLA exhibit a substantial bias for the intercepts of both the RI and the
RI+RS model. There is also some discrepancy for the other fixed effects in the RI+RS
model.
The upper half of Table 1 summarizes the differences between the posterior mean
estimates obtained with INLA or MCMC and with ML estimates. In the lower half of
Table 1, relative differences are given, by scaling the differences from the upper part
with the MCMC marginal posterior standard deviation, in the same way as done in
the simulation study by [2]. The left part of Table 1 reports differences for the RI, the
right half for the RI+RS model. For comparison with the ML estimates, we fixed the
hyperparameter of the RI model at the ML estimate σ2b=16.04. For the RI+RS model
the random intercept variance was fixed at σ2b1 =47.75, the random slope variance at
σ2b2 = 1.04 and the correlation at ρ = -0.05.
Table 1. Differences (top) and relative differences (bottom) between parameter estimates obtained with MCMC,
INLA and ML for the RI (left) and the RI+RS (right) model. Relative differences are scaled with the MCMC
marginal posterior standard deviation. Comparisons of INLA and MCMC with ML are based on hyperparameter
values fixed at the corresponding ML estimates.
RI model RI+RS model
MCMC ML ML MCMC ML ML
INLA INLA-fix MCMC-fix INLA INLA-fix MCMC-fix
intercept -0.073 0.225 0.014 0.101 1.228 0.038
treatment -0.041 0.038 -0.003 -0.651 -0.362 -0.012
time -0.024 -0.003 0.003 0.000 -0.056 0.000
time × treatment -0.006 0.000 -0.001 -0.184 -0.119 0.007
intercept -0.156 0.557 0.034 0.104 1.692 0.053
treatment -0.067 0.068 -0.006 -0.661 -0.346 -0.011
time -0.519 -0.075 0.070 0.001 -0.424 0.000
time × treatment -0.084 -0.004 -0.018 -0.990 -0.593 0.037
We see especially from the lower part of Table 1 that INLA shows large relative differ-
ences compared to MCMC but also to ML. While the relative differences in the RI model
are not larger than 0.519, the differences are substantially larger in the RI+RS model
with values up to 0.99. Relative differences also increase if we compare INLA with ML,
to a maximum of 0.557 for the RI model and 1.692 for the RI+RS model. In contrast,
the estimates based on MCMC are much closer to the ML estimates, with a maximum
relative difference of 0.07.
The differences shown in the upper half of Table 1 for the RI-model may be con-
sidered as acceptable, with a maximal difference of 0.073 on the log-odds ratio scale.
However, more substantial discrepancies can be seen for the RI+RS model, in particular
for comparisons involving INLA estimates. See Table 1 in Appendix B for the fixed effect
estimates of the models presented in Figure 1, 2 and Table 1.
The argument inla.control includes several settings which can be modified and which
affect the accuracy of the numerical integration of the hyperparameters in r-inla. We
increased the numerical accuracy and set the step length for the integration to dz = 0.2
from the default value dz = 1, the step length for the gradient calculations to h = 1e-5
from default h = 0.01, the tolerance criteria for the change in the posterior to tolerance
= 1e-6 from default tolerance = 0.005 and we changed the integration strategy to
int.strategy = "grid" which uses as default the less accurate central composite design
(int.strategy = "ccd"). The differences between the posterior distributions shown in
Figure 1 and 2 only improved slightly by using these settings, compared to the default
ones.
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Figure 3. Random effect estimates bi for the RI and the RI+RS model. Estimates are marginal posterior means
obtained by MCMC.
Throughout the paper we used the default simplified.laplace approximation strat-
egy in r-inla. Changing the approximation strategy to laplace did not reduce the
differences for the posterior distributions as illustrated in the Supplementary Material.
Additionally, Figure 2 in the Supplementary Material shows the marginal posterior dis-
tributions for the hyperparameters, which are substantially different for INLA compared
to ones based on MCMC.
3.2. Cluster-specific quasi-complete separation
Table 1 in Section 3.1 clearly indicates that differences between MCMC and INLA,
relative to the MCMC standard deviation, exceed the previously reported 30% for binary
response GLMMs [2]. A correction in the location of the posterior distribution has been
recommended as a possible error-correction [1]. But none of the different approximation
strategies did improve the location shift of the marginal posteriors obtained by INLA.
The differences between INLA and MCMC got even more pronounced if the time variable
was not centred.
A closer look at the random effect estimates, obtained by MCMC, gives some interest-
ing details. Figure 3 gives histograms of the means of the marginal posterior distribution
for the random effects. The upper part shows the random effect estimates for the RI and
the lower part for the RI+RS model. An additional scatter plot gives the joint distri-
bution of estimated random intercepts and slopes in the RI+RS model. Three clusters
can be distinguished: there are 160 patients, who always stay in the non severe state
during the observation period (marked with a red circle), 14 patients who stay always in
the severe state (marked with a blue cross), while the remaining 115 patients (marked
with black triangles) switch their health state at least once. Figure 3 indicates that pa-
tients without any variation in the response build clusters and take extreme values for
the random effect estimates. As a result, the empirical distribution of the random effect
9
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estimates does not resemble a normal distribution. This hints to a substantial cluster-
specific quasi-complete separation problem for the toenail data, as discussed in Section
2.3.
However, there are two patients who are always in the severe response category but
their random intercept does not cluster with random effects from the other patients who
always stay in the severe state. The reason for the comparably low random intercept is
that these two patients are only observed at two, respective three follow-up visits. Thus
they are not close to the patients who were observed seven times in the severe response
state. Also they were only observed at centered times below zero such that their random
slope estimate is negative. On the other hand there is one random effect which is close to
the cluster of random effects for patients always being in the same state, although this
patient switches the response. This patient was observed at seven occasions but only at
the very last observation a moderate infection was declared, such that this profile is very
similar to having always a response equal to one.
4. Simulation with varying cluster-specific quasi-complete separation
To assess a possible problem of INLA with cluster-specific quasi-complete separation in
more detail, we undertook two simulation studies, with a varying proportion of cluster-
specific quasi-complete separation. The first study is based on one simulated dataset
only, for which we manipulate the response such that the proportion of patients always
having response equal to zero changes. The results are used to examine if the differences
between INLA and MCMC respectively ML, discussed in Section 3.1, are persistent or
just a random artefact of the toenail data. In the second simulation study we investigate
the accuracy of the parameter estimates by INLA by randomly generating replicates of
the dataset and assessing the root mean squared error and bias.
In Section 4.1 and 4.2 we simulate balanced datasets with n observations per patient
otherwise similar to the toenail infection data. The observed time period ranges from
-4.5 to 4.5 and the time differences between follow-up visits are rescaled according to the
choice of n. We set the fixed effect for time to 0.8 and for the time treatment interaction
to -0.8 while the main effect for treatment is assumed to be zero. The random intercept
standard deviation σb is set to two.
4.1. Comparison of estimation methods by changing the response
For the comparison of the three estimation methods we generated one initial dataset,
with I = 300 patients observed at baseline and six follow-up visits (n = 7). The simulated
dataset was guaranteed to have an initial proportion of patients with constant response
profile fixed at 5% of all patients. We then successively started to manipulate the response
of this dataset and increased the proportion of patients who always remain in state zero
by another 5% or 15 patients, until we reached a proportion of 75%. In this way we
continually increased the degree of cluster-specific quasi-complete separation in the data.
The plots in Figure 4 show the absolute differences between the parameter estimates
by INLA, MCMC and ML. As before, the comparison with ML is based on fixed hyper-
parameters. The upper half in Figure 4 shows these differences for a RI and the lower
part for a RI+RS model. We see that INLA and MCMC agree well if there is only a low
proportion of patients who always remain in the same health state. But with increasing
proportion of patients with a constant response profile, the differences between MCMC
and INLA increase. If the proportion is 40% or larger, we see substantial discrepancies.
The same pattern is visible in the middle panel of Figure 4, where INLA is compared
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Figure 4. Absolute differences between the marginal posterior means obtained with INLA and MCMC and with
ML estimates for simulated data with increasing degree of cluster-specific quasi-complete separation for a RI
(upper row) and RI+RS (bottom row) model. Hyperparameters were fixed at the ML estimates for comparisons of
INLA and MCMC with ML. The value for the absolute difference of the intercept between ML and INLA (δ fixed)
with a proportion of 75% of patients always in the not severe state is 3.1 and not shown in the corresponding plot.
with ML. Here the differences for the fixed intercept seem to increase even more quickly.
The last column in Figure 4 compares MCMC with ML which does not show any large
differences, even for a large proportion of patients with a constant response profile. The
few occasional differences between MCMC and ML for the RI+RS model, shown in the
bottom right plot of Figure 4, may be explained by the unstable fixed effect parame-
ter estimates based on lme4 (see Appendix A). In this simulation we always used 40
quadrature points in the GHQ-approximation.
4.2. Assessment of root mean squared error and bias
The comparison of methods in Section 4.1 shows that discrepancies between INLA and
the other two methods increase along with increasing degree of cluster-specific quasi-
complete separation. Therefore we assess the accuracy of INLA estimates in the following
simulation study. In order to keep the scope limited we report results for the random
intercept model only. There are three parameters which we allow to vary, the number of
patients I, the number of observations per patient n and the fixed intercept. We used
four different settings with I equal to 50 or 125 and with n equal to 10 or 25. The fixed
intercept is varying from -8.5 to -2 by 0.5 steps such that the proportion of patients always
observed in the same state is varying. The fixed intercepts were chosen such that a large
range of cluster-specific quasi-complete separation results in the simulated datasets. For
a given fixed intercept the proportion of patients always observed in the same state is not
necessarily the same across the four different scenarios. Still the range of cluster-specific
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Figure 5. RMSE for marginal posterior means of fixed effects β for a RI model based on 1’000 iterations with
different number of patients I and number of observations per patient n.
quasi-complete separation reaches from below 20% to above 80% in all four simulations.
For each of the 14 different intercepts and for each of the four scenarios we iteratively
simulate 1’000 datasets, resulting in 56’000 r-inla calls. We rule out any datasets which
include a complete separation of the response given the treatment, which would result in
diverging fixed effect estimates and repeat the iteration if this occurs. For the four param-
eter combinations we report the root mean squared error RMSE=
√
1/N
∑N
i=1(βˆi − β)2
in Figure 5 and the bias 1/N
∑N
i=1 βˆi − β in Figure 6 based on the marginal posterior
means.
Figure 5 shows for all four combinations of I and n an increasing RMSE with increasing
proportion of patients always having the same response for all fixed effect estimates.
Although the simulation with n = 10 and I = 125, in the bottom left plot, has a
lower RMSE compared to the other three scenarios. The RMSE in all plots of Figure 5 is
increasing with increasing quasi-complete separation Figure 6 illustrates that there is also
an increasing bias with increasing proportion of quasi-complete separation. Compared to
the other three scenarios Figure 6 shows that for I = 125 and n = 10 the assessed bias
is relatively small.
Although the intercept has the largest bias also the other fixed effects are affected
increasingly by increasing cluster-specific quasi-complete separation. This is in line with
the results for the toenail dataset in Section 3.1 and also with the simulation in Section
4.1, where the estimates for the intercept based on INLA had the largest difference
compared to the other two methods.
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Figure 6. Bias for marginal posterior means of fixed effects β for a RI model based on 1’000 iterations with
different number of patients I and number of observations per patient n.
5. Discussion
We showed that the approximation error by INLA increases for binary response GLMMs
if the data shows a substantial and increasing degree of cluster-specific quasi-complete
separation. INLA estimates agree rather well with MCMC and ML, unless the degree of
cluster-specific quasi-complete separation is high. The simulation in Section 4.1 disclosed
already large discrepancies if the proportion of patients with a constant response is 40%.
Differences shown in Figure 4 are in the same range as the ones found for the toenail
infection trial in Section 3.1, where 55.4% of the patients always stayed in the not severe
state. This large degree of cluster-specific quasi-complete separation causes INLA to fail
to produce reliable parameter estimates.
This was confirmed by the simulation study in Section 4.2, which illustrated that
the RMSE as well as the bias increases with increasing proportion of patients always
being in the same state. Although MCMC sampling is known to converge to the true
posterior distribution if the number of samples is large enough, it would require much
more computing time to analyse the same number of replicated datasets. However, INLA
is much faster than MCMC, required less than 10 seconds per call and thus it was possible
to assess the RMSE and bias with r-inla based on this rather large number of replicates
with modest computational effort.
As illustrated in Appendix A also ML estimation may result in numerical instabilities
in such situations and MCMC may request a large number of iterations. However, only
INLA shows already at a comparably low degree of cluster-specific quasi-complete sep-
13
Paper II - 77 -
aration a systematic bias. This finding contrasts the results by [2] and [3], who do not
investigate this scenario and thus are too optimistic regarding INLA’s accuracy.
In the context of Bayesian inference most often critique is directed to the choice of the
prior distributions. Usually one would assume that there must be a possibly very infor-
mative prior, which helps to stabilize the deteriorating INLA estimates if cluster-specific
quasi-complete separation is present. We thus looked at different prior specifications for
the hyperparameters. It has been argued [23] that an inverse gamma prior on the ran-
dom effects variances may result in large sensitivity of parameter estimates. Indeed, the
alternative half-normal prior distribution on σb [23] shows less prior sensitivity [32]. We
therefore investigated if part of the discrepancies between INLA and MCMC are due to
the inverse gamma prior in the RI model. Naturally, as consequence of adapting the prior,
the parameter estimates changed for the toenail data. However, the differences between
INLA and MCMC did not decrease, such that our main findings persisted under the
alternative half-normal, and also under more informative prior specifications. Another
model modification is to relax the normality assumption for the random effects in the
RI model and to use a t-distribution. This model can be considered in r-inla [33], but
differences still did not decrease substantially.
Alternatively, the non-normal distribution of the random effects, shown in Figure 3,
suggests to use a mixture of normal distributions [34, 35]. This formulation has been
shown to provide a better fit to the data [36]. However, implementation of such a mix-
ture model in INLA is not straightforward and a combination with an expectation-
maximization (EM) type algorithm might be required [37].
Nevertheless there are possibly ways in how this specific problem could be addressed
in INLA to improve its performance, e. g . in [1] section 6.1 a possible alternative way to
approximate the posterior marginals for the hyperparameters based on a Gaussian copula
is mentioned. Finally it is important to highlight that (quasi) complete separation in
mixed models is not INLA related, but a general problem, for which awareness should be
high, indifferently what kind of inference is applied. If encountering cluster-specific quasi-
complete separation for a binary response GLMM based on longitudinal data, one could
perhaps avoid this by Markov models based on time-dependent transition probabilities
Pr(yij = 1 | yi(j−1),β,bi,D) instead of Pr(yij = 1 |β,bi,D) as discussed in [27, 38].
If using INLA for a binary, or even binomial GLMMs, one should always pay some
effort in investigating if there is cluster-specific quasi-complete separation present in the
data. In practice one should check if the variance for the hyperparameters is large and
if there are clusters with very high and very low random effect estimates. These may be
valuable hints towards a possible large cluster-specific quasi-complete separation, which
requires further investigation, as INLA may under these circumstances provide biased
parameter estimates.
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Appendix A. ML estimation for toenail data and varying quadrature points
The choice of the number of quadrature points may have an influence on the fixed effect
estimates in RI and RI+RS models [26]. Specific implementations may differ in different
software packages [5]. We illustrate in Figure A1 that the fixed effect estimates for the
toenail data are varying with the number of quadrature points used in the adaptive
GHQ-approximation. This confirms the findings by [26] who compared adaptive and non-
adaptive GHQ-approximation. Figure A1 shows differences for the fixed effect estimates
obtained by PROC NLMIXED in SAS and lme4 in R confirming the findings by [5] who also
state a large difference between the two software implementations. Figure A1 suggests
that, to obtain accurate estimates, the RI+RS model needs more quadrature points than
the simpler RI model. Strikingly, the fixed effects obtained by lme4 start to vary again
for more than 81 quadrature points. Additionally lme4 repeatedly produced a warning
message resulting from the optimization algorithm nlminb which is indicated by small
bars at the bottom of the two glmer plots. For 82 and 83 quadrature points, indicated
with crosses, glmer aborted with an error message.
Again the lme4 version 0.999999-2 was used, as the number of quadrature points is
hard coded to a maximum of 25 in later versions. The R version 2.15.3 (2013-03-01) was
used. If a newer R version together with lme4 version 0.999999-2 is used, convergence
criteria and related error and warning messages may be different. For SAS we used version
9.3. In contrast to the text above, models shown in Figure A1 are based on the data with
uncentred timescale. Due to randomization of the trial and the uncentred timescale the
treatment effect was omitted for the models here.
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Figure A1. Fixed effects estimates for toenail data with varying number of quadrature points. A x indicates that
glmer finished with ”Error message: Downdated X’X is not positive definite, 1.” and | that glmer finished with
”Warning message:In mer finalize(ans) : false convergence (8)”.
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Appendix B. Parameter estimates for RI and RI+RS model for toenail data
Table B1. Fixed effect estimates and hyperparameters by INLA, MCMC and ML estimation for the RI (upper
part) and RI+RS model (lower part). For the fixed effects the standard errors are shown in parentheses. For INLA
and MCMC the means of the marginal posterior distribution are shown. The last two columns show the results if
the hyperparameter values are fixed at the estimates obtained by ML.
INLA MCMC ML INLA-fix MCMC-fix
intercept -3.441 -3.515 -3.482 -3.707 -3.495
(0.406) (0.469) (0.396) (0.386) (0.404)
treatment -0.737 -0.778 -0.753 -0.791 -0.749
(0.507) (0.605) (0.571) (0.552) (0.566)
time -0.372 -0.396 -0.390 -0.387 -0.393
(0.0404) (0.0460) (0.0434) (0.0402) (0.0435)
time × treatment -0.133 -0.139 -0.139 -0.139 -0.138
(0.0618) (0.0705) (0.0709) (0.0640) (0.0696)
σ2b 12.848 16.858 16.036
intercept -6.280 -6.180 -6.588 -7.816 -6.627
(0.797) (0.974) (0.766) (0.703) (0.726)
treatment -0.848 -1.499 -1.593 -1.231 -1.581
(0.818) (0.985) (1.144) (1.039) (1.047)
time -0.761 -0.761 -0.824 -0.768 -0.824
(0.147) (0.175) (0.151) (0.136) (0.132)
time × treatment -0.144 -0.328 -0.344 -0.224 -0.351
(0.184) (0.186) (0.239) (0.211) (0.201)
σ2b1 25.7083 42.7380 47.7495
σ2b2 0.7441 0.9055 1.0356
ρ 0.0249 -0.0742 -0.0531
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This supplementary material provides additional information to the main text of
the paper "Quasi-complete Separation in Random Effects of Binary Response Mixed
Models". The supplementary material contains additional information to the random
intercept (RI) and the random intercept plus random slope (RI+RS) models, presented
in the main text in Section 3. In Section 1 the marginal posterior distributions for
the fixed effects and the hyperparameters obtained with integrated nested Laplace ap-
proximations (INLA) with the simplified Laplace approximation approach and with
the full Laplace approximation are compared. Section 2 provides convergence dia-
gnostics for the models parameters obtained with MCMC.
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1 Simplified and full Laplace approximations in INLA
The following plots compare the marginal posterior distributions of the fixed effect
parameters and hyperparameters obtained with INLA and MCMC. For the simplified
Laplace approximation the inla.control option is set to
control.inla = list(
strategy = "simplified.laplace",
int.strategy = "grid",
h = 1e-5,
tolerance = 1e-6)}
which are the settings used also for the results reported in the main text. For the
full Laplace approximation the inla.control option is set to
control.inla = list(
strategy = "laplace",
fast = FALSE,
int.strategy="grid",
h = 1e-5,
tolerance = 1e-6)
for which the results are reported in the following Figure 1 to 3. In general the full
Laplace approximation in INLA is more accurate compared to the simplified Laplace
approximation but in most cases nearly coincide according to ?. However, for the
RI and RI+RS models of the toenail infection data we found substantial differences
between the two approximation strategies and the simplified Laplace approximation
was closer to the results obtained by MCMC, if the hyperparameters are not fixed. This
differences may well be related to the problem of substantial cluster-specific quasi-
complete separation. In the main text the reported results are always based on the
simplified Laplace approximation.
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1.1 Estimation with prior distribution
In Figure 1 the marginal posterior distributions for the fixed effects β based on INLA
with simplified and with full Laplace approximation and with MCMC are shown
with a prior distribution on the hyperparameters. The same prior distributions for the
hyperparameters as described in the main text are used. Figure 2 shows the corres-
ponding marginal posterior distributions for the hyperparameters.
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Figure 1: Marginal posterior distributions of β by MCMC (histogram), INLA with sim-
plified Laplace (INLA-SL, black line) and based on INLA with full Laplace
(INLA-FL, red line).
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Figure 2: Marginal posterior distributions of hyperparameters for the RI and RI+RS
models by MCMC (histogram), INLA with simplified Laplace (INLA-SL,
black line) and based on INLA with full Laplace (INLA-FL, red line).
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1.2 Estimation with fixed hyperparameters
In Figure 3 the marginal posterior distributions for the fixed effects β based on INLA
with simplified and with full Laplace approximation and with MCMC are shown with
fixed hyperparameters. The hyperparameters are fixed at the same values as obtained
by ML estimation and as indicated in the main text.
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Figure 3: Marginal posterior distributions of β by MCMC (histogram), INLA with sim-
plified Laplace (INLA-SL fix, black line) and based on INLA with full Laplace
(INLA-FL fix, red line). Hyperparameters values are fixed at corresponding
ML estimates.
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2 Convergence diagnostics
In this section we provide convergence diagnostics of the MCMC run for the RI and
RI+RS model based on the toenail dataset for which the results were presented in
Section 3 in the main text. Convergence diagnostics are reported for all four models,
the RI and the RI+RS model with a prior on the hyperparameters and with fixed
hyperparameters. We show the convergence diagnostics for all fixed effects (β) of
each model, of the hyperparameters if not fixed and for the random effect estimates
of patient 233, who is one of the patients which always had a response value equal to
one, plus two additional random effects of two patients in each model with the two
highest autocorrelations at lag 1 in the MCMC run. For each reported parameter we
show a excerpt of the traceplot, the autocorrelation as well as Geweke convergence
diagnostics.
The excerpt for the traceplot covers the last 500 iterations of the MCMC run from
iteration 1900 to 2400. We only report part of the MCMC run in the traceplot as the
plot based on all 2400 kept iterations does not show any details about structures in
the traceplot. Before reporting this excerpt, each traceplot based on all iterations was
inspected to have possible jumps in the Markov chain. This was not the case for
none of the reported parameters of the four models such that the shown excerpt is
representative for the complete traceplot and thus the mixing of the Markov chain
was found to be sufficient.
The autocorrelation was determined by the function autcorr.diag in the coda pack-
age and the maximum lag length was set to 10. The index in the autcorrelation plots
and the Geweke diagnostic are values without thinning e. g. a autocorrelation for lag 1
has an index equal to iteration 200 in the plot. Except for the intercept, the time, the
time treatment interaction and the hyperparameters in the RI+RS, there is no substan-
tial autocorrelation in the MCMC run of the fixed effect parameters. Even for these
coefficients in the RI+RS model the autocorrelation is modest and drops quickly to
zero after six lags and if hyperparameters are fixed in the RI+RS model there is no
autocorrelation present any more.
The Geweke diagnostics are computed by the function geweke.plot in the coda
package in R. The Geweke statistic compares the posterior means computed based on
the second half of the MCMC iterations with the means computed based on a decreas-
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ing fraction of the first half of the MCMC iterations. The Geweke test statistic is a
standardized z-score based on the difference between the two sample means divided
by its estimated standard error. The standard error is estimated from the spectral dens-
ity at zero and so takes into account any autocorrelation. The plot with the Geweke
diagnostics shows what happens if successively larger numbers of iterations are dis-
carded from the beginning of the chain. The first half of the Markov chain is divided
into 7 segments, for which the Geweke’s Z-score is repeatedly calculated. The first
Z-score is calculated with all iterations in the chain, the second after discarding the
first segment, the third after discarding the first two segments, and so on. The last
Z-score is calculated using only the samples in the second half of the chain. The two
horizontal dashed lines indicated the 2.5% and 97.5% quantile of the standard normal
distribution. A Geweke Z-score which is far away from the dashed lines implies that
the two means, of the first and the second part of the Markov chain, are probably not
equal which implies that the stationary distribution was not reached. The presented
plots with the Geweke statistics show that some of the Geweke Z-scores are outside
the 2.5% or the 97.5% interval but all of them are still close to these quantiles and all
of them have absolute values which are smaller than three.
From this analysis we would finally not reject the hypothesis of convergence to a
stationary distribution of the MCMC run for the presented models. This was clearly
not the case for MCMC runs with a smaller number of iterations, less thinning or
based on different MCMC samplers.
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2.1 Random intercept model (RI) with prior
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Figure 4: Convergence diagnostics for fixed effects of RI model: traceplot, autocorrel-
ation and Geweke diagnostics.
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Figure 5: Convergence diagnostics for hyperparameters and selected random effects
of RI model: traceplot, autocorrelation and Geweke diagnostics.
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2.2 Random intercept model (RI) with fixed hyperparameters
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Figure 6: Convergence diagnostics for fixed effects of RI model with fixed hyperpara-
mters: traceplot, autocorrelation and Geweke diagnostics.
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Figure 7: Convergence diagnostics for selected random effects of RI model with fixed
hyperparameters: traceplot, autocorrelation and Geweke diagnostics.
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2.3 Random intercept and slope model (RI+RS) with prior
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Figure 8: Convergence diagnostics for fixed effects of RI+RS model: traceplot, autocor-
relation and Geweke diagnostics.
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Figure 9: Convergence diagnostics for hyperparameters of RI+RS model: traceplot,
autocorrelation and Geweke diagnostics.
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Figure 10: Convergence diagnostics for selected random effects of RI+RS model: tra-
ceplot, autocorrelation and Geweke diagnostics.
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Figure 11: Convergence diagnostics for selected random effects of RI+RS model: tra-
ceplot, autocorrelation and Geweke diagnostics.
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2.4 Random intercept and slope model (RI+RS) with fixed
hyperparameters
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Figure 12: Convergence diagnostics for fixed effects of RI+RS model: traceplot, auto-
correlation and Geweke diagnostics.
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Figure 13: Convergence diagnostics for selected random effects of RI+RS model: tra-
ceplot, autocorrelation and Geweke diagnostics.
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Figure 14: Convergence diagnostics for selected random effects of RI+RS model: tra-
ceplot, autocorrelation and Geweke diagnostics.
18
- 100 - Paper II
PAPER III
Network meta-analysis with integrated nested Laplace
approximations
Rafael Sauter, Leonhard Held
Paper published in Biometrical Journal.

1038 Biometrical Journal 57 (2015) 6, 1038–1050 DOI: 10.1002/bimj.201400163
Network meta-analysis with integrated nested Laplace
approximations
Rafael Sauter∗ and Leonhard Held
Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84,
CH-8001 Zu¨rich, Switzerland
Received 17 July 2014; revised 23 March 2015; accepted 27 May 2015
Analyzing the collected evidence of a systematic review in form of a network meta-analysis (NMA)
enjoys increasing popularity and provides a valuable instrument for decision making. Bayesian infer-
ence of NMA models is often propagated, especially if correlated random effects for multiarm trials
are included. The standard choice for Bayesian inference is Markov chain Monte Carlo (MCMC) sam-
pling, which is computationally intensive. An alternative to MCMC sampling is the recently suggested
approximate Bayesian method of integrated nested Laplace approximations (INLA) that dramatically
saves computation time without any substantial loss in accuracy. We show how INLA apply to NMA
models for summary level as well as trial-arm level data. Specifically, we outline the modeling of multi-
arm trials and inference for functional contrasts with INLA. We demonstrate how INLA facilitate the
assessment of network inconsistency with node-splitting. Three applications illustrate the use of INLA
for a NMA.
Keywords: Bayesian inference; Integrated nested Laplace approximations; Network
meta-analysis; Node-splitting.
 Additional supporting information including source code to reproduce the resultsmay be found in the online version of this article at the publisher’s web-site
1 Introduction
A systematic review on a particular outcome assembles the evidence of all available and relevant
trials. A meta-analysis is the statistical tool used to analyze the results of the collected trials. The
conventional meta-analysis performs pairwise treatment comparisons only. However, often one is not
only interested in comparing two treatments but in a set of different interventions used to treat the same
outcome. Instead of analyzing a series of pairwise comparisons one can describe the set of treatments
as a network. The evidence, collected by the trials, is available for many but not necessarily for all
possible direct pairwise treatment comparisons in this network. Still we can compare the remaining
treatments indirectly as suggested by Bucher et al. (1997), relying on the evidence obtained by the
observed direct comparisons. The conventional pairwise meta-analysis method in combination with
the idea of indirect treatment comparisons is the cornerstone of a network meta-analysis (NMA) or
mixed treatment comparison.
Analyzing a network of treatments enjoys increasing popularity resulting in an increasingly growing
literature although this approach implies several challenges and is more complicated than the conven-
tional pairwise meta-analysis. Mills et al. (2012) discuss possible biases caused by trials included in a
NMA that are not sufficiently homogeneous or with too different interventions or study populations.
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Mills et al. (2013) give an overview of the implications caused by between trial heterogeneity in a net-
work, comparable to the heterogeneity in a pairwise meta-analysis. They also discuss the consequences
of network inconsistencies. Results based on aNMAmay easily be flawed if these aspects are not taken
into account. See Salanti (2012) for a discussion about the concepts and assumptions behind a NMA
and the growing importance of this method.
Generally, a NMA model can be estimated by maximum likelihood, but the hierarchical structure
of the model may result in a complicated expression for the likelihood that requests numerical
optimization. Alternatively Bayesian inference is often encouraged. The standard way for a Bayesian
inference is Markov chain Monte Carlo (MCMC) sampling that is however computationally
intensive. A fast and accurate alternative to MCMC has been proposed by Rue et al. (2009), the
integrated nested Laplace approximations (INLA) of the marginal posterior distribution of the model
parameters.
In this article, we discuss the inference of NMA with INLA and demonstrate that the estimates
obtained by INLA are very close to the ones byMCMC. In Section 2, we first introduce two established
NMA models, one for summary level and one for trial-arm level data and we show how they account
for heterogeneity and inconsistency. In Section 3, we discuss Bayesian inference of NMAmodels with
INLA. We place emphasis on the incorporation of multivariate random effects for multiarm trials,
inference for functional contrasts and the implementation of the node-split approach to examine
network inconsistencies (Dias et al., 2010). The implementation of NMA in INLA is further illustrated
by three applications in Section 4. A brief discussion is provided in Section 5. Additionally, we provide
R-code in the Supplementary Material that demonstrates the key implementation features of a NMA
with INLA.
2 Statistical models for network meta-analysis
A network for a meta-analysis consists of a number of observed direct pairwise comparisons among
T different treatments. The remaining relative effects among all possible pairwise comparisons are
available by indirect comparisons, if a combination of direct treatment comparisons is observed that
allows to form the indirect comparison. Different pairwise effect measures could be used in an NMA
such as the odds ratio, the risk ratio or the risk difference. See Norton et al. (2012) and van Valkenhoef
and Ades (2013) for a discussion about differences in NMA results if different effect measures are
chosen. In this paper, we exclusively use the odds ratio as effect measure, but other measures could be
used as well.
In Section 2.1, we introduce a NMA model for summary level data. Section 2.2 discusses a NMA
model for trial-arm level data with a binomial outcome. In Section 2.2 the number of events and the
total number of patients is reported on the basis of every trial-arm in the network, in contrast to
summary level data that only report effect measures for each pairwise treatment comparison.
2.1 Summary level data
The model described in this section follows the one described by Lumley (2002). An effect measure
yi jk, here the log-odds ratio, comparing treatment j with k in trial i is observed together with its
squared standard error σ 2i jk for several independent two-arm trials i = 1, 2, . . . ,S. The treatment pair
k, j ∈ {1, . . . ,T } compared in trial i is one combination among T (T − 1)/2 possible combinations.
The log-odds ratio yi jk is assumed to follow a normal distribution and is modeled as
yi jk ∼ N
(
d jk + γi jk, σ 2i jk
)
. (1)
The relative treatment effect d jk is the difference between the treatment effects d j and dk, say, such that
d jk = d j − dk. The observed squared standard error σ 2i jk of each effect measure is used as an inverse
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weight to scale the model variance. The model allows for an additional source of uncertainty by intro-
ducing variation through random effects γi jk. Excessive variation between trials, called heterogeneity,
is captured by the random effects γi jk ∼ N(0, τ 2). This trial-specific heterogeneity captures differences
between trials comparing the same treatments but being different in terms of trial-specific features, for
example differences between study-populations. The random effects variance τ 2 is a measure for the
degree of heterogeneity in the network. A large random effect γi jk indicates that there is a between-trial
variability exceeding the expected sampling variability for the treatment comparison j versus k in
trial i.
The model for summary level data contains only information about pairwise treatment differences
and includes thus two-arm trials only. In order to make the model identifiable, we need to fix the
treatment effect of some arbitrary baseline treatment at zero. By consequence, we only need T − 1
parameters to fully describe the model with its network structure. If we choose treatment 1 as baseline
thenwe define the basic contrasts db = (d12, d13, . . . , d1T ), the treatment effects relative to the baseline
treatment. Based on db we can fully describe the network structure. The relative treatment effects not
contained in db, the so-called functional contrasts d f , can be expressed as linear combinations of db
under the assumption of consistency. Network consistency means that there is no discrepancy between
the evidence obtained fromdirect and indirect comparisons. To illustrate this, assume thatwe have three
treatments 1, 2, 3 with all three possible pairwise treatment comparisons being observed. If treatment
1 is chosen as baseline then the basic contrasts are db = (d12, d13), but we may also be interested in
the functional contrast d f = d23. Under consistency, we have d23 = d13 − d12, i. e. d f = Fdb where
F = (1,−1). If the network consists of N pairwise comparisons, then the number of functional
contrasts is N − T + 1.
A crucial component of every NMA is the assessment of network inconsistencies, that is the exam-
ination of the possibility that consistency restrictions are not fulfilled. If the equality of indirect and
direct comparisons does not hold, it is possible to capture this inconsistency by introducing additional
random effects ξ jk ∼ N(0, κ2) in Eq. (1),
yi jk ∼ N(d jk + γi jk + ξ jk, σ 2i jk), (2)
where the variance κ2 is a measure for the degree of inconsistency in the network. Consistency of a
pairwise comparison between treatments j and k is thus put into doubt if we have a large random
effect estimate of ξ jk.
2.2 Trial-arm level data
Themodel discussed in this section has been introduced byLuandAdes (2006). Compared to themodel
for summary level data of Section 2.1, where every trial is assumed to have two arms only, it is possible in
a model for trial-arm level data to account for multiarm trials. Each trial i = 1, 2, . . . ,S has treatment
arms t1(i), . . . , tKi (i) ∈ {1, . . . ,T } with at least Ki ≥ 2 treatment arms. The first treatment j = t1(i)
is chosen as baseline treatment and compared with the remaining treatments k = t2(i), . . . , tKi (i).
For each trial i and baseline treatment j the number of events yi j and number of patients ni j is
observed. Correspondingly, also for the remaining treatments yik and nik is observed. The number
of events is (conditionally) independent for each trial-arm and follows a binomial distribution, that
is yi j ∼ Bin(ni j, πi j ) as well as yik ∼ Bin(nik, πik). The log-odds ratio d jk of baseline treatment j
versus treatment k can now be modeled with logistic regression as
logit(πi j ) = ai j (3)
logit(πik) = ai j + d jk + γi jk. (4)
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The treatment effect ai j of baseline treatment j in trial i is a nuisance parameter and the main interest
is in the log-odds ratio d jk.
Similar to the model for summary level data, possible trial-specific heterogeneity is captured by
the random effects γi jk ∼ N(0, τ 2). However, treatment comparisons in a multiarm trial with more
than two treatments are not independent, because they are based on the same baseline data. For
example if trial i compares treatments 1, 2, and 3, we take the dependency into account by assuming
a multivariate normal distribution for the random effects vector γ i = (γi12, γi13). In general, in a
multiarm trial i withKi different treatments, γ i is a vector of length (Ki − 1) and follows a multivariate
normal distribution
γ i ∼ N(0,Ti)
where Ti is a symmetric covariance matrix of dimension (Ki − 1) × (Ki − 1). A fully parametrized,
unstructured covariance matrix with (Ki − 1)(Ki − 2)/2 parameters is not very practical as usually
there are not many multiarm trials comparing the same set of treatments in a network. Therefore a
reduction of the number of parameters in order to increase the efficiency of the parameter estimates is
often warranted. Higgins and Whitehead (1996) suggest an exchangeable or homogeneous covariance
matrixwhere all treatment-specific variances on the diagonal ofTi are set to τ
2. Ifwe assume consistency
in the network then the correlations between random effects for any two treatments of the same trial
are equal to ρ = 1/2 (see Higgins and Whitehead, 1996, Section 5.1). This implies that covariances
in Ti are under consistency all equal to τ
2/2. Throughout the remainder we use such a homogeneous
correlation matrix for Ti.
Basic and functional contrasts and modelling of network inconsistency through random effects is
different formodels based on trial-arm level data compared tomodels for summary level data described
in Section 2.1. The vector of basic contrasts db of length T − 1 in a NMA for trial-arm level data
can now be any set of directly observed effect parameters, which define a spanning tree (see Lu and
Ades, 2006, Section 2.3), that is a connected sub-graph of the network covering all vertices without
any loops. The remaining functional contrasts d f can again be described as linear combinations of db.
As the equality of indirect and direct comparisons in a network may not be fulfilled, we introduce
additional random effects that allow for deviations from the consistency restrictions. The loop-specific
approach by Lu and Ades (2006) proposes that for every independent three-way loop a random
effect is added (see also Dias et al., 2010). In contrast to the situation with pairwise comparisons, the
presence of multiarm trials imply that the number of random effects is not necessarily the same as
the number of functional contrasts. However, if a direct comparison is only observed in one multiarm
trial, then any indirect comparison based on the other treatments in the same trial does not form an
independent loop. Thus, multiarm trials are assumed to be inherently consistent. Consider a three-way
loop with treatments j, k, l , where we now introduce a random effect ξ jkl ∼ N(0, κ2) in model (4). To
do so, we relax the consistency relation dlk − dl j = d jk to dlk − dl j = d jk + ξ jkl and hence replace d jk
with d jk + ξ jkl in (4):
logit(πik) = ai j + d jk + γi jk + ξ jkl . (5)
As before, the degree of inconsistency is represented by the random effects variance κ2 and a large
estimate of ξ jkl indicates a discrepancy between the direct and indirect evidence. Identification of all in-
dependent three-way loops can be complicated for a network with many multiarm trials. Furthermore,
parametrization of the inconsistency random effects is not unique in combination with correlated
multivariate heterogeneity random effects (see Sections 4.2 and 4.5 in Lu and Ades, 2006). An alter-
native to infer inconsistency by including additional random effects is offered by node-splitting, see
Section 3.3.
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3 Bayesian inference for network meta-analysis models with integrated
nested Laplace approximations
The NMA models discussed above are hierarchical models that can be described by three stages: the
first stage is the observational model p(y |α)with respect to the observed data ywhere α = (a, db, γ, ξ)
includes all model parameters. Here a = (a1 j, . . . , aS j ) denotes the vector of all baseline treatment
effects in the model for trial-arm level data and is not needed for a model based on summary level
data. The random effects vector γ contains all trial-specific random effects γ i. Likewise, ξ contains
all incoherence random effects ξ jk of the model based on summary level data or ξ jkl in the case of
trial-arm level data. The second stage p(α | θ) is a latent Gaussian Markov random field (GMRF) as
described in chapter 2 of Rue and Held (2005). The GMRF is controlled by hyperparameters, here
θ = (τ 2, κ2), which build the third stage p(θ).
The INLAapproachproposedbyRue et al. (2009) generates accurate approximations to themarginal
posterior distributions of the latent Gaussian model α by applying a Laplace approximation (Tierney
and Kadane, 1986) to the posterior distribution of θ and a second Laplace approximation to the
posterior of the components of α for selected values of the hyperparameters. The approximation of
the marginal posterior distributions to the model parameters α is obtained by numerical integration
over the hyperparameters. INLA were shown to deliver accurate approximations with reduced com-
putational costs compared to MCMC in a variety of examples. Fong et al. (2010) demonstrated the
applicability of INLA to generalized linear-mixed models. See Schro¨dle et al. (2011) for applications
to spatio-temporal models and Paul et al. (2010) for a bivariate meta-analysis of diagnostic tests with
INLA. The available software package for INLA embraces a wide range of models that is progressively
expanded as for example by measurement error models described by Muff et al. (2015).
The software r-inla implements the INLA approach, is available on http://www.r-inla.org/
and includes an R-interface. In the following Sections 3.1 and 3.2, we discuss the implementa-
tion of NMA in r-inla for summary and a trial-arm level data models. The node-split approach
with r-inla is introduced in Section 3.3. Each feature discussed in Subsections 3.1 to 3.3 is com-
plemented by an application in Section 4. We compare the results obtained with the INLA ap-
proach with MCMC, where we rely on the R-package gemtc (van Valkenhoef and Kuiper, 2014)
using JAGS (Plummer, 2003) a generic MCMC sampler using BUGS-code. However, the gemtc-
package can not fit models with both heterogeneity and incoherence random effects, as shown in
Table 1 that gives an overview of which models can be estimated with the utilized software pack-
ages. The NMA model with incoherence, for summary level data could be estimated by extending
the gemtc-code and for trial-arm level data the BUGS-code provided by Lu and Ades (2006) on
http://www.bristol.ac.uk/social-community-medicine/projects/mpes/code/ was adapted
to fit into JAGS.
Table 1 Used software packages for NMA: ‘x’ can be estimated, ‘na’ not available.
r-inla gemtc JAGS
NMA models for summary level data:
random effects (heterogeneity + inconsistency) x na x
NMA models for trial-arm level data:
fixed effects x x x
random effects (heterogeneity) x x x
random effects (heterogeneity + inconsistency) x na x
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Source code for MCMC sampling and the r-inla implementation and datasets together with
an accompanying R-package to reproduce the results is available as Supporting Information on the
journal’s web page.
3.1. Summary level data
The NMA model for summary level data described in Eq. (2) is a linear mixed model. Linear-mixed
models with different random effects can be implemented in r-inla (Fong et al., 2010) and Schmidt
and Nehmiz (2014) used INLA to estimate such a NMA model with hazard ratios as effect measures
and compared the results to the ones by MCMC.
However, there are two peculiarities in the linear-mixed model (2) that need special attention:
weighting the outcome with the inverse of the squared standard error σ 2i jk and inference for the
functional contrasts d f . As in a standard meta-analysis, we want to use σ
2
i jk as inverse weight. This
can be done in r-inla by using the scale argument in the function call. As discussed in Sections
2.2 and 2.1, the functional contrasts d f can be described as linear combination of db and we want to
get the marginal posterior distributions of d f . The r-inla software package allows to compute the
marginal posterior distribution of any linear combination of the latent field (see Section 4.4 inMartins
et al., 2013) and thus the full marginal distributions for d f can be obtained. If one is interested in
the functional contrasts one has to define these linear combinations in advance and hand them over
in the lincomb argument of the r-inla function call. Further implementation details for these two
peculiarities are described in the Supplementary Material.
3.2 Trial-arm level data
The NMAmodel for trial-arm level data described by (3) to (5) is a binary regression model with logit
link function. The distribution of the response must be specified in r-inla by the family argument
and the total number of study participants needs to be specified by the argument Ntrials. Functional
contrasts can be obtained in r-inla by building linear combinations in the same way as described in
Section 3.1. In the case of a multiarm trial we want to correlate the random effects of the latent field
for all arms of the same trial i, as discussed in Section 2.2. The use of such correlated multivariate
random effects is possible in r-inla. Riebler et al. (2012) use INLA for correlated multivariate age-
period-cohort models. Their model includes several countries and for each country a second order
random walk over time is used. These random walks are correlated across countries. Here, we want to
introduce an exchangeable correlation structure across trial-arms. Correlating the random effects for
the outcomes of a three-arm trial means that we correlate two components of the latent field.
To implement the correlation across study arms in r-inla we need to rewrite the homogeneous
random effects covariance Ti. Using the uniform correlation matrix Ci = (1− ρ)Ii + ρJi, where Ii is
the identity matrix and Ji is a matrix of ones, both of dimension (Ki − 1), we can write Ti = Ci ⊗ τ 2
where ⊗ is the Kronecker product. This describes the random effects correlation structure for the
response vector yi of trial i. As described in Section 2.2, we need to fix the hyperparameter ρ to
the initial value 1/2 but this initial value must be transformed to the internal scale used by r-inla
(see Section 1.2 in Supplementary Material). The homogeneous correlation model described here is
implemented in r-inla under the name model=‘exchangeable’.
To identify the corresponding random effects in each trial, we need to define a grouping vector gi
that is needed to determine the structure of Ci. The first entry of gi is NA as no random effect is present
in the baseline model (3). The remaining entries are numbered from 1 to Ki − 1, representing the
random effects γi j1, . . . , γi j,(Ki−1) in model (4). For example, if trial i compares treatments 1, 2, and 3,
we have a bivariate random effects vector γ i = (γi12, γi13) and the grouping vector is gi = (NA, 1, 2).
See section 4.6 in Martins et al. (2013) and the Supplementary Material for further details about this
r-inla feature.
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3.3. Assessing inconsistency with node-splitting
A key element of every NMA is to assess the degree and source of inconsistency in the network.
Evidence inconsistencies can be modeled by random effects for treatment pairs (Section 2.1) or for
independent loops (Section 2.2). An alternative to the random effects approach is to compare only the
direct evidence of a relative treatment effect with the indirect evidence for the same relative treatment
effect. This procedure corresponds to a cross-validation of the network leaving out all observations
covering direct evidence on a specific treatment pair, as discussed by Lumley (2002, Section 5.2) for
summary level, and by Lu and Ades (2006, Section 5.3) for trial-arm level data.
A modification of cross-validation is node-splitting as suggested by Dias et al. (2010, Section 3.5).
As in cross-validation, the data are split into two independent sources of information on direct and
indirect evidence for a pair of treatments j and k, say. However, in the node-split approach the
heterogeneity hyperparameter τ 2 is estimated based on all the data. Assessing inconsistency by node-
splitting implies that themodel is fitted repeatedly for every directly observed comparison of treatments
j and kwhere also indirect evidence is available. For every model fit, we obtain a posterior distribution
for the hyperparameter τ 2, for the baseline treatment effects a and for the direct and indirect relative
treatment effects ddir.jk and d
ind.
jk .
The node-split approach can be implemented in r-inla using a joint model with two separate
likelihood functions. Specifically, suppose treatment j and k are directly compared in s trials Djk ⊂
{1, . . . ,S}. In trial i ∈ Djk there are 2 responses, yi j and yik, which form the direct evidence and are
incorporated as vector
Y( j,k) = (yi1 j, yi1k, yi2 j, yi2k, . . . , yis j, yisk)

in the first likelihood. There are K = ∑Si=1 Ki treatment arms in total, so the indirect evidence is
represented by the remaining K − 2s responses, incorporated as vector Y−( j,k), say, in the second
likelihood. The unknown parameters a, db, and γ must be organized accordingly in the two likelihoods.
Of note, r-inla allows that the two likelihoods share some commonparameters, here the heterogeneity
variance τ 2. We can therefore use r-inla to compute the posterior distribution of the difference of the
direct treatment effect ddir.jk and the indirect treatment effect d
ind.
jk from the first and second likelihood,
respectively, as a linear combination.
Martino et al. (2011) describe a joint model where one likelihood defines data for survival times
while the second likelihood defines a quantitativemeasure for a longitudinal profile of the same patient.
They implement a joint model in r-inla with two likelihoods where a hyperparameter for the frailties
in the survival likelihood and the random effects in the longitudinal likelihood is shared. See Martins
et al. (2013, Section 4.1) for further details on how to use two likelihoods in r-inla.
4 Applications
In this section, we present three different applications: a NMA based on summary level data in Section
4.1, one based on trial-arm level data in Section 4.2 and node-splitting for a NMA in Section 4.3. We
assume the same prior distributions for the components of α and θ as in Lu and Ades (2006) and Dias
et al. (2010). Specifically, for all components of α we assume independent normal priors with mean
zero and variance 1000. Independent uniform priors on the interval [0, 10] are used for the random
effects standard deviations τ and κ.
The implementation of the user-specified uniform prior on the hyperparameters, which is achieved
in r-inla by handing over a table with the prior density evaluated at an appropriate grid, is discussed
in detail in the SupplementaryMaterial. As in Lu andAdes (2006), 20,000 iterations with an additional
burnin of 30,000 iterations are used for MCMC analyses in Sections 4.1 and 4.2. In Section 4.3, we
used 300,000 iterations and an additional burnin of 200,000 samples to get the posterior distributions
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for each node-split. The number of iterations is the same as used by Dias et al. (2010) who mention
that most of the models reach convergence for much less iterations while some of the node-splits need
many sampling iterations to satisfy diagnostic convergence criteria.
4.1 Acute myocardial infarction summary level data
An acute myocardial infarction is caused by a clot in a coronary artery. There exist different interven-
tions to remove the clot that have been compared by several trials. The summary level data discussed
here are taken from Lumley (2002, Table 2 in Section 5.2.). The data describe a network of six different
treatments after a myocardial infarction (1: streptokinase, 2: t-PA, 3: accelerated t-PA, 4: reteplase, 5:
anistreptilase, 6: angioplasty). There are 16 directly observed treatment comparisons covering nine dif-
ferent among 15 possible treatment pairs for which the log-odds ratio and the corresponding squared
standard error σ 2i jk are reported. We choose streptokinase (treatment 1) as baseline by setting its coef-
ficient to zero. Thus db contains the five relative treatment effects to the baseline treatment 1. Figure
1 shows the marginal posterior densities for all basic contrasts and for one functional contrast d43
(reteplase vs. accelerated t-PA). The last two plots in Fig. 1 show the marginal posterior densities for
the two hyperparameters τ 2 and κ2 that are both very close to zero suggesting that there is neither a
large heterogeneity nor a large incoherence in the network.
The histograms illustrate the densities based on the MCMC samples and the straight lines show
the corresponding densities obtained by r-inla. Both methods MCMC and INLA produce very
similar results. The largest absolute difference for the posterior median estimate of the log-odds ratio
relative treatment based on MCMC and INLA among all basic contrasts was found for the contrast
d16 (0.015). The MCMC run with 50,000 iterations took approximately 2.1 seconds while r-inla only
took 1.1 seconds.
4.2 Smoking cessation trial-arm level data
The effect of four interventions, which support participants in their efforts to quit smoking, were
compared by several trials originally discussed by Hasselblad (1998) but also by Lu and Ades (2006),
Dias et al. (2010), andKessels et al. (2013). The trial-arm level datameasures the number of individuals
who successfully quit smoking after 6–12 months. Data are taken from Table 1 in Lu and Ades (2006).
The smoking cessation data describes a fully connected network comparing the effects of four different
interventions (1: self-help, 2: individual counselling, 3: group counselling, and4: no contact) and reports
the number of successes and number of participants in 24 trials. There are two three-arm trials, one for
treatments 1, 3, and 4 and one for treatments 2, 3, and 4. As baseline treatment we choose intervention
1 such that the basic contrasts db = (d12, d13, d14) define a spanning tree of the graph. As in Lu and
Ades (2006) we analyze three models, one with fixed effects setting τ 2 = 0, one with random effects
for heterogeneity and a model with random effects for heterogeneity and loop-specific inconsistency.
The inconsistency in the third model is described by the three random effects ξ123, ξ124, ξ134, one for
each functional contrast d23, d24, d34, and each specific for one of the three independent loops in the
network.
Figure 2 shows the posterior median and the 95% equi-tailed credible interval (CI) obtained by
INLA and by MCMC for all parameter estimates of the three models. The results in Fig. 2 are
consistent with the results reported by Lu and Ades (2006) in Table 2. Due to illustrative purposes, we
present the hyperparameters in Fig. 2 as standard deviations τ , κ, instead of variances. The median
and the 95%-CI for τ in Fig. 2 show that there is substantial heterogeneity present in the network. The
inconsistency random effects standard deviation κ with the 2.5% quantile very close to zero is lower
than the standard deviation for heterogeneity τ . Correspondingly, the three random effect estimates
ξ123, ξ124, ξ134 are close to zero. Adding the inconsistency parameters, additional to heterogeneity
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Figure 1 Marginal posterior density estimates of all basic contrasts relative to baseline treatment, for
one functional contrast d43 and for the hyperparameters τ
2, κ2 by MCMC (histogram) and by INLA
(straight line) for the myocardial infarction data.
random effects, does not have a large impact on the estimates for the contrasts db and d f . A table with
the numbers illustrated in Fig. 2 is available in the Supplementary Material.
The posterior distributions by MCMC and INLA for the basic and functional contrasts show all
very good agreement. The largest absolute difference between the posterior median of both methods
among all comparisons in the fixed effects model is for d12 but is still very small (0.0031). Similarly,
the largest difference in the model with heterogeneity random effects is found for d13 with (0.0047).
The model with additional inconsistency random effects shows the largest absolute difference for the
contrast d23 (0.0125). Of course the differences and the ordering of the relative treatment comparisons
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Figure 2 Median and 95% equi-tailed credible interval (CI) of the marginal posterior distributions
of all relative treatment effects, the heterogeneity τ, and incoherence κ standard deviation as well as
the incoherence random effects ξ1kc by MCMC (points) and by INLA (triangles) for the smoking
cessation data.
with the largest discrepancies between MCMC and INLA may change if the MCMC run is repeated
while the results by INLAare deterministic. TheMCMCrunwith 50,000 iterations took approximately
10.8 seconds for the model with random effects for heterogeneity and incoherence. With r-inla the
computing time was 1.6 seconds.
4.3 Node-splitting for thrombolytic drugs
This application, like the one in Section 4.1, compares treatments after an acute myocardial infarction.
Here, treatments are limited to thrombolytic drugs, whereas in Section 4.1 also physical interventions
by angioplasty were included in the analysis and data are on trial-arm instead of summary level. Data
are taken from Dias et al. (2010) but are also discussed in Lu and Ades (2006) in Table 3. The dataset
compares nine different treatments and reports the number of deaths in 30 or 35 days and number of
patients in each treatment arm for 50 different trials. There is direct evidence for 16 different pairwise
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Table 2 Posterior mean and standard deviation of the difference ddiff.jk of direct and indirect log odds
ratios with corresponding conflict p-value for all node-splits of the thrombolytic treatment network.
All results have been obtained with INLA. Left column is based on the fixed effects model, right
column based on the random effects model.
ddiff.jk Fixed effects model Random effects model
j, k Mean Std. dev. p-value Mean Std. dev. p-value
1, 2 −0.19 0.23 0.43 −0.24 0.28 0.38
1, 3 0.09 0.10 0.39 0.25 0.25 0.28
1, 5 0.12 0.12 0.34 0.40 0.34 0.20
1, 7 −0.27 0.22 0.22 −0.23 0.25 0.35
1, 8 −0.18 0.56 0.75 −0.13 0.58 0.83
1, 9 −0.41 0.25 0.10 −0.39 0.28 0.16
2, 7 −0.05 0.42 0.92 0.02 0.45 0.97
2, 8 −0.14 0.45 0.75 −0.13 0.47 0.79
2, 9 −0.43 0.24 0.077 −0.51 0.29 0.071
3, 4 −0.65 0.67 0.33 −0.87 0.73 0.22
3, 5 −0.12 0.12 0.33 −0.40 0.34 0.19
3, 7 0.26 0.21 0.22 0.21 0.24 0.37
3, 8 0.27 0.45 0.56 0.22 0.48 0.66
3, 9 1.20 0.41 0.001 1.21 0.43 0.002
treatment comparisons but there are only 14 independent loops for which a node-split is possible.
We performed the node-splitting of a fixed effect model, setting τ 2 to zero and a model including
heterogeneity random effects. We use the same measure of inconsistency as proposed by Dias et al.
(2010). They define the measure for the degree of inconsistency (ddiff.jk ) as the difference of the log-odds
ratios based on direct and indirect evidence, that is ddiff.jk = d dir.jk − d ind.jk . We thus compute the posterior
distribution of ddiff.jk from which a two-sided conflict p-value (Marshall and Spiegelhalter, 2007) can be
easily derived.
The inconsistency estimates obtained by INLA are shown in Table 2, both for the fixed and the
random effects model. The fixed effects estimates are very similar to the MCMC estimates shown in
(Dias et al., 2010, Table 2). We also used MCMC sampling for the node-splitting of the same network
with both the fixed and random effects models. Inconsistency estimates by INLA agreed well with the
results by MCMC. Detailed results can be found in Section 2 in the Supplementary Material. Of note,
the node-split analysis of the moderately large thrombolytic treatment network with 14 node-splits and
heterogeneity random effects took 3.2 hours with MCMC, approximately 14 minutes per node-split.
The corresponding NMA model has 60 parameters and hyperparameters, so carrying out MCMC
sampling for all 14 node-split analyses means that we need to check convergence of 840 parameters.
r-inla was 276 times faster and needed only 42 seconds to complete the 14 node-splits that is
3 seconds per node-split.
5 Discussion
The application of INLA to NMA models in Sections 4.1, 4.2, and 4.3 showed results very close to
those obtained with MCMC. However, computation time with INLA is drastically reduced compared
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to MCMC sampling. Further, there is no need to examine convergence of the MCMC samples. This
is a key advantage, in particular if the network is large. Indeed, for a large network the number
of parameters in the model increases dramatically along with the effort required to investigate the
convergence assumption for every parameter if MCMC sampling is applied. These two points make
INLA more attractive to use for Bayesian inference of a NMA model.
However, there are several peculiarities in many NMA models for which the implementation in
r-inla is not straightforward. The use of correlated multivariate random effects for multiarm trials
using the Kronecker product for the covariance matrix is one of the specialities which we discussed.
Implementation of the node-split approach is another NMA characteristic which we could accomplish
in r-inla using two separate likelihoods.
Node-splitting with INLA is also possible in very large networks like the application discussed
by Veroniki et al. (2013) who examine inconsistency in 40 different networks with a dichotomous
outcome and a total of 303 loops. INLA has a great potential for performing Bayesian inference
for NMA models and offers a major alternative to MCMC software. INLA also offers possibilities
for routine prior sensitivity examination (Roos and Held, 2011; Roos et al., 2015), which may be
particularly useful in a NMA. We note that ranking of treatments as discussed by Lu and Ades (2006,
Section 3.5) is not possible with INLA, but this approach has been recently critized by Puhan et al.
(2014) as misleading since it does not take the quality of treatment effect estimates into account.
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This document contains additional material accompanying the paper ”Network meta-analysis
with integrated nested Laplace approximations”. In Section 1 we discuss the technical details
about how to implement the NMA models, presented in Section 3 and 4 in the main text, with
r-inla. Section 2 shows the detailed results, which were used for Figure 2 in the main text, as
a table. In Section 3 the parameter estimates obtained by MCMC and INLA for the application
from Section 4 in the main text are shown.
1 Implementation of NMA models with the INLA R-package
The r-inla R-package is provided on http://www.r-inla.org/. The software can be installed
by executing the following command lines in a R-session.
install.packages("INLA", repos="http://www.math.ntnu.no/inla/R/stable")
Information about the installed version can be retrieved by typing inla.version(). In order
to be able to reproduce the applications from the main text make sure to install the accompa-
nying R-package nmainla which is available for download as supplementary material as well (see
?install.packages).
install.packages("nmainla_1.0.tar.gz")
library(nmainla)
The package nmainla essentially contains the datasets for the myocardial infarction example of
Section 4.1, for the smoking cessation example of Section 4.2 and for the thrombolytic network
used for the node-splitting in Section 4.3 of the main text. Detailed information for all three
datasets can be obtained by typing ?myodat, ?smokdatDI or ?thrombdatDI. Additionally there is
a wrapper function nodesplit_inla, calling r-inla repeatedly for a list of node-splits and two
additional functions creatINLAdat and make.lincomb.vector used to organise the datasets. See
the nmainla package documentation for details about these functions and datasets.
Section 1.1 discusses the summary level data application from Section 4.1 in the main text.
The implementation of a user-specified uniform prior with r-inla, and the settings for linear
combinations covering the functional contrasts df are also discussed in this section. Section 1.2
discusses the implementation of the trial-arm level data discussed in Section 4.2 in the main text.
∗corresponding author: e-mail: rafael.sauter@uzh.ch
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The implementation of multi-arm trials with a homogeneous covariance structure is discussed in
this section. Section 1.3 shows how to implement the node-splitting for the application presented
in Section 4.3 in the main text.
1.1 Summary level model
The INLA results for the NMA of the myocardial infarction data discussed by Lumley (2002) was
discussed in Section 4.1 in the main text.
require(nmainla)
data(myodat)
head(myodat)
stre tpa atpa ret anis angio Y sigma prec ind1 ind2 trtpair ind
1 1 -1 0 0 0 0 -0.0260 0.0394 644.1805 1 2 1 1
2 1 0 0 0 -1 0 -0.0048 0.0392 650.7705 1 5 2 2
3 0 1 0 0 -1 0 0.0212 0.0395 640.9229 2 5 3 3
4 1 0 -1 0 0 0 -0.1727 0.0552 328.1874 1 3 4 4
5 -1 1 0 0 0 0 -0.0684 0.0778 165.2117 2 1 1 5
6 -1 1 0 0 0 0 -0.0432 0.0634 248.7834 2 1 1 6
The response yijk is named Y in the data frame myodat. The observed trial variance σ
2
ijk is
called sigma. prec is the inverse of sigma defining the precision σ−2ijk. There is a vector for the
heterogeneity random effects ind identifying the trials (index i in the main text) and for the
incoherence random effects trtpair (index j, k in the main text), which identifies the treatment
pairs. Each trial has two treatments defined by the variables ind1 (index j in the main text) and
ind2 (index k in the main text). The other variables (stre, tpa, atpa, ret, anis, angio)
cover the covariates for the basic contrast parameters db.
The r-inla software package requires the user to define a model formula using the typical R
syntax (see ?formula). The model formula will be called by the function inla. Additionally
to the model formula there are several arguments in the r-inla function call which need to be
specified.
The first step to implement the NMA of Section 4.1 is to define the prior distribution of the
hyperparameters in the latent field. We want to use the same distributions as used by Lu and
Ades (2006) and Dias et al. (2010), which is the uniform distribution τ ∼ U(0, u) and κ ∼ U(0, u)
where we set the upper bound of the distribution to u = 10. The implemented priors e.g. a
Gamma prior on the hyperparameter can be called in r-inla by the argument f(..., model
= "iid", hyper(list=(prior=loggamma)). Every latent field is initiated by f(...). In this
example an independent random noise latent field, named model = "iid" is called, which is the
only latent field used for the NMA examples presented here. The "iid" latent model defines the
prior distribution on the log-transformed precision parameter of an independent and Gaussian
distributed random variable. As the uniform prior distribution is not implemented in r-inla we
must define it. First we define the uniform distribution for the hyperparameter on the r-inla
internal scale, which is in most of the cases the log-scale of the hyperparameter and which requests
to transform the density. The transformation of densities can be done by applying the change-of-
variables formula (see Held and Sabane´s Bove´, 2014, Appendix A.2.3)): if fX(x) is a probability
density function of X one can compute the probability density function fY (y) of the transformed
variable Y = f(X) by
fY (y) = fX{f−1(y)}
∣∣∣∣df−1(y)dy
∣∣∣∣ = fX(x) ∣∣∣∣df(x)dx
∣∣∣∣−1 .
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The latent model r-inla puts the prior on θ = f(τ) = log(τ−2) and respectively on θ = f(κ) =
log(κ−2). We continue with the parameter τ only, but results are equivalent for κ. The uniform
distribution for the interval [0, 10] is fτ (τ) = 1/10. Thus in this case we have f
−1(θ) =
√
1
exp(θ)
and df
−1(θ)
dθ = 1/2
√
exp(θ) such that
fθ(θ) =fτ{f−1(θ)}
∣∣∣∣df−1(θ)dθ
∣∣∣∣ = (1/10) · 1/2√exp(θ)
if
√
1
exp(θ) is in [0, 10]. This density is defined as R-function hyperunif.function:
#Upper limit for uniform distribution:
ul <- 10
#Function for Uniform distribution:
hyperunif.function <- function(x){
if(exp(x)^-0.5 < ul & exp(x)^-0.5 > 0){
logdens <- log(1/ul)
}else{
logdens <- log(0.1e-320)
}
logdenst <- logdens+log(0.5*exp(-x/2))
return(logdenst)
}
The uniform distribution function hyperunif.function must be evaluated at a suitable grid of
points, defining prior.table, which can then be called as prior in r-inla:
#Define grid:
lprec <- seq(from = -40, to = 40, len = 20000)
#Create table:
prior.table <- paste(c("table:", cbind(lprec, sapply(lprec, FUN=hyperunif.function))),
sep = "", collapse = " ")
The next step is to define the NMA model-formula. We have two latent "iid" fields, one for
heterogeneity (ind) and one for incoherence (trtpair), which defines a linear mixed models with
different random effects. For both hyperparameters in each latent field we will use the uniform
prior defined above as prior.table. The other variables for db enter the model as fixed effects
outside f(...) and we exclude a global intercept, using -1:
inla.form.myo <- Y ~ -1 + tpa + atpa + ret + anis + angio +
f(ind, model = "iid",
hyper = list(theta = list(prior = prior.table))) +
f(trtpair , model = "iid",
hyper = list(theta = list(prior = prior.table)))
As we are eventually also interested in the functional contrasts df we need to define a linear
combination for these, before calling the inla(...) function. There is a built in function
inla.make.lincombs in the r-inla package which defines the linear combinations. We build
a linear combination for the relative treatment difference of ret against angio.
LCmyo <- inla.make.lincombs(ret = 1, atpa=-1 )
names(LCmyo) <- c("ret_atpa")
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Now the model can be estimated by calling inla():
inla.myo <- inla(inla.form.myo, data = myodat,
family = "normal",
control.fixed = list(mean = 0, prec = 1/1000),
control.family = list(hyper = list(prec = list(
fixed = TRUE,
initial = 0))),
scale = prec,
lincomb = LCmyo,
control.inla = list(lincomb.derived.only = FALSE),
control.compute = list(dic = TRUE,cpo = TRUE)
)
The function inla(...) requests a model-formula like inla.form.myo and a dataset data =
myodat as input. Besides the prior distribution for the hyperparameters one needs also define
the fixed effect prior distribution. In r-inla coefficients are defined as fixed effects if they are
not covered by a latent field f(...). For the fixed effects r-inla assumes a normal distribution,
which is in this case essentially the same as defining a separate latent field with model = "iid"
but with different prior distributions.. The parameters for the normal distribution of the fixed
effects can be controlled within the inla(...) function by the argument control.fixed. We
again follow Lu and Ades (2006) and Dias et al. (2010) and set the prior distribution for the basic
contrasts to db ∼ N(0, 1000). For normal distributions r-inla uses mainly precisions which is
equal to the inverse of the variance. control.fixed. Thus we set prec = 1/1000 and mean = 0.
The distribution of the response is defined by the argument family = "normal". This ar-
gument is set to binomial for the applications of Section 4.2 and 4.3 in the main text. The
control.family argument sets additional options which are related to the response e.g. the link
function. In the summary level data example of Section 4.1 in the main text we want to scale the
response variance with the observed σ2ijk. This means that we first need force the random noise
which is always automatically added to the model by r-inla to be equal to zero. This is done by
fixing the hyperparameter in control.inla to zero: list(hyper = list(prec = list(fixed
= TRUE, initial = 0))). The error can then be weighted with 1/σ2ijk by using the precision
(prec) stored in the data frame, addressed by the argument scale = prec.
The linear combination which we prepared in advance are called in inla(...) by the argument
lincomb. The argument control.inla offers many options relevant for the numerical accuracy
of the approximations r-inla produces. The call used here lincomb.derived.only = FALSE
increases the accuracy for the linear combination defined by LCmyo but generates a higher com-
putational cost. The argument control.compute is useful as it offers the option to additionally
compute the DIC model choice criterion. Many of the options described here have a documenta-
tion which can be accessed by typing e.g. ?control.inla. r-inla generates an object of class
inla. If one is willing to invest more computational effort one can improve the estimates for the
hyperparameters by using the function inla.hyperpar(...) calling the inla object:
inla.myo <- inla.hyperpar(inla.myo)
There are several useful functions to analyse the results:
summary(inla.myo)
plot(inla.myo)
While detailed statistics about the marginal posteriors can be accessed by
inla.myo$summary.fixed
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or
inla.myo$summary.random$trtpair
it is also to possible to access the marginals directly by
inla.myo$marginals.fixed
or
inla.myo$marginals.random$trtpair
which can be used as input for functions which operate on these marginals e.g. transform them.
See ?inla.tmarginal.
1.2 Trial-arm level model
The INLA results for the smoking cessation interventions network is discussed in the paper in
Section 4.2. We present here the r-inla code for estimating a NMA model for the smoking cessa-
tion data. We especially highlight how multi-arm trials are modelled with correlated multivariate
random effects.
First load the data and bring it into a suitable format by using the functions in the package
gemtc and in the accompanying package nmainla.
#Load data (available in nmainla):
data(smokdatDI)
#Rearange data:
smokdat <- mtc.data.studyrow(data = smokdatDI,
armVars = c('treatment' = 't',
'responders' = 'r','sampleSize' = 'n'),
nArmsVar = 'na' ,
studyNames = 1:nrow(smokdatDI),
patterns = c('%s', '%s%d'))
#Create baseline variable:
smokdat$baseline <- rep(smokdatDI$t1, times = smokdatDI$na)
#Study as factor:
smokdat$mu <- as.factor(smokdat$study)
#See indices suitable to INLA:
#(See function ?creatINLAdat in the nmainla package.)
smokdatINLA <- creatINLAdat(dat = smokdat,
treatmentvar = "treatment",
baselinevar = "baseline",
studyvar = "study")
The gemtc-function mtc.data.studyrow converts datasets in the one-study-per-row format to the
one-arm-per-row format which is also requested by gemtc. The nmainla-function creatINLAdat
adds indicator variables to a data frame which define the baseline contrasts (d1j), the heterogeneity
random effects (re), for the correlated multi-arm trials the grouping vector which defines the
covariance structure (g) and cycle-specific inconsistency random effects (w). The resulting data
frame is suitable to use in the inla(...) function.
In the smoking dataset there are three basic contrasts d12, d13 and d14. Now define a model-
formula for r-inla with correlated multivariate random effects for heterogeneity and additional
trial-specific random effects for the inconsistency. This corresponds to the third model in the last
plot of Figure 1 in the main text.
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#Formula:
inla_form.smokeREinc <- responders ~ -1 + mu + d12 + d13 + d14 +
f(re, model = "iid",
hyper = list(theta1 = list(
prior = prior.table)),
group = g,
control.group = list(model = "exchangeable",
hyper = list(rho = list(fixed = TRUE,
initial = cor.inla.init)))) +
f(w, model = "iid",
hyper = list(theta1 = list(
prior = prior.table)))
The baseline contrasts are included in the model by ...+ d12 + d13 + d14 +.... The parameter
mu represents the baseline treatment effect aij for every trial i. The random effects for heterogeneity
are included in the model similar to Section 1.1 by f(re, model="iid", .... The variable re in
the dataset smokdatINLA represents the trials i. We also use again the uniform prior defined in the
prior.table object as in Section 1.1. In contrast to Section 1.1 we introduce now the grouping
for the multi-arm trials by adding the argument group = ... inside the latent field f(re, ...).
We assign to the argument the vector g in the dataset smokdatINLA (group = g). This vector
defines the position in the covariance structure T i of every arm in the trial. The elements for
the baseline treatments in g are set to NA. By the argument control.group we specify further
how the correlation structure Ci looks like. We specify the model to model = "exchangeable"
and fix the hyperparameter ρ to a certain value cor.inla.init by setting fixed = TRUE. Using
fixed = TRUE will fix the hyperparameter at the value defined by initial = ... or the default
value if no initial value is set. To set the initial value at ρ = 1/2 we must transform the ρ to the
r-inla internal scale. In the case of the correlation parameter for multivariate random effects the
internal scale for r-inla is Fisher’s z-transformation for ρ = 1/2 which is
log
(
1 + ρ(R− 1)
(1− ρ)
)
where R is the maximal number of arms for the multi-arm trial with the most treatments in the
network (Riebler et al., 2012, see section 3). So we define the transformed ρ as cor.inla.init as
# Transform group-correlation 0.5 to internal.scale of INLA:
cor <- 0.5 #correlation between treatment comparisons of the same multi-arm trial.
ngroup <- 2 #number of groups is equal to the maximum number
#of pairwise treatment comparisons in a (multi-arm) trial.
#transformation to internal INLA-scale.
cor.inla.init <- log((1 + cor * (ngroup - 1))/(1 - cor))
Besides the correlated multivariate random effects for heterogeneity we have additionally the
inconsistency random effects defined by f(w,...) which is very similar to the definition in Section
1.1. The code example illustrates that function arguments, like for hyperparameters, inside a latent
field f(...) must be defined as nested lists.
Now we can use again the function inla(...) to evaluate the model by calling the formula-
object described above.
#Call inla:
inla.smokeREinc <- inla(as.formula(inla_form.smokeREinc),data = smokdatINLA,
family = "binomial", Ntrials = sampleSize,
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control.fixed = list(expand.factor.strategy = "inla",
mean = 0, prec = 1/1000),
)
As the response is binomial in this case we need to define family = "binomial" together with
Ntrials = ... linking to the vector in the dataset that contains the number of events. The
argument expand.factor.strategy = "inla" is needed to define how r-inla should handle the
factor variable of the baseline treatments mu. Essentially this defines how the design matrix for
this factor variable is created. See http://www.r-inla.org/faq for more details about this point.
The other two models shown in Figure 1 in the main text can be estimated by modifying the
formula inla_form.smokeREinc. For the random effects model without inconsistency random
effects the latent field f(w, ...) simply needs to be removed. For the fixed effects model both
latent fields f(re, ...) and f(w, ...) can be completely removed from the formula.
1.3 Node-splitting
We present here the implementation of the node-splitting for the NMA of the thrombolytic treat-
ment network. The INLA results for the node-splitting of the thrombolytic treatment network
were compared with MCMC in Section 4.3 in the main text. To implement the node-splitting
approach in r-inla a wrapper function nodesplit_inla is made available in the accompanying
package nmainla. This function just repeatedly calls r-inla for a list of node-splits and organises
the data such that two separate likelihoods can be applied as described in the paper.
First the data need to be loaded from the package nmainla and organised in a similar way as
the dataset in Section 1.2 in this document.
#load data:
data(thrombdatDI)
# Tranform data per studyrow (gemtc-conform format):
thrombdat <- mtc.data.studyrow(data = thrombdatDI,
armVars = c('treatment' = 't',
'responders' = 'r',
'sampleSize' = 'n'),
nArmsVar = 'na' ,
studyNames = 1:nrow(thrombdatDI),
patterns = c('%s', '%s%d'))
# Create baseline variable:
thrombdat$baseline <- rep(thrombdatDI$t1, times = thrombdatDI$na)
# Study as factor:
thrombdat$mu <- as.factor(thrombdat$study)
#use function creatINLAdat()
#(see Rfunctions_inlaNMA.R) to add suitable indices:
thrombdatINLA <- creatINLAdat(dat = thrombdat,
treatmentvar = "treatment",
baselinevar = "baseline",
studyvar = "study")
The pairwise treatment comparison for which a node-split is possible, meaning that indepen-
dent direct and indirect evidence is available in the network, was assessed by using the function
mtc.nodesplit.comparisons available in the gemtc package. To do this one need to construct
a network first by using mtc.network in the gemtc package which we can also plot as shown in
Figure 1.
© 2004 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.biometrical-journal.com
Paper III - 123 -
8 Rafael Sauter and Leonhard Held: Supplementary Material for network meta-analysis with INLA
#network
net_thrombdat <- mtc.network(data.ab=thrombdat)
plot(net_thrombdat)
#Get node-splits:
nodecomp_thrombdat <- mtc.nodesplit.comparisons(net_thrombdat)
The resulting list with the treatment pairs is stored as two-column matrix in nodecomp_thrombdat.
l
l
ll
l
l
l l
l
1
2
3
4
5
6
7
8
9
Figure 1 Plot of the network for thrombolytic trial-arm level data generated based on
net_thrombdat which is a mtc.network-object defined in R-package gemtc.
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Now we have all the ingredients to use r-inla for node-splitting with the function node-
split_inla:
inla.node.thrombRE <- nodesplit_inla(dat = thrombdatINLA,
nodelist = nodecomp_thrombdat,
treatmentvar = "treatment",
studyvar = "study",
baselinevar = "baseline",
responsevar = "responders",
samplesizevar = "sampleSize",
mod = "RE",
priorREhyper = "hyper = list(theta1 = list(prior =
prior.table))",
varf = 1000)
The nmainla-function nodesplit_inla(...) is a wrapper calling repeatedly r-inla generat-
ing the direct and indirect estimates for a given list of node-splits, defined here by nodelist =
nodecomp_thrombdat in a NMA network. This function essentially produces the same results as
the gemtc-function mtc.nodesplit which uses MCMC sampling. As described in the main text in
Section 4.3, nodesplit_inla creates for every node-split a inla-formula with two separate like-
lihoods. A sample code for the implementation of two separate likelihoods in an other context in
r-inla can be found on http://www.r-inla.org/examples/case-studies/martino-akerkar-
and-rue-2010 , which refers to the application discussed in Martino et al. (2011).
The option varf is the fixed effect prior variance for the baseline treatments and the baseline
factors in the NMA-model. The option mod defines the NMA-model and is either equal to FE for
a fixed effect model without random effects or equal to RE for a NMA-model with heterogeneity
random effects. If mod = RE then there are three more options which should be set: priorREhy-
per defines the prior for the hyperparameters which is the variance of the heterogeneity random
effects, priorghyper defines the prior for the grouping hyperparameters for multi-arm trials which
is the correlation between multi-arm trials random effects and cor.group which defines the group
correlation for multi-arm trials called by priorghyper. The cor.group argument must be on the
r-inla internal scale and its default value is equal to 1.098612 which corresponds to a correla-
tion of 1/2 which is justified by the consistency assumption. All remaining options and further
descriptions can be obtained by typing ?nodesplit_inla.
Warning: the nodesplit_inla function was not tested extensively and was developed for the
applications presented here. Although it handles multi-arm treatments up to now it was only
used for a limited number of examples and with three-arm trials only. Currently the function
will not capture all possible NMA set-ups with multi-arms and thus may probably fail for some
applications or produce wrong results! At the moment the function nodesplit_inla(...)is
applicable for logistic regression NMA-models only!
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2 Results for smoking cessation data models
Table 1 shows the posterior median and the 95% equi-tailed credible interval (CI) for the param-
eters of the three models presented in Section 4.2 in the main text. The upper part of Table 1
shows the results obtained by MCMC and the lower part the same estimates obtained by INLA.
The figures of Table 1 are illustrated as forest plots in Figure 2 in the main text.
Random effects
Fixed effects heterogeneity heterogeneity + incoherence
Median 95%-CI Median 95%-CI Median 95%-CI
MCMC:d12 0.228 -0.019 to 0.475 0.488 -0.288 to 1.306 0.448 -0.453 to 1.361
d13 0.765 0.651 to 0.879 0.835 0.391 to 1.339 0.857 0.398 to 1.394
d14 0.841 0.497 to 1.185 1.096 0.267 to 2.006 1.072 -0.012 to 2.233
d23 0.537 0.275 to 0.798 0.346 -0.466 to 1.173 0.251 -0.903 to 1.289
d24 0.612 0.239 to 0.990 0.607 -0.333 to 1.586 0.634 -0.493 to 1.791
d34 0.076 -0.262 to 0.415 0.260 -0.551 to 1.098 0.217 -0.962 to 1.318
τ 0.818 0.550 to 1.275 0.845 0.562 to 1.311
κ 0.567 0.033 to 4.174
ξ123 -0.080 -1.513 to 0.828
ξ124 0.006 -1.307 to 1.255
ξ134 0.001 -1.248 to 1.264
INLA: d12 0.227 -0.019 to 0.474 0.487 -0.269 to 1.274 0.439 -0.470 to 1.361
d13 0.764 0.650 to 0.879 0.833 0.397 to 1.309 0.852 0.393 to 1.375
d14 0.840 0.498 to 1.184 1.088 0.278 to 1.953 1.063 0.009 to 2.213
d23 0.537 0.276 to 0.798 0.346 -0.443 to 1.142 0.120 -2.465 to 2.153
d24 0.611 0.238 to 0.989 0.600 -0.317 to 1.545 0.623 -1.914 to 3.079
d34 0.076 -0.261 to 0.414 0.255 -0.532 to 1.059 0.232 -2.255 to 2.692
τ 0.814 0.547 to 1.266 0.840 0.560 to 1.319
κ 0.541 0.030 to 3.558
ξ123 -0.111 -1.550 to 0.870
ξ124 0.003 -1.430 to 1.313
ξ134 0.005 -1.320 to 1.322
Table 1 Quantiles of the marginal posterior distributions of all (baseline and functional) relative
treatment effects by MCMC (top) and by INLA (bottom) for the smoking cessation data. The last
lines show the estimates for the random effects variance of the incoherence τ2 and the heterogeneity
κ2 as well as the incoherence random effect estimates ξ1kc.
3 Node-splitting results for thrombolytic infarction data
One MCMC run with 100’000 iterations and a burnin of 200’000 samples was used to get the
posterior distributions for all models presented in Section 4.3 in the main text. The rather large
number of MCMC iterations is the same as indicated by Dias et al. (2010) motivated by the node-
splitting. They mention that most of the models reach convergence for much less iterations while
some of the node-split models need so many sampling iterations to satisfy the applied diagnostic
convergence criteria. For MCMC sampling we rely on the R-package gemtc (van Valkenhoef and
Kuiper, 2014) using JAGS (Plummer, 2003).
The thrombolytic treatment dataset compares 9 different treatments (1: streptokinase , 2: t-
PA, 3: accelerated t-PA, 4: streptokinase and t-PA, 5: reteplase, 6: tenecteplase, 7: PTCA, 8:
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urokinase, 9: anistreptilase) and reports the number of deaths in 30 or 35 days and number of pa-
tients in each treatment arm for 50 different trials. There are two three arm trials, one comparing
treatments 1, 3 and 4 and one comparing treatments 1, 2 and 9. The network provides direct evi-
dence for 16 different pairwise treatment comparisons (see also Figure 1). The pairwise treatment
comparison for which a node-split is possible, meaning that independent direct and indirect evi-
dence is available in the network, was assessed by using the function mtc.nodesplit.comparisons
available in the gemtc package. As treatment 6 was only compared in one trial with treatment
3 there is no indirect evidence and thus there is no node-split possible for d36. There is also
no node-split for treatment 1 and 4 as there is only one other three arm trial which compares
treatment 4 with treatment 3. As we assume no inconsistency within a multi-arm trial we have
no other independent source of indirect evidence for d14. There remain 14 possible node-splits for
the direct relative treatment comparisons. The 14 possible node-splits between treatments t1 and
t2 are contained in the data frame nodecomp_thrombdat produced by the R-code above:
nodecomp_thrombdat
t1 t2
1 1 2
2 1 3
3 1 5
4 1 7
5 1 8
6 1 9
7 2 7
8 2 8
9 2 9
10 3 4
11 3 5
12 3 7
13 3 8
14 3 9
We use the same measure of inconsistency as proposed by Dias et al. (2010). They define the
measure for the degree of inconsistency (ddiff.jk ) as the difference of the log-odds ratios based on
direct and indirect evidence, i.e. ddiff.jk = d
dir.
jk −d ind.jk . We thus compute the posterior distribution
of ddiff.jk . The result for the inconsistency estimates are shown in Table 2 for the fixed effects model
and the model with random effects for heterogeneity obtained by MCMC and INLA. The results
are consistent with the ones discussed in table 2 in Dias et al. (2010).
The largest inconsistency in the random and fixed effect model is found if the node for treatment
3 and 9 is split. The estimate for the marginal posterior mean of the relative treatment d39 based
on the direct evidence is 1.36 for the random effect model by INLA. The corresponding estimate
based on indirect evidence is 0.16 while the analysis based on the full data under the consistency
assumption gives a marginal posterior mean estimate dˆ39 = 0.30 with INLA. A cross-validation
approach which does not use the complete data to estimate the baseline treatment effect and
heterogeneity hyperparameter yields an inconsistency estimate for the node d39 equal to 1.28
with a standard error equal to 3.65. The difference to the inconsistency estimate based on node
splitting is with 1.21 not very large. The estimate for the standard error of the inconsistency is with
node splitting only equal to 0.43 as reported in Table 2. The large difference in the uncertainty
about the inconsistency between node splitting and cross validation is due to the fact that with
cross-validation the heterogeneity hyperparameter τ2 is quite different as it is estimated for the
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Fixed effects Random effects
MCMC INLA MCMC INLA
Mean Stdev. Mean Stdev. Mean Stdev. Mean Stdev.
ddiff.12 -0.342 0.258 -0.186 0.234 -0.342 0.258 -0.242 0.277
ddiff.13 0.088 0.105 0.090 0.104 0.088 0.105 0.251 0.247
ddiff.15 0.115 0.120 0.116 0.121 0.115 0.120 0.397 0.337
ddiff.17 -0.273 0.219 -0.269 0.220 -0.273 0.219 -0.227 0.246
ddiff.18 -0.203 0.574 -0.184 0.559 -0.203 0.574 -0.126 0.585
ddiff.19 -0.453 0.255 -0.406 0.252 -0.453 0.255 -0.394 0.281
ddiff.27 -0.078 0.430 -0.049 0.422 -0.078 0.430 0.017 0.450
ddiff.28 -0.156 0.453 -0.143 0.446 -0.156 0.453 -0.126 0.474
ddiff.29 -0.419 0.246 -0.426 0.245 -0.419 0.246 -0.510 0.290
ddiff.34 -0.588 0.706 -0.649 0.668 -0.588 0.706 -0.868 0.726
ddiff.35 -0.116 0.121 -0.116 0.121 -0.116 0.121 -0.397 0.337
ddiff.37 0.263 0.211 0.258 0.210 0.263 0.211 0.213 0.240
ddiff.38 0.284 0.463 0.267 0.453 0.284 0.463 0.216 0.484
ddiff.39 1.233 0.418 1.196 0.409 1.233 0.418 1.209 0.425
Table 2 Inconsistency mean and standard deviation for all node-splits of the thrombolytic
treatment network for the fixed effects and the random effects model obtained by MCMC and by
INLA.
direct comparison of d39 only based on two observations. In the case of the fixed effect model
the difference between cross-validation and node-splitting would be smaller as the heterogeneity
parameter τ2 is equal to zero. The node-split for the moderately large network of the thrombolytic
treatment network with 14 node-splits and heterogeneity random effects took 192.9 minutes with
80’000 MCMC iterations which is 827 seconds per node-split or model. INLA was about 276 times
faster and only used 42 seconds to complete the 14 node-splits which is 3.0 seconds per node-split.
This difference in computation time is directly scalable with an increasing number of node-splits
in a network.
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Summary: The prior distribution is a key ingredient in Bayesian inference. Prior information on regression coeffi-
cients may come from different sources and may or may not be in conflict with the observed data. Various meth-
ods have been proposed to quantify a potential prior-data conflict, such as Box’s p-value. However, are no clear
recommendations how to react to possible prior-data conflict in generalized regression models. To address this
deficiency, we propose to adaptively weight a pre-specified multivariate normal prior distribution on the regression
coefficients. To this end, we relate empirical Bayes estimates of prior weight to Box’s p-value and propose alternative
fully Bayesian approaches. Prior weighting can be done for the joint prior distribution of the regression coefficients
or - under prior independence - separately for pre-specified blocks of regression coefficients. We outline how the
proposed methodology can be implemented using integrated nested Laplace approximations (INLA) and illustrate
the applicability with a Bayesian logistic regression model for data from a cross-sectional study. We also provide a
simulation study that shows improved performance of our approach in the case of prior misspecification in terms of
root mean squared error and coverage. Supplementary material gives details on software code and another application
to a Bayesian analysis of binary longitudinal data from a randomized clinical trial using a generalized linear mixed
model.
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1. Introduction
Appropriate specification of the prior distribution is a key ingredient in Bayesian statist-
ics. It is also considered as the most controversial feature of Bayesian inference. In this
paper we discuss the role of the prior distribution in regression models from a novel
perspective. We consider a commonly used setup where a proper multivariate normal
prior is assigned to the regression coefficients. Prior weighting is achieved by a scalar
g > 0, acting multiplicatively on the prior covariance matrix. Thus, the prior weight is
represented by the inverse w = 1/g. The focus of this paper will be on empirical and
fully Bayesian approaches to estimate the inverse prior weight g from the data at hand.
We distinguish four different sources for a prior distribution. First, prior information
may come from historical data of the same structure as the current data. For example,
data from past clinical trials may be used to construct a suitable prior for the analysis
of data from a current trial with the same outcome. Approaches to integrate historical
data include the robust meta-analytic approach (Schmidli et al., 2014) and the power
prior (Ibrahim and Chen, 2000; Duan et al., 2006; Neuenschwander et al., 2009), which
introduces a weight parameter to discount historical data.
Secondly, the prior distribution may come from elicitation of expert opinion (O’Hagan
et al., 2006; Spiegelhalter et al., 2004, Section 5.2). For example, Miettinen et al. (2008)
develop a risk prediction model for the presence of pneumonia, elicited from 22 clinical
experts. This model has been subsequently updated in Held et al. (2012) using data
on more than 600 patients presenting with cough and fever at a general practitioner’s
practice in Switzerland.
However, historical data or expert opinion may not be available for the problem at
hand, but an informative prior may still be warranted based on contextual reasoning.
Greenland (2006, 2007a,b, 2009) argues strongly that proper priors should be used in
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the analysis of epidemiological studies to avoid implicit unrealistic assumptions of the
corresponding frequentist analysis (operationally equivalent to a Bayesian analysis with
improper priors on the parameters of interest). For example, Greenland (2006) specifies
a normal prior with mean zero and variance 1/2 for a log odds ratio parameter to reflect
the prior belief that the median odds ratio is 1 and the odds ratio is between 1/4 and 4
with 95% probability a priori. Other choices for prior mean and variance are possible, of
course, and Greenland (2006) recommends to perform a sensitivity analysis by varying
the prior variance.
Fourthly and finally, proper default prior distributions may be used as a conservative
guess or to avoid the problem of diverging maximum likelihood estimates in logistic re-
gression due to complete separation (Albert and Anderson, 1984). For example, the ridge
prior, with prior mean zero and prior covariance matrix proportional to the identity mat-
rix, is a commonly used default prior. Zellner’s g-prior for linear models (Zellner, 1986),
with prior covariance matrix proportional to the covariance matrix of the maximum
likelihood estimate (MLE) of the regression coefficients, is another default prior, which
has the attractive feature that g can be interpreted as relative inverse prior sample size,
see for example Marin and Robert (2007, Section 3.2.2) or Liang et al. (2008). The g-prior
is a natural approach to incorporate prior correlations between regression coefficients
(see the application described in supplementary material) and automatically adjusts for
different variances of the covariates. Suitable extensions of the g-prior to generalized
linear models (GLMs) are discussed in Sabanés Bové and Held (2011). Both ridge and g-
priors are often used for Bayesian model selection, where the prior distribution needs to
be proper to ensure that the marginal likelihood is well-defined and the corresponding
Bayes factors (Kass and Raftery, 1995) can be calculated.
Methodology to estimate the inverse prior weight g goes back to the literature on ridge
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regression (Lindley and Smith, 1972; Hoerl et al., 1975; Box, 1980). Empirical Bayes (EB)
estimates of g in the context of g-priors have been proposed by Copas (1983) both for
the linear and the logistic regression model. Fully Bayesian (FB) approaches to estimate
g have been advocated in the linear model with regression splines (Denison et al., 2002,
Section 3.5 and references in Section 3.8), using an inverse gamma hyperprior for g
in combination with a ridge prior. The support of the inverse gamma distribution is
the whole positive real line, thus the prior weight can be either de- or increased. Prior
distributions for the parameter g of the g-prior have been proposed in Cui and George
(2008); Liang et al. (2008) and Held et al. (2015) in the context of Bayesian model selection.
This paper is structured as follows. In the generalized linear model with a multivariate
normal prior on the regression coefficients (Section 2) we first discuss methodology
originally proposed by Box (1980) to quantify the prior-data conflict, see also Spiegel-
halter et al. (2004, Section 5.8), Greenland (2006) and Evans and Moshonov (2006). We
then proceed and describe methods to estimate the prior weight, represented by the
parameter 1/g. This leads to adaptive prior weighting, as opposed to approaches with
fixed prior weight. We review empirical Bayes procedures (Copas, 1983, 1997) to estimate
g in the g-prior setting and extend those to any normal prior. Furthermore, we show that
EB estimates of g correspond to intermediate solutions between prior-data agreement
and disagreement. We finally propose fully Bayes procedures to estimate g using a
suitable hyperprior for g. If blocks of regression coefficients are a priori independent,
then the approach can be extended to separately weight each block. Application in more
complex regression models is also possible, for example in generalized linear mixed
models. Inference for Bayesian GLMs with a hyperprior on g is done using integrated
nested Laplace approximations (INLA) (Rue et al., 2009), to avoid the commonly used
computer-intensive Markov chain Monte Carlo (MCMC) simulation.
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Two applications are considered in this paper: A Bayesian logistic regression model for
data from a cross-sectional study (Sullivan and Greenland, 2013) is described in Section
3.1, while a Bayesian analysis of binary longitudinal data with a generalized linear mixed
model is outlined in supplementary material. Section 3.2 describes additional simulation
studies that have been performed to investigate the properties of the proposed method-
ology.
2. Methodology
Consider a generalized linear model (GLM) with outcomes yi, i = 1, . . . , n, and linear
predictor ηi = α+ x>i β, where the vector of regression coefficients β has dimension d.
The mean µi = h(ηi) of yi is obtained with the response function h(ηi), the variance
function v(µi) determines the variance of yi. We use a Gaussian prior with mean ν
and covariance matrix gΣ for β, i. e. β ∼ N(ν, gΣ). The intercept α can be extremely
sensitive to how covariates are centered and how factors are coded, so we follow the
recommendations by Greenland and Mansournia (2015, Section 7) and use Jeffreys’ prior
f (α) ∝ 1. More informative priors may induce unjustifiable shrinkage of the intercept
towards an arbitrary prior mean. We note that also Gelman et al. (2008) use an extremely
dispersed Cauchy prior for the intercept, negligibly different from our flat prior.
2.1 Prior-data conflict
Box (1980) has suggested an approach to quantify a potential conflict between the prior
distribution and the observed data. The methodology is based on the prior predictive
distribution f (y) of the data Y and compares the distribution of f (Y) with f (y), evalu-
ated at the observed data y = yobs. Box’s p-value is based on the probability
Pr{ f (Y) 6 f (yobs)}, (1)
Paper IV - 135 -
Adaptive prior weighting in generalized regression 5
where a small value of (1) implies that the observation yobs has relatively low prior
predictive density, i. e. indicates prior-data conflict. To avoid some anomalous behavior,
Evans and Moshonov (2006) proposed to replace Y in (1) with a minimal sufficient
statistic for the parameter of interest. This ensures that the method provides a measure of
prior-data conflict only, and not a confounded check of the model + prior combination.
In more recent work, Evans and Jang (2011a) show the consistency of the Evans and
Moshonov (2006) methodology and discuss the lack of invariance of the original Box
(1980) approach, see also Evans and Jang (2010, 2011b).
However, exact computation of (1) is difficult in GLMs. Therefore, Greenland (2006)
suggested to consider the MLE βˆML (of course a minimal sufficient statistic for β) as
the “data” with (asymptotic) βˆML | β ∼ N(β,T ) distribution (Fahrmeir and Kaufmann,
1985), where T denotes the (estimated) covariance matrix of the MLE. Combining this
with a N(ν, gΣ) prior for β gives the (approximate) prior predictive distribution βˆML ∼
N(ν,T + gΣ). The standardized difference
T(g) = (βˆML − ν)>(T + gΣ)−1(βˆML − ν) (2)
can then be evaluated against a χ2-distribution with d degrees of freedom to compute
Box’s p-value. This approximates the predictive check by Box (1980, eq. (3.9)) for the
linear model based on the F-distribution using an additional improper prior f (σ2) ∝ σ−2
on the residual variance.
2.2 Estimates of prior weight
In the absence of prior information on Σ, the generalized g-prior (Sabanés Bové and
Held, 2011) can be used as default. The corresponding prior covariance matrix is taken
as Σ = c (X>WX)−1 where W is a diagonal matrix with corresponding weights on the
diagonal (e. g. the binomial sample sizes for logistic regression). Here, the columns of
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the design matrix X = (x1, x2, . . . , xn)> are assumed to be centred, i. e. X>W1 = 0. The
constant c = c(α) depends on the specific GLM and is defined as
c(α) = v(h(α)){h′(α)}−2 (3)
where h′(.) is the derivative of h(.), see Copas (1983) for a derivation for binary outcomes
and Sabanés Bové and Held (2011) for a general treatment. Under the generalized g-
prior, the implied shrinkage of the MLE βˆML is approximately as in the linear model
(Held et al., 2015) with posterior mean
E(β | y) ≈
(
n · βˆML + n/g · ν
n + n/g
)
,
which reduces to
E(β | y) ≈ g
g + 1
βˆML (4)
for ν = 0. Thus t = g/(g + 1) can be interpreted as shrinkage factor for the generalized
g-prior with prior mean 0.
To derive an EB estimate of g, we note that we can re-write (2) with T ≈ c (X>WX)−1
(Copas, 1983) as
T(g) =
1
1 + g
1
c
(βˆML − ν)>(X>WX)(βˆML − ν). (5)
Equating (5) with its expectation d (subject to g > 0) gives the analytic solution
gˆ = max
{
1
d
1
c
(βˆML − ν)>(X>WX)(βˆML − ν)− 1, 0
}
≈ max{zobs/d− 1, 0}, (6)
here zobs denotes the observed deviance (relative to the null model with β = 0), obtained
from fitting a standard GLM (Copas, 1983, 1997) to the data at hand. By construction,
plugging-in (6) into (5) gives (for gˆ > 0) T(gˆ) = d, so Box’s P-value can be easily
evaluated for the adapted N(ν, gˆΣ) prior with EB estimate gˆ. Box’s P-value turns out
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to be 0.32, 0.37, 0.39 → 0.5 for increasing degrees of freedom d = 1, 2, 3 → ∞. This
illustrates that in regular cases (where gˆ > 0) the empirical Bayes approach to estimate
g is a way to avoid extreme prior-data agreement and disagreement with unremarkable
Box’s P-values between 0.32 and 0.5. If gˆ = 0 then Box’s P-value will be even larger.
The approach can be easily extended to arbitrary prior mean ν if we evaluate the
deviance not against the null model ν = 0 but against a model with non-zero prior mean
ν. This can be achieved by fitting a GLM with offset Xν. For arbitrary prior covariance
matrix Σ an empirical Bayes-type (moment-based) estimate of g can be implemented by
equating (2) with the mean d of the χ2(d)-distribution and numerically solving for g.
The empirical Bayes approach avoids arbitrary choices of g which may be at odds
with the data. However, the uncertainty about the estimate gˆ is ignored, i. e. the estimate
gˆ is treated as the true value g. This is particularly worrying if gˆ = 0, since then the
posterior of β degenerates to a point mass at the prior mean ν, no matter what the data
are. In contrast, a fully Bayesian approach to estimate g will incorporate the uncertainty
about the estimate from its posterior distribution. If the prior distribution comes from
historical data, a beta prior is commonly used for 1/g, which restricts the range of g
to values larger than unity (Duan et al., 2006). The prior can therefore only be down-
but not up-weighted. However, if the prior distribution is not based on historical data,
then also increasing the weight of the prior distribution may be warranted by the data
at hand. We will illustrate this in Application 3.1.
For Bayesian model selection based on the g-prior, Liang et al. (2008) suggest to use
the hyper-g prior with prior density
f (g) =
a− 2
2
(1 + g)−a/2 (7)
for g, which is proper for a > 2. This prior distribution is a special case of a class of prior
distributions proposed by Cui and George (2008) and induces a beta distribution for the
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shrinkage factor t = g/(g + 1): t ∼ Be(1, a/2− 1). Of particular interest is the case a = 4,
where the prior on the shrinkage factor t is standard uniform and thus the prior median
of g is 1. Furthermore, the distribution of w = 1/g is the same as the distribution of g, i. e.
the prior has no preference regarding up- or down-weighting. The cdf of g has a simple
analytic form, F(g) = g/(g+ 1), so prior probabilities of interest can be easily calculated,
e. g. Pr(1/2 6 g 6 2) = 1/3 or Pr(1/19 6 g 6 19) = 0.9. We consider this “standard”
hyper-g prior as sufficiently dispersed since g has infinite expectation. Furthermore,
under the generalized g-prior a uniform prior on the shrinkage factor t implies that
the posterior mode of the shrinkage factor t = g/(g + 1) is asymptotically equal to the
corresponding EB estimate based on (6) (Held et al., 2015). Thus, the standard hyper-
g prior regularizes empirical Bayes and can be considered as a natural choice for a
hyperprior for g.
An alternative symmetric prior would be f (g) = pi−1g−0.5 (1 + g)−1, which corres-
ponds to t ∼ Be(1/2, 1/2), the so-called horseshoe prior (Carvalho et al., 2010). This
choice is also indifferent regarding up- or down-weighting, but puts substantially more
prior mass to extreme values of g. For example, under the horseshoe prior Pr(1/161 6
g 6 161) ≈ 0.9.
The Strawderman-Berger (short Strawderman) prior (Berger, 1980), obtained from (7)
with a = 3, places more weight on larger values of g, i. e. treats g not symmetric. For
example, the prior median is 3. Another non-symmetric prior on g is inverse gamma
distribution IG(a, b) with mode b/(a + 1). This choice is often made for convenience due
to conjugacy in the normal linear model (Denison et al., 2002, Section 3.3), but lacks a
deeper motivation as a suitable prior for the weight parameter w = 1/g.
Whatever prior for g is used, calculation of the posterior distribution can be done using
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numerical integration with INLA (Rue et al., 2009), which we describe in Section 2.3. We
also comment briefly on alternative MCMC procedures.
2.3 Implementation in INLA
The traditional choice to implement the proposed approach would be Markov chain
Monte Carlo (MCMC), but we prefer a numerical approach based on INLA to avoid
potential convergence problems and the associated Monte Carlo error of MCMC. How-
ever, adaptive prior weighting with the R-INLA interface (see Martins et al. (2013, Section
2.3) for a summary) requires specific amendments to the model which we now briefly
describe. More details can be found in Supplementary Material.
Consider a GLM as described in Section 2 with linear predictor ηi = α+ x>i β where
β ∼ N(ν, gΣ) a priori. R-INLA does not allow to specify this prior directly, so the for-
mulation needs to be re-written as ηi = α+ x>i ν+ x
>
i β˜ where β˜ ∼ N(0, gΣ). Therefore,
oi = x>i ν can be used as offset variable and it is sufficient to consider priors for the
regression coefficients β˜ with mean zero. The idea is to treat the mean-zero regression
coefficients β˜ as a Gaussian Markov random field (GMRF) (Rue and Held, 2005) with
pre-specified precision matrix Σ−1 - up to the possibly unknown multiplicative weight
factor w = 1/g. However, it is not possible to directly compute the product x>i β˜ for all
observations i = 1, . . . , n. The trick is now to use the copy feature (Martins et al., 2013,
Section 4.3) in order to define d identical copies of β˜ in the model formulation, eventually
multiplied with the covariate values xj = (x1j, . . . , xnj)>, j = 1, . . . , d.
The R-INLA default treats the weight w = 1/g as unknown and uses a gamma hy-
perprior for it. However, the software allows the user to define any suitable prior density,
either as an expression or in tabulated form, given the value of the prior density on a
suitable grid. Note that INLA requires this to be done for log(w). Here we have used
the tabulated approach for the standard hyper-g, horseshoe and Strawderman prior and
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have computed the corresponding density of log(1/g) with a change-of-variables. The
weight w can also be fixed at any pre-specified value which we have used to treat the
case g = 1.
The described implementation can be generalized to independent GMRFs β˜1, . . . , β˜p,
say, in order to weight the corresponding components of β with separate weight para-
meters g1, . . . , gp, see end of Section 3.1 for an example. It is also straightforward to
adaptively weight the prior on the regression coefficients β in more complex models
such as generalized linear mixed models, see the application described in Supplementary
Material.
A possible implementation with MCMC would combine the Gamerman (1997) al-
gorithm for Bayesian generalized linear models (for fixed g) with a Metropolis-Hastings
sampler from the full conditional of g. This can be easily and efficiently implemented,
but the analysis with INLA is still much faster and provides estimates without Monte
Carlo error. This is particularly important for the simulation studies reported in Section
3.2, where we fit hundred thousands of different prior-data combinations.
3. Applications
3.1 Bayesian analysis of a logistic regression model
Sullivan and Greenland (2013) consider data from a cross-sectional study on obstetric
care and neonatal death at a teaching hospital. The binary outcome variable (death
yes/no) is related to 14 explanatory variables. They are all binary with frequencies
between 0.3% (variable hydram) and 77% (variable nomonit). There are only 17 deaths
observed among 2992 births. Sullivan and Greenland (2013) give more information about
the data originally from Neutra et al. (1978) and select an informative prior for β for a
Bayesian logistic regression analysis. The corresponding regression coefficient vector β
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is assumed to be a priori normally distributed with mean νSG = log(OR), where the
vector OR = (2, 2, 2, 4, 2, 1, 4, 2, 2, 2, 4, 2, 2, 4)> contains the prior median odds ratios for
each explanatory variable. The prior covariance matrix Σ has been chosen to be diagonal
with all variances equal to 1/2. The intercept is considered as a nuisance parameter with
improper (flat) prior.
There is no evidence for prior-data disagreement for the informative N(νSG,Σ) prior
(equation (2) gives Box’s p=0.91). Even if the prior mean ν would be set to zero, i. e.
for a β ∼ N(0,Σ) prior, there would be no compelling evidence for prior-data conflict
(Box’s p=0.13). The EB estimates of g are gˆ = 0.00 and gˆ = 2.10 in these two cases.
Box’s p-values using the EB estimates of g in the prior covariance matrix gˆΣ are p=0.60
and p=0.45, respectively, so in both cases close to 0.5, as expected from the discussion in
Section 2.2.
If we combine the Sullivan and Greenland (2013) prior with the standard hyper-g prior
(7) (with a = 4), the resulting posterior for g (see Figure 1) has median 0.16 (equi-tailed
95% credible interval (CI): 0.01 to 0.81). Thus, the hyper-g prior increases the weight
of the prior on the regression coefficients by a median factor of 1/0.16 ≈ 6.3, which
corresponds to a reduction of the prior variance from 0.5 to 0.08. However, there is quite
large uncertainty regarding g where values larger than 1 still have some posterior mass.
Sullivan and Greenland (2013) pay particular attention to one explanatory variable,
hydram (x7), an indicator of hydramnios during pregnancy, with MLE 60 (95% Wald
confidence interval 5.7 to 635, profile likelihood confidence interval 2.8 to 478) of the
corresponding odds ratio exp(β7). The Sullivan and Greenland (2013) prior for the
corresponding log odds ratio β7 is normal with mean log(4) and variance 1/2, resulting
in a prior median odds ratio of 4 with equi-tailed 95% prior CI from 1 to 16. Combining
this prior with the data gives posterior median 6.1 (95% CI: 1.6 to 22.8) for the odds ratio.
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Figure 1: Hyper-g prior and posterior density of g (left) and the corresponding t = g/(1 + g) (right) in the
logistic regression example. Posterior 1 based on N(νSG, gΣ) prior for β. Posterior 2 based on N(0, gΣ)
prior for β.
If we treat g as unknown with hyper-g prior, then the posterior median of exp(β7) is 4.3
(95% CI: 2.3 to 10.5). Although the hyper-g prior implies a substantially more dispersed
marginal prior on the odds ratio (95% prior CI: 0.21 to 75.0), the posterior is actually
narrower than for fixed g = 1. The corresponding OR estimates under the hyper-g,
horseshoe and Strawderman prior are given in Table 1, together with DIC values to assess
the model fit. The posterior distributions of the corresponding regression coefficient
β7 (i. e. the log odds ratio) are compared in Figure 2. Of note, the posterior under the
horseshoe prior is substantially more peaked and narrower than under the hyper-g and
Strawderman prior. The model fit turns out to be 3-4 units better for the three fully
Bayesian approaches compared to the analysis with fixed g = 1, with the horseshoe
prior having the lowest DIC value.
The same analysis has been conducted with prior mean ν = 0 and the same diagonal
prior covariance matrix Σ. The resulting posterior of g has median 1.20 (95%-CI: 0.46
to 3.13) and is also displayed in Figure 1. Thus, the hyper-g prior now decreases the
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Figure 2: Posterior density of regression coefficient β7 for the variable hydram in the logistic regression
example with fixed (g = 1) and adaptive (hyper-g) prior weighting. Top: N(νSG, gΣ) prior. Bottom:
N(0, gΣ) prior.
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weight of the prior on the regression coefficients, but only slightly by a median factor
of 1/1.20 = 0.83, with considerable uncertainty regarding g. Accordingly, the posterior
distribution of the regression coefficient related to the variable hydram now barely differs
whether we use fixed g = 1 or the hyper-g prior, see Figure 2. Indeed, the posterior
median of exp(β7) is now 1.6 (95% CI: 0.4 to 6.3) for g = 1 and 1.8 (95% CI: 0.4 to 13.4)
for the hyper-g prior, estimates for the other two priors (horseshoe and Strawderman-
Berger) are given in Table 1, again with DIC values, which are now very similar for the
different approaches.
Figure 1 also shows prior and posterior of t = g/(g + 1). For the prior mean νSG,
the posterior mode of t is close to zero, as expected from the EB estimate gˆ = 0. For
prior mean 0, the posterior mode of t is 0.55, slightly smaller than the corresponding EB
estimate gˆ = 2.10/(1 + 2.10) = 0.68. The difference can be explained by the substantial
non-normality of the posterior distribution of β, cf . the difference between the Wald and
the profile likelihood confidence interval for β7 given above. Also, the correspondence
of the EB and FB estimates has been shown only for the (generalized) g-prior, which is
not used here.
One could argue that the above change to the prior mean ν = 0 should be accompanied
by a more flexible formulation for the prior variances. To do so, we now introduce a new
prior “block hyper-g” formulation with three different g parameters: g1 for the block of
nine covariates with original prior mean of log(2), g2 for the block of four covariates
with prior mean of log(4), and g3 parameter for the single covariate with prior mean 0.
Thus the prior weight is now allowed to vary from block to block.
The posterior median of g1 is 0.19 (95% CI: 0.02 to 1.4), g2 has posterior median 4.1
(95% CI: 0.9 to 20.9), while g3, the inverse prior weight of the single covariate with
prior mean 0, has posterior median 0.64 with large posterior uncertainty (95% CI: 0.04
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to 9.6). Thus, the weight of the prior distribution has been increased by a median factor
of 1/0.19 ≈ 5.3 for the first block of parameters, whereas the weight of the second block
(which includes the variable hydram) has been decreased by a median factor of 4.1. For
example, the posterior median of exp(β7) is now 5.5 (95% CI: 0.4 to 95.5). Thus, the
decreased weight of the prior distribution leads to a substantially larger OR estimate
and a decreased precision of the regression coefficient, compared to the analysis with
one unknown weight parameter 1/g. Of note, this formulation gives the best model fit
with DIC value 182.6, see Table 1.
ν = νSG ν = 0
OR 95% CI DIC OR 95% CI DIC
ML 60 5.7 to 634.7 60 5.7 to 634.7
g=1 6.1 1.6 to 22.8 183.4 1.6 0.4 to 6.3 188.3
Strawderman 4.3 2.3 to 11.1 180.5 1.9 0.4 to 16.1 188.8
Hyper-g 4.3 2.3 to 10.5 180.3 1.8 0.4 to 13.4 188.8
Horseshoe 4.1 2.6 to 8.4 179.6 1.8 0.4 to 14.4 188.9
block Hyper-g 5.5 0.4 to 95.5 182.6
Prior (g=1) 4.0 1.0 to 16.0 1.0 0.25 to 4.00
Table 1: Odds ratio (OR) estimate and 95% credible interval for hydramnios coefficient with prior mean
νSG (left) or prior mean 0 (right) together with DIC for different priors on g.
3.2 Simulation studies
In a simulation study we have compared our approach with different hyperpriors for g
(including fixed g = 1) and different degrees of misspecification of the prior mean (Sec-
tion 3.3) or the covariance matrix (Section 3.4). To do so, we simulate β from a (possibly
misspecified) “prior” distribution and subsequently y from a logistic regression model
with linear predictor α + X>β, here X is the same design matrix as in the application
described in Section 3.1. For the subsequent analyses with INLA we use a normal prior
for β with mean νSG and covariance matrix gΣ where Σ = diag(0.5, . . . , 0.5).
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3.3 Simulation study I with shifted mean
Misspecification of the prior mean νSG is achieved by adding a shift parameter es, s =
1, . . . , S to each component of νSG. Here we use es ∈ e = (−2.6,−2.4, . . . , 0, . . . , 2.4, 2.6),
so S = 27, and sample β(k)s , k = 1, . . . , K = 1000 from N(νSG + es,Σ). For each β
(k)
s
we compute the linear predictor η(k)s = α + X>β(k)s and the risk probability vector
pi
(k)
s =
exp(η(k)s )
1+exp(η(k)s )
and finally generate binary response vectors y(k)s ∼ Bin(pi(k)s , 1). To
avoid problems with complete separation, the intercept α has been chosen such that the
proportion of events (y = 1) is close to 0.5. The simulated data (y(k)s ,X) are now analysed
with R-INLA using a N(νSG, gΣ) prior for β and the following priors on g: Fixed g = 1,
Hyper-g, horseshoe and Strawderman-Berger.
In total, 27× 1000× 4 = 108 000 calls of R-INLA have been made. Except for fixed
g = 1, the posterior median of g has been computed and averaged across K = 1000
analyses for each es. This is shown in the top row of Figure 3. One can see how the
different approaches react to prior misspecification with increasing estimates of g for
increasing |es|. There are only minor differences between the different approaches with
a slight bias towards g > 1 of the Strawderman prior in the case of no misspecifcation
(es = 0).
The next row in Figure 3 gives the root mean squared error (RMSE)√√√√ 1
K
1000
∑
k=1
{
E(β j | y(k)s )− (νj + es)
}2
between the posterior mean of β j and the true underlying mean νj + es, here νj denotes
the j-th component of the prior mean vector νSG. Shown are the results for two covariates,
nullip with a balanced proportion of 49% “cases” and hydram with only 0.3% cases. The
third row gives the corresponding mean posterior standard deviation (MPSD) of the two
covariates. We show only results for the hyper-g approach, since the other two priors
gave virtually identical results. It is interesting to see how the hyper-g approach reacts
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to model misspecifcation with much lower RMSE and larger MPSD in the case of model
misspecification. As one would expect, differences between hyper-g and fixed-g (both in
terms of RMSE and MPSD) increase with increasing amount of misspecifcation.
Finally, the last row in Figure 3 gives the coverage of equi-tailed 95% credible intervals
for the components of β, averaged across all 14 covariates. Whereas the hyper-g and the
horseshoe prior (Strawderman gives very similar results) have coverage very close to the
nominal 95% level, the empirical coverage of the fixed-g analysis drops quickly to values
of 85% and below.
3.4 Simulation study II with scaled covariance matrix
In a second simulation study, we have investigated the effect of misspecification of the
prior covariance matrix. The study has been conducted as in Section 3.4, with the only
difference that β is now generated from a N(νSG, δsΣ) distribution where the S = 31
components of δ = (1/20, . . . , 1, . . . , 20), equally-spaced on the log-scale, quantify the
amount of prior misspecification.
The results are shown in Figure 4. The adaptive approaches react to prior misspecific-
ation with smaller values of the posterior medians of g for small values of δs and vice
versa. The RMSE of the fixed-g approach increase dramatically for larger δs, whereas the
increase of the hyper-g approach is only moderate. Of note, the MPSD of the hyper-
g is now smaller than for the fixed-g approach for small of δs. The coverage of the
95% credible intervals is again very close to the nominal level for the hyper-g approach
(Strawderman again not shown, since visually indistinguishable). The horseshoe prior
gives similar results, but with coverage slightly too low for small values of δs. The fixed-g
approach has coverage too high for small values of δs and coverage too low for larger
values of δs.
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4. Discussion
We have proposed a novel approach to update the weight of the prior distribution
in the light of the current data. We have focused on the common scenario where the
prior distribution for the regression coefficients is multivariate normal. Adaptive prior
weighting is achieved by introducing an unknown multiplicative scalar g for the prior
covariance matrix. A hyperprior for g allows to adaptively estimate the weight of the
prior distribution in the light of the current data. The application showed that the hyper-
g prior allows for both up- or down-weighting of the prior distribution. Another example
with a correlated prior on the regression coefficients is given in Supplementary material.
Prior information on regression coefficients from historical data can often be assumed
to be normal due to the approximate normality of the posterior distribution, e. g. Bern-
ardo and Smith (2000). A normal prior distribution is therefore a natural choice. The
explicit incorporation of a prior weight parameter in our approach can be used to inform
researchers on the appropriateness of the original prior being used. The simulation study
has shown that the posterior distribution of g informs appropriately about possible
misspecification of the prior distribution.
However, if the interest is primarily in the regression coefficients, an alternative way to
interpret a hyperprior on the inverse prior weight parameter g is to consider the implied
marginal prior distribution on the regression coefficients, a scale mixture of normals
(West, 1987). The prior weight w = 1/g is then considered a nuisance parameter and
its posterior distribution is only of secondary interest. For example, usage of an inverse
gamma hyperprior leads to a “robust” Student t rather than a normal prior distribution
(Zellner and Siow, 1980) for the regression coefficients. As a special case one obtains
a Cauchy prior as proposed in Gelman et al. (2008) for logistic regression. From that
perspective, our approach can be viewed as replacing a normal prior on the regression
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coefficients with a “robustified” scale mixture of normals prior. In contrast to Student t
or Cauchy priors, the hyper-g prior on g allows for a symmetric treatment of the weight
parameter and can be viewed as a regularized version of empirical Bayes, thus balancing
prior-data agreement and disagreement. However, the implied marginal distribution of
the regression coefficients does not have a standard form (Liang et al., 2008).
As an extension of our approach we have introduced several independent weight
parameters for blocks of regression coefficients in the application described at the end
of Section 3.1. In the limit, even every regression coefficient can have its own weight
parameter as long as the prior covariance matrix is diagonal. The advantage of the
implementation in INLA is that the proposed methodology can easily be applied in
more complex models, e. g. generalized linear mixed models as in our second application
described in Supplementary Material. In future work we also plan to compare the
sensitivity of the posterior of the regression coefficients (with and without adaptive prior
weighting) with respect to mean and covariance matrix of the normal prior (Roos and
Held, 2011; Roos et al., 2015).
Supplementary Material
Supplementary Material describes the implementation of the proposed methodology
with INLA in detail and an application longitudinal data using a generalized linear
mixed model.
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Figure 3: Simulation I: Mean posterior median estimates of g (top row), root mean squared differences
(RMSE) and mean posterior standard deviation (MPSD) for two explanatory variables (nullip and hydram)
(middle rows) and average coverage of 95% credible intervals across all explanatory variables (bottom
row).
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Figure 4: Simulation II: Mean posterior median estimates of g (top row), root mean squared differences
(RMSE) and mean posterior standard deviation (MPSD) for two explanatory variables (nullip and hydram)
(middle rows) and average coverage of 95% credible intervals across all explanatory variables (bottom
row).
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This supplementary material guides through technical details of the applications presen-
ted in Section 3 in the main text. We discuss the implementation of a multivariate normal
prior
β ∼ N(ν, gΣ) (1)
on the regression coefficients β in a generalized regression model with integrated nested
Laplace approximations (INLA) (Rue et al., 2009). INLA is implemented, freely available
and comes with a R user interface (r-inla) which can be installed by the following R
command
install.packages("INLA", repos="http://www.math.ntnu.no/inla/R/stable").
Information about the installed version can be retrieved by typing
inla.version().
For this document and the applications in the main text we used the r-inla version
built on 2014-07-04. In Section 1 we introduce how a generalized linear model (GLM)
is defined with r-inla. Section 2 illustrates the implementation of a user defined prior
in r-inla and Section 3 provides the code to reproduce the results of the applications
presented in the main text as well as an additional example of a clinical trials with a
longitudinal data structure.
1. Generalized regression with INLA
A generalized linear model (GLM) is described by a likelihood for the observations yi
with i = 1, . . . , n and a linear predictor ηi = α+ x>i β, where β has length d. A Bayesian
analysis requires prior distributions on all unknown parameters. Different likelihoods
and priors are implemented in r-inla. An overview, descriptions and implementation
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details can be found on http://www.r-inla.org/. In Section 1.1 we describe the imple-
mentation of the multivariate prior (1) in r-inla.
1.1 Multivariate normal priors in INLA
The model analyzed by the inla function is defined by a formula, similar to a glm
formula (see ?inla and ?formula). The function inla() computes the marginal posterior
distribution for all model parameters, defined in the formula argument and generates an
inla-object. In r-inla a latent model is defined by calling f(..., model = ), where ...
must be replaced by a variable name describing the dependence structure in the latent
model. Details about the available models can be found by typing ?f.
To implement the prior (1) with mean ν = 0, we use the latent model "generic0". The
"generic0" latent model allows to use a generic multivariate normal prior with precision
matrix Q = wC. A prior distribution on the precision hyperparameter w can be defined.
In the context of the main text we use C = Σ−1 and w = 1/g. The following R-code
shows a sample model-formula, which uses the generic0-field for d = 2 covariates:
#define inla-model:
inlaFormula <- 1 + f(indexName1,
varName1,
model = "generic0",
Cmatrix = priorPrecision,
initial = log(0),
fixed = FALSE,
hyper = list(theta = list(
prior = "loggamma",
param = c(a, b)
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) ) )
+ f (indexName2, varName2, copy = "indexName1")
As in the glm-models "-1" would remove the global intercept. Usually, if we assume
a separate improper prior on the intercept (α), we keep the intercept, in the same way
as in the code above. In the GLM application indexNamep refers to the pth covariate
and consists only of integers equal to p defining an index variable among d different
covariates. varNamep gives the covariate name, referring to the corresponding variable
and is used as weight in the latent field. The Cmatrix argument defines the precision
matrix C = Σ−1. Thus priorPrecision is a covariance matrix of dimensions d× d. The
argument initial is used to set a starting value for w and fixed indicates whether w
should be fixed at its starting value. The argument hyper defines the prior distribution
for w which in this case is a log-Gamma distribution with parameter a and b on the
log-precision θ = log(w), which is the r-inla internal scale for the hyperparameter w.
The settings for the hyper argument are ignored if fixed = TRUE.
If the GLM includes d > 1 covariates then we need to call additional (d− 1) latent fields
using the copy argument defined as f(..., copy="indexName1"). This copy feature is
used to define the latent field correctly if more than one covariate is included and weights
each component of the latent field, as described in more detail in Martins et al. (2013,
Section 4.3). Thus, the object inlaFormula defined above, includes d = 2 covariates
(varName1 and varName2). The following R-code calls the inla function and computes
the model defined above:
#inla-call:
result <- inla(formula = inlaFormula,
data = data,
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family = "binomial",
family = paste(inla.family),
offset = Offs,
control.fixed=list(mean = PriorMeanIntercept,
prec = PriorPrecIntercept
))
The likelihood of the model is defined by the argument family and a data-frame or a
list with the requested variable names must be provided in the data argument. The argu-
ment control.fixed allows to set prior distribution parameters for fixed effects and the
intercept. We assume that all covariates are in the latent field except the global intercept
for which we assume a prior mean defined by the numeric value PriorMeanIntercept
and a prior precision defined by the numeric value PriorPrecIntercept.
As the generic0 model assumes a zero mean prior, we need to define suitable offsets
oi = x>i ν to allow for a non-zero prior mean ν. Adding the offset implies that ηi =
α+ x>i ν+ x
>
i β˜. If one is interested to use different priors on separate blocks of covariates,
as discussed in Section 3.1 in the main text, one needs to repeatedly define separate
generic0 latent-fields for each block, which is explained in more detail in Section 3.2. In
Section 1.2 we introduce the function pwGLM which is a wrapper function calling r-inla
and which facilitates the implementation of the multivariate normal prior defined in (1).
1.2 Adaptive prior weighting with the pwGLM function
In order to appropriately define the latent field, in dependency of the covariates β
included in the GLM, the prior means ν and prior covariance Σ, we wrote the R-function
pwGLM which generates the corresponding model. The function is available in the sup-
plementary R-package pwGLMinla. This function was adapted and extended from an
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earlier implementation used by Held et al. (2012). The function pwGLM takes the following
arguments (default settings are given after " = "):
• response: the response vector in the regression model.
• data: a data frame with the covariates in the regression model.
• priorMean: a vector with the prior mean ν of length d, the same as the number of
covariates.
• priorPrecision: a precision matrix with dimension d × d. If separate priors for k
covariate blocks is used (i. e. sepG is a vector) then priorPrecision is used for every
covariate block (only possible if each of k blocks is of equal dimension) or priorPreci-
sion needs to be a list of length k with each list element containing a precision matrix
of suitable size fitting to the corresponding covariate block.
• priorG = "loggamma": defines the hyper-g prior on log(1/g), either the name of an
INLA built-in prior, a table or expression. If separate priors for k covariate blocks is
used (i. e. sepG is a vector) then priorG is applied to every of the k covariate blocks or
needs to be a list of length k defining possibly different priors for each covariate block.
• HyPar = NULL: parameters for the prior-distribution of the hyper-g prior. If priorG is a
table or expression or if fixedG=TRUE then HyPar will be ignored. If separate priors for
k covariate blocks is used (i. e. sepG is a vector) then HyPar is applied to every of the k
covariate blocks or needs to be a list of length k defining possibly different parameters
of the prior distributions for each covariate block.
• initialG = 0: starting value for the hyper-g prior. If priorG is a table or expression
then initialG will be ignored. If separate priors for k covariate blocks is used (i. e. sepG
is a vector) then initialG is applied to every of the k covariate blocks or needs to be a
vector of length k defining possibly different starting values for the hyperparameters
for each covariate block.
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• fixedG = FALSE: should hyper-g prior be fixed at initialG. If fixedG = TRUE then
the prior distribution on hyper-g (HyPar) will be ignored. If separate priors for k
covariate blocks is used (i. e. sepG is a vector) then fixedG is applied to every of the
k covariate blocks or needs to be a vector of length k defining possibly different fixed
hyperparameters for each covariate block.
• sepG = 1: defines separate covariate blocks for which a separate generic0 latent-field
will be implemented and thus also a separate hyper-g prior will be used. If sepG = 1
(default) then only one covariate block is used. If sepG is a vector of length d, the same
length as the number of covariates, with k different entries, then each covariate will be
assigned to the corresponding covariate block. The k entries in sepG should be integers
1, 2, . . . , k.
WARNING: The order of the covariates (e. g. in formula) must correspond to the index
in sepG. If sepG is a vector it will affect the meaning of other options (priorPrecision,
priorG, HyPar, fixedG and initialG).
• intsep = TRUE: should the intercept be treated separately without any hyper-g prior.
If intsep = FALSE, a possible intercept must be included like the other covariates and
the precision matrix must be extended correspondingly.
• PriorMeanIntercept = 0: prior mean for intercept if intsep = TRUE.
• PriorPrecIntercept = 0: prior precision for intercept if intsep = TRUE.
• FormExt = NULL: an extension of the model formula which is not covered by β (e. g. an
additional latent field for patient-specific random intercepts in the case of a generalized
linear mixed model).
• AddDat = NULL: additional data only used in the additional latent field and only re-
quested if FormExt!=NULL.
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• inla.family = "binomial": the GLM-family name defining the likelihood, default is
a binomial distribution, see www.r-inla.org/models/likelihoods.
• verbose = TRUE: prints the INLA-formula, is not the INLA-verbose argument.
• inla.strat = list(strategy = "simplified.laplace",
int.strategy = "grid", dz = 0.3): control variables in inla which are defined dif-
ferently than the inla defaults, see ?control.inla.
• updateHyper = TRUE: should the marginal posterior of the hyperparameter be updated
i. e. computed more precisely requiring more computing time,
see ?inla.hyperpar.
A call to pwGLM returns a list summarizing the results with the following named elements
containing the following values:
• coefNames: the names of the coefficients included in the model.
• inlaResult: the inla object returned by the inla call. Essentially all the information in
the other elements of the list returned by pwGLM can also be found here and are derived
form this object. In case of any doubts one should always check with the content in the
inlaResult list element.
• betaMedian: the median of the marginal posterior distributions for the included cov-
ariates β.
• betaMean: the mean of the marginal posterior distributions for the included covariates
β.
• betaFixed: the prior-mean ν, which is used to compute the offset oi = x>i ν.
• gQuantiles: the quantiles (2.5%, 50% and 97.5%) of the marginal posterior distribution
of g (or several g’s if sepG is a vector).
The function pwGLM is primarily used to construct the INLA model formula which can be
evaluated by the inla-function. Within pwGLM the function inla from the r-inla package
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is called. Additional arguments to the function inla may be assigned in the pwGLM call
which are then passed to inla.
Examples in Section 3 show the detailed use of pwGLM. The function pwGLM together
with the datasets used for the applications in Section 3 in the main text is made readily
available as R-package pwGLMinla in order to facilitate the reproduction of the presented
results.
2. Defining different prior distributions for g
In Section 2.1 we show how to implement the hyper-g prior with a = 4 such that it
can be used in inla and respectively by pwGLM. The hyper-g prior is used in Section 3
and for the same applications discussed in the main text. The hyper-g prior with a = 4
corresponds to a standard uniform distribution on the shrinkage factor t = g1+g which
is equivalent to Beta distribution t ∼ Be(1, 1). Alternatively to a hyper-g prior one could
be interested in specifying any other Beta distribution on t. The implementation and
necessary transformations for a t ∼ Be(a1, a2) distribution is illustrated in Section 2.2.
The package r-inla allows to use certain pre-specified priors as well as user defined
priors. In this section we demonstrate the usage of a user defined prior. As r-inla
internally uses often a log-transformation of the parameter and because one occasionally
wishes to switch between a prior specification on g or on the shrinkage factor t = g1+g
one needs to apply the change-of-variables formula (see Held and Sabanés Bové, 2014,
Appendix A.2.3) to transform the prior densities: if fX(x) is a probability density func-
tion of X one can compute the probability density function fY(y) of the transformed
variable Y = f (X) by
fY(y) = fX{ f−1(y)}
∣∣∣∣d f−1(y)dy
∣∣∣∣
= fX(x)
∣∣∣∣d f (x)dx
∣∣∣∣−1 .
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2.1 Hyper-g prior
In r-inla it is possible to implement a user-defined prior for the hyperparameters (g in
in our case). This can be done either by defining a function by using the muparser library
or by defining a table with the prior evaluated on a suitable grid (see http://www.
r-inla.org/models/priors). We choose the tabulated version for the implementation
presented below.
Change of variables for hyper-g. We want to use the hyper g-prior fg(g) = a−22 (1 +
g)−a/2 with a = 4 such that fg(g) = (1 + g)−2. The latent model generic0 in r-inla
is parameterized with precision Q = wC where w = 1/g and C = Σ−1. Internally r-
inla uses θ = log(w). Thus we need to transform the prior density appropriately to θ
using the change-of-variables formula: applied here for the transformation θ = f (g) =
log(1/g) and f−1(θ) = exp(1/θ) = exp(−θ).
The absolute value of the derivative is
∣∣∣ d f−1(θ)dθ ∣∣∣ = |− exp(−θ)| = exp(−θ) and thus the
probability density function of θ is
fθ(θ) = fg{ f−1(θ)}
∣∣∣∣d f−1(θ)dθ
∣∣∣∣
=(1 + exp(−θ))−2 · exp(−θ).
In r-inla the log-density is required: log( fθ(θ)) = log{(1+ exp(−θ))−2 · exp(−θ)}. This
is the input prior-distribution needed for r-inla corresponding to a hyper-g prior on g.
R-function for hyper-g prior:. Function implemented in R:
hypergprior <- function(t){
densg <- ((1+exp(-t))^-2)*exp(-t)
logdensg <- log(densg)
return(logdensg)
}
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Generate a table which can be used by inla:. The hypergprior-function must be evalu-
ated on a suitable grid and stored in an object which can be called by inla.
#define a suitable grid:
lprec <- seq(-100, 100, len=20000)
#evaluate prior:
prior.table <- paste(
c("table:",
cbind(lprec, sapply(lprec,FUN=hypergprior))
), sep = "", collapse = " ")
In Section 3.1, 3.2 and 3.3 the hyper-g prior will be applied by calling the object
prior.table.
2.2 Beta distribution on t
The hyper g-prior implies a Beta distribution on the shrinkage factor of the form t ∼
Be(1, a/2− 1). So far we looked at the hyper-g prior with a = 4, assuming a standard
uniform on t. But one could define alternative Beta priors on t. Beta-priors on t which
could be of interest is e. g. the case where (a < 4). With a = 3 we get the Strawderman-
Berger prior t ∼ Be(1, 1/2) or the Horseshoe prior for with t ∼ Be(1/2, 1/2).
In order to implement a Beta prior on t we must again apply the transformation of vari-
ables. As the r-inla internal scale is again on θ = log(w) = log(1/g) the transformation
function to the shrinkage factor is θ = f (g) = log(1/g) = log
(
1−t
t
)
, the inverse function
is f−1(θ) = 1
(1+exp(θ)) and the absolute value of the derivative
∣∣∣ d f−1(θ)dθ ∣∣∣ = ∣∣∣ exp(θ)(1+exp(θ))2 ∣∣∣.
For t ∼ Be(a1, a2) the probability density function is ft(t) = B(a1, a2)−1ta1−1(1− t)a2−1
(see Held and Sabanés Bové, 2014, Appendix A.5.2). Applying the change-of-variables
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formula we get the probability density function for θ to be
fθ(θ) = ft{ f−1(θ)}
∣∣∣∣d f−1(θ)dθ
∣∣∣∣
=B(a1, a2)−1
(
1
1 + exp(θ)
)a1−1 (
1− 1
(1 + exp(θ)
)a2−1 exp(θ)
(1 + exp(θ))2
.
In r-inla again the log-density is required: log( fθ(θ)) which is the input prior-distribution
needed for r-inla for defining the prior on θ = log(1/g) corresponding to a Beta-prior
on the shrinkage factor t.
R-function for Beta prior on t:. Function implemented in R:
betatprior <- function(t, a1=NULL, a2=NULL){
tinv <- 1/(1+exp(t))
densbeta <- dbeta(tinv, shape1=a1, shape2=a2)*exp(t)/(1+exp(t))^2
logdensbeta <- log(densbeta)
return(logdensbeta)
}
Generate a table which can be used by inla:. The betatprior-function must be evaluated
on a suitable grid and stored in an object which can be called by inla.
#define a suitable grid:
lprec <- seq(-100, 100, len=20000) ##CHANGE this LINE if INLA crashes!
#evaluate prior:
prior.table.t <- paste(
c("table:",
cbind(lprec, sapply(lprec,FUN=betatprior,
a1=0.5, a2=0.5))),
sep = "", collapse = " ")
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3. Applications
In this section we demonstrate the application of adaptive prior weighting by using
pwGLM for the logistic regression example discussed by Sullivan and Greenland (2013)
in Section 3.1. The application of three separate g-priors on covariate blocks for this
dataset is demonstrated in Section 3.2 and the application of prior weighting to a binary
response generalized linear mixed model for longitudinal data about the comparison of
two treatments against a toenail infection in Section 3.3. In order to be able to run the
examples from Section 3.1, 3.2 and 3.3 make sure to install the accompanying R-package
pwGLMinla first (see ?install.packages).
3.1 Adaptive prior weighting in a logistic regression model
#load library
library(pwGLMinla)
#load data
data(logregdat)
#rescale dyslab:
logregdat$dyslab=logregdat$dyslab/3
#Design matrix w/o intercept:
logregdatX<- subset(logregdat, select=-death)
Ntrials <- rep(1, nrow(logregdatX))
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#define priorMeanG:
priorMeanG <- log(c(2,2,2,4,2,1,4,2,2,2,4,2,2,4))
#define priorPrecisionG:
priorPrecisionG <- diag(rep(2, ncol(logregdatX)))
#call pwGLM:
resultLog <- pwGLM( response = subset(logregdat, select=death),
data = logregdatX,
priorG = prior.table,
priorMean = priorMeanG,
priorPrecision = priorPrecisionG,
verbose = TRUE,
inla.family = "binomial",
Ntrials = Ntrials, # number of trials for binomial
intsep = TRUE)
#Plot the marginal posterior of g:
#1. extract the marginal posterior from INLA-object:
marg.g.inv <- resultLog$inlaResult$marginals.hyperpar[[1]]
#2. use inla.tmarginal to transform from w=1/g to g:
marg.g <- inla.tmarginal(function(x) 1/x, marg.g.inv, method="linear")
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#3. Plot:
plot(marg.g[,"x"], marg.g[,"y"], type="l",
xlim=c(0,2), ylim=c(0,1), xlab="g", ylab="density")
#Plot the marginal posterior of hydram:
#1. Extract the prior Mean of hydram (covariate with index 7):
m1 <- resultLog$betaFixed[7]
#2. Extract the marginal posterior of hydram from the latent field:
beta <- resultLog$inlaResult$marginals.random$ihydram$index.7
#3. Add prior mean
beta[,1] <- beta[,1] + m1
#4. Plot
plot(beta, type = "l",
xlab = "beta", ylab = "density")
3.2 Adaptive prior weighting with separate hyper-g priors
Instead of using one single g for β one can use several g-priors on covariate blocks, as
mentioned in Section 3.1 in the main text. Here we show how the case of three separate
g’s can be implemented with the pwGLM(...) function.
First we define again the prior mean, which is set here to zero and the prior covariance
matrix. As we want to use three different g-prior on three different covariate blocks we
need to define three separate covariance matrix of adequate size and join them in a
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single list. The first block addresses nine covariates for which in the above example a
prior mean equal to log(2) was assigned. The second covariate block of size four covers
the covariates with previous prior mean equal to log(4) and the last g addresses a single
variable (abort) with previous prior mean equal to log(1).
#Prior mean set to zero:
priorMeanZero <- rep(0, length(priorMeanG) )
#Three separate prior (diagnoal) covariance matrix:
priorlogsepg1 <- diag(9)*2
priorlogsepg2 <- diag(4)*2
priorlogsepg3 <- 2
#Join the three prior covariance matrix as list:
priorlistLOG <- list(
priorlogsepg1,
priorlogsepg2,
priorlogsepg3)
Then we apply pwGLM which calls r-inla. The argument sepG defines which variables
are addressed by which covariate block, where the order corresponds to the order of the
variables in the data object logregdatX.
#call pwGLM:
resultLogSepG <- pwGLM(response=subset(logregdat, select=death),
data=logregdatX,
priorG=prior.table,
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priorMean=priorMeanZero,
priorPrecision=priorlistLOG,
fixedG=FALSE,
sepG=c(1,1,1,2,1,3,2,1,1,1,2,1,1,2),
verbose=TRUE,
Ntrials=Ntrials, # number of trials for binomial
intsep=TRUE,
updateHyper=FALSE,
inla.strat=list(strategy = "simplified.laplace",
int.strategy = "grid", dz=0.8),
)
#The three separate g are stored in object resultLogSepG:
gsep <- resultLogSepG$gQuantiles
3.3 Bayesian analysis of binary longitudinal data
A randomized, double-blinded clinical trial has been conducted to compare a novel oral
treatment A for toenail infections against standard therapy (treatment B). Results from
this study have been published in De Backer et al. (1998). Data are available on http://
onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291467-9876/homepage/50_3.htm.
The data, also described in detail by Molenberghs and Verbeke (2005), include 1908
observations from I=294 patients. Patient i = 1, . . . , I has longitudinal observations yij
at occasions j = 1, . . . , ni with associated timepoints tij. At each visit, patients were
evaluated for the degree of onycholysis. The outcome was rated absent, mild, moderate
or severe onycholysis and was dichotomized to a binary response with either absent or
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mild (yij = 0) or moderate to severe (yij = 1) onycholysis. The first observation was
always at baseline (tij = 0) prior to treatment. The follow-up visits were planned to take
place after 1, 2, 3, 6, 9 and 12 months since the initial visit. The actually observed time
since baseline tij is somewhat varying from patient to patient and is recorded in months.
There are also some missing values, so the dataset is unbalanced.
We present here how the prior weighting for the toenail application can be implemen-
ted with pwGLM. The toenail dataset in its unedited form is available in the R-package
pwGLMinla. There are some data preparation steps necessary before it can be used: r-
inla and pwGLM.
#load data
data(toe)
# Data preparation
#rename treatment:
toe$trt <- toe$Treatment
#rename time variable:
toe$time <- toe$Month
#create time:Treatment interaction variable:
toe$timetrt <- toe$time
toe$timetrt[toe$Treatment==0] <- 0
toe$timectrt <- toe$timec
toe$timectrt[toe$Treatment==0] <- 0
#remove 5 patient-id with only one obs:
idrm <- as.numeric(names(which(table(toe$ID)==1)))
#Five patients with ID 45 48 63 99 377 have only on baseline visit.
#These will be removed from the toe-data.
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toe <- toe[-which(toe$ID%in%idrm), ]
#number of observations:
n <- dim(toe)[1]
#replace id-names for toe as r-inla expects seq(1:n) as id-name:
m <- length(unique(toe$ID)) #number of patient-ID's
for(i in 1:m){
idi <- unique(toe$ID)[i]
toe[which(toe$ID==idi), "id1"] <- i
} #end for loop
#remove duplicate variables:
toe <- toe[, -which(names(toe)%in%c("Treatment","Month", "ID")) ]
#Ntrials argument for r-inla stored in a separate object:
Ntrials <- rep(1, nrow(toe))
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Figure 1: Proportion of toenail infections and empirical log odds ratio for treatment A
and B.
The left plot in Figure 1 shows the proportion of patients with a (moderate or severe)
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toenail infection receiving treatment A or B at each of the scheduled follow-up visits.
The right plot shows the empirical log odds ratio of treatment A versus B for a toenail
infection.
A logistic regression model with independent patient-specific random intercepts bi ∼
N(0, σ2b ), i. e. logit(piij) = α + x
>
ij β + bi, is used to describe the probability of infection
piij = Pr(yij = 1). The covariate vector xij = (trti, tij, tij × trti)> includes a binary treat-
ment indicator trti (0 for control treatment B, 1 for new treatment A), time measured in
month (tij), and an interaction term of time and treatment (tij × trti). Note that the main
interest is in this interaction parameter βtime×trt, as treatment differences at baseline,
represented by the main effect βtrt, are expected to be small.
For a Bayesian analysis we follow Fong et al. (2010), who have proposed an inverse
gamma prior for the random intercept variance in logistic regression models: σ2b ∼
IG(0.5, 0.0164). For the regression coefficients β we specify a normal prior distribution
with mean µ and covariance matrix gΣ. The components of µ are zero except for the
effect of time tij in the control group, where we expect an overall drop of infection
prevalence from 0.5 to 0.1 in 12 months. This corresponds to log odds of log(1/9)/12 =
−0.183 per month, so µ = (0,−0.183, 0)>.
The following code defines the prior mean and prior covariances (and precision) for
the fixed effects β:
#Prior mean:
mean.toe <- c(0, log(1/9)/12, 0)
# Correlation between effects:
vec <- c(0,1,2,3,6,9,12)
sel <- length(vec)
- 178 - Paper IV
Supplementary material for"Adaptive prior weighting in generalized regression" 20
x1 <- c(rep(1,sel), rep(0,7))
x2 <- rep(vec, 2)
x3 <- x1*x2
X <- cbind(x1,x2,x3)
my.cor <- cov2cor(t(X)%*%X)
# function Greenland computes the variance of
# normal prior for limits of 95\% CI credible
# interval on OR scale
greenland <- function(lower, upper, level=0.95, scale=1){
z <- qnorm((1+level)/2)
num <- (log(upper)-log(lower))/scale
my.var <- (num/(2*z))^2
return(my.var)
}
# treatment effect at baseline is expected to be
# between 0.9 and 10/9 with prob 95&
v1 <- greenland(0.9, 10/9)
# probability of infection in control group is
# expected to change with not more than 0.9 --> 0.1 (or 0.1 --> 0.9)
# with prob 95% in 12 months
v2 <- greenland(9, 1/9, scale=12)
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# treatment effect is expected to be between 1/4 and 4
# with prob 95% in 12 months
v3 <- greenland(4, 1/4, scale=12)
#Prior covariance matrix:
my.cov <- diag(c(v1,v2,v3))
for(i in 1:2)
for(j in (i+1):3)
my.cov[i,j] <- my.cov[j,i] <-
my.cor[i,j]*sqrt(my.cov[i,i])*sqrt(my.cov[j,j])
#Precision:
my.prec <- solve(my.cov)
The prior variances for β are determined as follows:
• The treatment effect exp(βtrt) at baseline is expected to be close to unity, since the
study was randomized. Specifically, we assume that the effect is between 9/10 and
10/9 with 95% probability, which corresponds to a prior variance of 0.0029 for βtrt.
• If the overall time trend would be zero, then we would expect the variation of the
change of infection prevalence in the control group over the 12 months to be within
the range 0.9→ 0.1 to 0.1→ 0.9 with 95% probability. This leads to a prior variance of
0.0087 for βtime, which we also consider as suitable for a non-zero overall time trend.
• The time-treatment interaction effect exp(βtime×trt) is expected to be between 1/4 and
4 with 95% prior probability after 12 months, which corresponds to a prior variance of
0.0035 for βtime×trt.
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As in the generalized g-prior, the covariances in Σ are determined based on the correla-
tions in X>X (the weight matrix W is the identity matrix here), where the design matrix
X is based on two representative patients with regular visits, one from each treatment
group:
X> =

1 1 1 1 1 1 1 0 0 0 0 0 0 0
0 1 2 3 6 9 12 0 1 2 3 6 9 12
0 1 2 3 6 9 12 0 0 0 0 0 0 0
 .
The resulting prior covariance matrix Σ is shown in Table 1.
treatment time time × treatment
treatment 0.0029
time 0.0027 0.0087
time × treatment 0.0024 0.0039 0.0035
Table 1: Prior covariance matrix for toenail data example.
Besides of using a g-prior on the fixed effects β we also want to implement patient-
specific random intercepts. This can be done in pwGLM by using the argument FormExt
which adds a list of additional latent fields to the r-inla formula. The additional data,
requested by the additional field defined by FormExt, must be handed over to pwGLM by
the argument AddDat.
For the hyperparameters of the additional latent field, which is the variance of the
random intercepts, we follow Fong et al. (2010), who have proposed an inverse gamma
prior, as described in the main text.
#FormExt additional latent field f(...) for random intercepts.
#define inla-formula for additional latent field (called by pwGLMinla):
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FormExttoe <- list(
"f(id1,
model=\"iid\",
hyper=list(theta=list(
prior=\"loggamma\",
fixed=F,
param=c(0.5, 0.0164))))",
"id1")
#define AddDat (data.frame used in FormExt) called by pwGLMinla:
addtoeid <- data.frame(toe$id1)
names(addtoeid) <- c("id1")
Now we can call pwGLM, including additionally the arguments FormExttoe and AddDat:
#call pwGLM:
resultToe <- pwGLM(response=subset(toe, select=Response),
data=subset(toe, select=-Response),
fixedG=FALSE,
initialG=log(1),
priorG=prior.table,
priorMean=mean.toe,
priorPrecision=my.prec,
verbose=TRUE,
FormExt=FormExttoe, #adding random intercepts
- 182 - Paper IV
Supplementary material for"Adaptive prior weighting in generalized regression" 24
AddDat=addtoeid, #patient-id used by FormExt
Ntrials=Ntrials, # number of trials for binomial
intsep=TRUE)
#fixed effect estimates on OR scale:
exp(resultToe$betaMedian)
treatment time time × treatment
Prior 1.00 (0.90 to 1.11) 0.83 (0.69 to 1.00) 1.00 (0.89 to 1.12)
MLE 0.80 (0.40 to 1.59) 0.67 (0.64 to 0.70) 0.87 (0.81 to 0.93)
g = 1 0.93 (0.86 to 1.01) 0.69 (0.66 to 0.73) 0.90 (0.85 to 0.96)
hyper-g 0.92 (0.80 to 1.06) 0.69 (0.65 to 0.73) 0.89 (0.82 to 0.96)
Table 2: Prior, MLEs, and posterior median odds ratios with 95% CI for toenail data
example.
Two models have been fitted with R-INLA, one with fixed g = 1, the other one with
hyper-g prior (shown by the code above and stored as object resultToe). The posterior
of g in the second model indicates no strong prior-data disagreement, with the weight
of the prior reduced by a median factor of gˆ=2.3, but with considerable uncertainty
(95%-CI: 0.67 to 10.1). The posterior odds ratio estimates, shown in Table 2, are therefore
not very different with or without adaptive prior weighting. The ML estimates, obtained
from an analysis with REML with the R-package lme4, show larger differences compared
to the Bayesian analysis, in particular for the treatment effect βtrt.
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